
        <html>
        <head>
            <style>
                body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
                h3 { color: #333; }
                .question { margin-bottom: 15px; }
                .options { margin-left: 20px; margin-bottom: 10px; }
                .solution { background: #f8f9fa; padding: 10px; border-left: 4px solid #007bff; }
                .credits { text-align: center; margin-top: 20px; font-size: 18px; }
                .rainbow-text { 
                    background: linear-gradient(90deg, red, orange, yellow, green, blue, indigo, violet); 
                    -webkit-background-clip: text; 
                    color: transparent; 
                    font-weight: bold; 
                }
            </style>
        </head>
        <body>
        
            <div class="question">
                <h3>Question No: 1</h3>
                <p><b>Which type of blood cell, when increased, signifies a heightened rate of erythropoiesis?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Basophil</li><li>2. Monocyte</li><li>3. Reticulocyte</li><li>4. Lymphocyte</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li>Erythropoiesis is the physiological process through which red blood cells (RBCs) are produced in the bone marrow. This process is vital for maintaining adequate levels of oxygen in the bloodstream, as RBCs are responsible for transporting oxygen from the lungs to tissues throughout the body. An increase in the production of RBCs typically occurs in response to various physiological stimuli, particularly when the body senses that oxygen levels are low or when there is a loss of blood.</li>&#10;</ul><p><strong>Role of Reticulocytes in Erythropoiesis</strong></p><ul>&#10;<li>Reticulocytes are immature red blood cells that are produced during erythropoiesis. They are characterized by the presence of ribosomal RNA, which is gradually lost as these cells mature into fully functional erythrocytes. When the bone marrow increases the production of reticulocytes, it indicates that there is a higher demand for red blood cells.</li>&#10;</ul><ul>&#10;<li><strong>Indicators of Increased Erythropoiesis:</strong></li>&#10;<ul>&#10;<li>An elevated reticulocyte count serves as a key indicator of increased erythropoiesis. This is particularly important in clinical settings; as healthcare providers can measure the reticulocyte count to assess how well the bone marrow is responding to anemia or other conditions that necessitate increased red blood cell production.</li>&#10;<li>A normal reticulocyte count typically ranges from about 0.5% to 2.5% of the total red blood cell count in healthy adults. A count that exceeds this range suggests that the bone marrow is actively producing more red blood cells, thus reflecting an increased rate of erythropoiesis.</li>&#10;</ul>&#10;</ul><p><strong>Comparison with Other Blood Cells</strong></p><p class="MsoListParagraph">&#10;&#10;&#10;&#10;&#10;</p><ul>&#10;<li>While reticulocytes are directly related to the production of red blood cells, the other listed cell types have distinct functions within the immune and circulatory systems:</li>&#10;<li><strong>Basophils:</strong> These are a type of white blood cell involved in inflammatory responses and allergic reactions. They release histamines and other chemicals that contribute to inflammation but do not play a direct role in the production of red blood cells. Their activity is often stimulated by granulocyte colony-stimulating factor, but their increase does not indicate erythropoiesis.</li>&#10;<li><strong>Monocytes:</strong> Monocytes circulate in the blood and can differentiate into macrophages and dendritic cells once they migrate into tissues. They are essential for phagocytosis (the process of engulfing and digesting cellular debris and pathogens) and for presenting antigens to T lymphocytes in the immune response. However, they do not influence erythropoiesis directly.</li>&#10;<li><strong>Lymphocytes:</strong> Lymphocytes are a critical component of the adaptive immune system and include T cells and B cells. They are responsible for orchestrating immune responses and do not have a role in the production or regulation of red blood cells.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 2</h3>
                <p><b>A 51-year-old man presents in the outpatient department due to severe chest pain lasting for the last 16 hours. The patient is a known diabetic and hypertensive. The cardiology resident and the consultant on call discuss the ECG changes and the zero-reference point. The consultant discusses that the zero reference point looks at the heart similarly to lead I. When recording leads on an ECG, the right arm is the negative electrode, and the positive electrode is which one of the following?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Left arm</li><li>2. Left leg</li><li>3. Right leg</li><li>4. Right arm + left leg</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li>By convention, the left arm is the positive&#160;electrode&#160;for the&#160;lead I&#160;of an ECG.</li>&#10;</ul><p><img title="image002.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/ad0f1852-b39e-4a91-9551-bfe917e0a600.png" alt="" width="309" height="256"></p><p><img title="image004.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/4c41d30f-4530-4dc6-aee1-afbb295915d0.png" alt="" width="250" height="234"></p><p><strong>Option B:&#160;Left leg</strong></p><ul>&#10;<li>It is a positive&#160;electrode&#160;for leads 2 and 3.</li>&#10;<li>It is negative for AVL and aVR.</li>&#10;</ul><p><strong>Option C:&#160;Right leg</strong></p><ul>&#10;<li>It has no role in&#160;ECG&#160;electrode&#160;placement.</li>&#10;</ul><p><strong>Option D:&#160;Right arm + left leg</strong></p><ul>&#10;<li>It is the lead 2, having negative on the right arm and positive on the left leg.</li>&#10;</ul><p><strong>Learning objective</strong></p><p><strong><img title="image006.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/2cb26407-f8da-4c5b-b9db-e32a6029b280.png" alt="" width="350" height="244"></strong></p><p><strong>LEADS</strong></p><p>&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;</p><ul>&#10;<li>An&#160;electrode&#160;is a pair of electrodes placed on a specific body position</li>&#10;<li>EINTHOVEN'S ECG:</li>&#10;<li>Creates 3 Bipolar leads by placing 2 electrodes at 2 different points</li>&#10;<li>Bipolar leads measure potential difference b/w 2 points</li>&#10;<li><strong>1<sup>st</sup>bipolar&#160;leads:</strong></li>&#10;<li>Lead I- Right arm negative and left arm positive</li>&#10;<li>Lead III- Left arm negative and left leg positive</li>&#10;<li>Lead II- Right arm negative and left leg positive</li>&#10;<li>These 3 leads create an EINTHOVEN triangle</li>&#10;<li>KIRCHHOFF'S LAW: The sum of all the potential in a closed loop&#160;is zero</li>&#10;<li>I + II +III = 0</li>&#10;<li>Wave of depolarisation towards positive&#160;electrode&#160;gives upward deflection</li>&#10;<li>Wave of depolarisation towards negative&#160;electrode&#160;gives downward deflection</li>&#10;<li>He reversed the&#160;polarity&#160;of Lead II, to get upward deflections</li>&#10;<li>Kirchhoff's Law</li>&#10;<li>I+III + (-II) = 0</li>&#10;<li>II = I + III &#8594; Einthoven Equation.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 3</h3>
                <p><b>Which aspect of normal hemostasis is associated with the functions of protein C, protein S, and plasminogen?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Lysis of clot</li><li>2. Vascular response</li><li>3. Plasma clotting factors</li><li>4. Platelet plug formation</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p><strong>Option a. Lysis of clot</strong><br>This option is correct because the process of clot lysis, or fibrinolysis, is critical in hemostasis to prevent excessive clotting and restore normal blood flow. Protein C and protein S are natural anticoagulants that play significant roles in regulating blood coagulation.</p>&#10;<ul>&#10;<li><strong>Protein C</strong> is activated by thrombin bound to thrombomodulin, and once activated, it works in conjunction with protein S to inactivate factors Va and VIIIa, leading to reduced thrombin generation and promoting clot lysis.</li>&#10;<li><strong>Plasminogen</strong> is another crucial component that, when activated, transforms into plasmin. Plasmin actively breaks down fibrin clots into smaller fragments known as fibrin degradation products (FDPs), effectively leading to the dissolution of the clot.</li>&#10;</ul>&#10;<p>Thus, the interaction of these proteins is essential for the process of clot lysis, making this option the correct answer.</p>&#10;<p><strong>Option b. Vascular response</strong></p>&#10;<ul>&#10;<li>This option refers to the initial phase of hemostasis, which involves the immediate reaction of blood vessels to injury. When a blood vessel is damaged, the vascular response includes vasoconstriction (narrowing of the blood vessel) to minimize blood loss and the activation of the endothelium, which can lead to the expression of adhesive molecules.</li>&#10;<li>While the vascular response is crucial in the overall hemostatic process, it does not specifically involve protein C, protein S, or plasminogen, and therefore is not the correct answer regarding their function.</li>&#10;</ul>&#10;<p><strong>Option c. Plasma clotting factors</strong></p>&#10;<ul>&#10;<li>Plasma clotting factors are a group of proteins in the blood that play a vital role in the coagulation cascade, leading to clot formation. Examples include factors I (fibrinogen), II (prothrombin), VII, VIII, IX, and X, among others. These factors are produced mainly in the liver and become activated during the clotting process.</li>&#10;<li>While plasma clotting factors are critical for hemostasis, they are not directly related to the functions of protein C, protein S, and plasminogen, which are more associated with the regulation of clot breakdown. Hence, this option is incorrect in the context of the question.</li>&#10;</ul>&#10;<p><strong>Option d. Platelet plug formation</strong></p>&#10;<ul>&#10;<li>This option pertains to the process of primary hemostasis, where platelets adhere to the site of blood vessel injury and aggregate to form a temporary &#34;plug.&#34; This process involves the activation of platelets and the release of various signaling molecules to recruit more platelets to the site of injury.</li>&#10;<li>Although platelet plug formation is an essential aspect of hemostasis, it is distinct from the role of protein C, protein S, and plasminogen, which are more involved in the regulation and breakdown of clots rather than their initial formation. Therefore, this option is also incorrect in relation to the question.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 4</h3>
                <p><b>Which of the following clotting factors deficiency will not affect prothrombin time?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. II</li><li>2. V</li><li>3. VII</li><li>4. VIII</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li>Deficiency of&#160;factor VIII&#160;affects the&#160;intrinsic&#160;pathway&#160;of coagulation, leading to prolonged&#160;activated partial&#160;thromboplastin&#160;time&#160;(aPTT) rather than&#160;prothrombin&#160;time (PT). PT evaluates the&#160;extrinsic&#160;pathway, while&#160;aPTT&#160;evaluates the&#160;intrinsic&#160;pathway.</li>&#10;</ul><p><strong>Incorrect Options:</strong></p><ul>&#10;<li><strong>Option A, B, and C:&#160;</strong>The&#160;deficiency&#160;of factors II (prothrombin), V, VII, and X may prolong the&#160;prothrombin&#160;time.</li>&#10;</ul><p><strong>Learning objective</strong></p><p>&#10;&#10;&#10;&#10;</p><ul>&#10;<li><strong>PT&#160;</strong>test evaluates the&#160;coagulation&#160;factors VII, X, V, II (prothrombin), and I (fibrinogen). Prolonged PT is seen in defects of the&#160;<strong>extrinsic pathway</strong>.</li>&#10;<li>The&#160;<strong>aPTT&#160;</strong>is used to evaluate the&#160;coagulation&#160;factors XII, XI, IX, VIII, X, V, II (prothrombin), and I (fibrinogen). Prolonged&#160;aPTT&#160;is seen in defects of the&#160;<strong>intrinsic pathway</strong>.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 5</h3>
                <p><b>The velocity of conduction is fastest in _____________part of cardiac conduction system.</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Bundle of His</li><li>2. Purkinje fibers</li><li>3. Ventricular muscle</li><li>4. Sino-atrial node</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p>The velocity of conduction in different components of the cardiac conduction system are:</p>&#10;<ul>&#10;<li><strong>Sino-atrial node (SA node): 0.05 m/s</strong></li>&#10;<li><strong>Atrial internodal pathways: 1 m/s</strong></li>&#10;<li>Atrio-ventricular node (AV node): 0.05 m/s</li>&#10;<li><strong>Bundle of His: 1 m/s</strong></li>&#10;<li><strong>Purkinje fibers: 4 m/s</strong></li>&#10;<li>Ventricular muscle fibers: 1 m/s</li>&#10;<li>The velocity of conduction is fastest in the Purkinje fibers (4 m/s) along the cardiac conduction pathway, whereas slowest in SA node and AV node (0.05m/s)</li>&#10;</ul>&#10;<p><strong>Other options: &#160;</strong></p>&#10;<ul>&#10;<li><strong>Options A, C and D:</strong> The velocity of conduction in other components of the cardiac conduction system (in the given options) are mentioned above.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 6</h3>
                <p><b>If a patient with blood type O Rh+ receives AB Rh– blood, what is the expected outcome?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. The patient’s Rh factor will react with the RBCs of the donor blood.</li><li>2. The anti-A and anti-B antibodies in the patient’s blood will hemolyze the donor blood.</li><li>3. The anti-A and anti-B antibodies in the donor blood will hemolyze the patient’s blood.</li><li>4. No adverse reaction is expected because the patient has no antibodies against the donor blood.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><b>Option a. The patient’s Rh factor will react with the RBCs of the donor blood. </b><ul ><li>This statement is incorrect. The Rh factor refers to the presence (Rh+) or absence (Rh−) of the Rh antigen on red blood cells. In this scenario, the patient has Rh+ blood, which means their blood contains the Rh antigen. The donor blood (AB Rh−) does not have the Rh antigen, so there would be no reaction based on the Rh factor. The adverse reaction arises primarily from the A and B antigens present in the donor blood and the corresponding antibodies in the recipient’s blood.</li></ul><b>Option b. The anti-A and anti-B antibodies in the patient’s blood will hemolyze the donor blood.</b><ul ><li>This is the correct answer. Individuals with type O blood do not have A or B antigens on their red blood cells but possess anti-A and anti-B antibodies in their plasma. When type AB blood, which has both A and B antigens, is transfused into a type O patient, the anti-A and anti-B antibodies in the recipient’s blood will target and attack the A and B antigens on the donor red blood cells, leading to hemolysis (destruction of the red blood cells). This is a severe transfusion reaction.</li></ul><b> Option c. The anti-A and anti-B antibodies in the donor blood will hemolyze the patient’s blood. </b><ul ><li>This statement is false. Type AB blood does not contain anti-A or anti-B antibodies; rather, it has A and B antigens. Therefore, there would be no anti-A or anti-B antibodies in the donor blood to react against the patient’s blood. Instead, the potential for hemolysis arises from the recipient’s antibodies reacting to the donor’s A and B antigens.</li></ul><b> Option d. No adverse reaction is expected because the patient has no antibodies against the donor blood. </b><ul ><li>This statement is incorrect. The patient with type O blood has significant antibodies against both A and B antigens. Thus, an adverse reaction is expected when AB blood is given because of these pre-existing antibodies. The presence of these antibodies in the patient’s plasma means that transfusing AB blood will provoke a hemolytic reaction, rather than an absence of adverse reactions.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 7</h3>
                <p><b>If the radius of a vessel is doubled, then the blood flow is increased by_______________.</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 8 times</li><li>2. 16 times</li><li>3. 32 times</li><li>4. 256 times</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li>According to the Hagen-Poiseuille equation, the blood flow through a vessel is directly proportional to the fourth power of the vessel radius. Therefore, if the radius of a vessel is doubled, the blood flow through the vessel is increased by 2<sup>4</sup> or 16 times.</li>&#10;</ul><p><strong>Hagen-Poiseuille equation:</strong></p><ul>&#10;<li>It describes the relationship between blood flow, pressure, resistance, and the characteristics of the blood vessel. It is given by the equation:</li>&#10;</ul><p>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Q = &#960;r<sup>4</sup>&#916;P / 8&#951;L</p><p>&#10;&#10;&#10;&#10;</p><ul>&#10;<li>Where Q is the blood flow rate, r is the radius of the blood vessel, &#916;P is the pressure difference between the two ends of the vessel, &#951; is the viscosity of the blood, and L is the length of the blood vessel.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 8</h3>
                <p><b>Which of the following is the effect of dopamine in low concentration?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <font face="Arial">+</font>ve inotropy</li><li>2. <font face="Arial">-</font>ve inotropy</li><li>3. +Ve lusitropy</li><li>4. -Ve lusitropy</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Intermediate doses result in the activation of myocardial β1 receptors, with positive inotropic effects. </li><li>Dopamine usually increases the systolic blood pressure and heart rate, with no or minor changes in diastolic pressure and peripheral vascular resistance.</li></ul><b> Clinical points: </b><ul ><li>At low concentrations, dopamine increases the heart rate by enhancing the pacemaker activity of the SA node. </li><li>This effect is mediated by an increase in cAMP levels, which leads to the activation of the funny current (If) and the hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in the SA node cells. </li><li>“Ionotropy” refers to the strength of the heart’s contraction, which is determined by the force and velocity of the contraction. </li><li>“Lusitropy,” on the other hand, refers to the rate of relaxation of the heart muscle.</li><li>A substance or condition that increases the strength of the heart’s contraction is said to have a positive inotropic effect (+ inotropy),</li></ul><b>Other options:</b><ul ><li><b>Option B:</b> While one that decreases the strength of the contraction is said to have a negative inotropic effect (- inotropy).</li><li><b>Option C:</b> A substance or condition that increases the rate of relaxation is said to have a positive lusitropic effect (+ lusitropy).</li><li><b>Option D:</b> Condition which decreases the rate of relaxation is said to have a negative lusitropic effect (- lusitropy).</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 9</h3>
                <p><b>Which of the following vessels doesn’t run in coronary sulcus?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Right coronary artery</li><li>2. Small cardiac vein</li><li>3. Circumflex branch of the left coronary artery</li><li>4. Anterior interventricular artery</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>The atria and ventricles are divided by the coronary sulcus, which encircle the heart. It contains:<ul ><li>Right coronary artery</li><li>Small cardiac vein</li><li>Circumflex branch of the left coronary artery</li><li>Coronary sinus </li></ul><p>Anterior interventricular artery passes through the anterior interventricular sulcus, not the coronary sulcus. <p></li></ul><b>Other options:</b><ul ><li</li><li><b>Option A:</b> The right coronary artery runs in the coronary sulcus, which is a groove that separates the atria from the ventricles on the surface of the heart.</li><li><b>Option B:</b> The small cardiac vein, also known as the right marginal vein, runs in the coronary sulcus alongside the right coronary artery.</li><li><b>Option C:</b> The circumflex branch of the left coronary artery runs in the coronary sulcus along the left side of the heart.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 10</h3>
                <p><b>Which one of the following mechanisms is seen in the baroreceptor reflex?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Feedforward</li><li>2. Negative feedback</li><li>3. Positive feedback</li><li>4. Adaptive control regulation</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The baroreceptor reflex is a physiological mechanism that helps to regulate blood pressure in response to changes in blood volume and pressure. </li><li>The reflex is initiated by specialized pressure sensors called baroreceptors, which are located in the walls of certain blood vessels and the heart.</li><li>Negative feedback mechanisms involve the response of a system to counteract or oppose a change in a regulated variable. </li><li>In the case of the baroreceptor reflex, a decrease in blood pressure or volume triggers an increase in sympathetic nervous system activity and a decrease in parasympathetic activity, leading to increased heart rate and vasoconstriction. This response helps to increase blood pressure and maintain homeostasis.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> Feedforward mechanisms involve the anticipatory control of a system in response to a known or expected stimulus.</li><li><b>Option C:</b> Positive feedback mechanisms involve the amplification of a change in a regulated variable, leading to a cascade of further changes.</li><li><b>Option D:</b> Adaptive control mechanisms involve the gradual adjustment of a system over time in response to changing conditions.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 11</h3>
                <p><b>A patient present with a heart rate of 45 beats per minute. This condition is known as:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Tachycardia</li><li>2. Bradycardia</li><li>3. Palpitations</li><li>4. Fibrillation</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Bradycardia is a medical term used to describe a slower than normal heart rate, typically defined as a heart rate less than 60 beats per minute in adults. A heart rate of 45 beats per minute falls into the bradycardia range.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> It is when heart rate exceeds the typical resting rate, which is usually considered to be above 100 beats per minute in adults.</li><li><b>Option C:</b> Palpitations refer to the sensation of a rapid, fluttering, or pounding heartbeat. It can be a symptom of various heart rhythm abnormalities</li><li><b>Option D:</b> Fibrillation refers to rapid and irregular contractions of the heart muscles, particularly the atria or ventricles.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 12</h3>
                <p><b>The opening of the right atrium into the right ventricle is guarded by which of the following valves?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Aortic semilunar valve</li><li>2. Bicuspid valve</li><li>3. Mitral valve</li><li>4. Tricuspid valve</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The tricuspid valve is located between the right atrium and the right ventricle. It consists of three cusps or leaflets and prevents the backflow of blood from the right ventricle into the right atrium when the ventricle contracts.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> The aortic semilunar valve is located between the left ventricle and the aorta. It prevents the backflow of blood from the aorta into the left ventricle when the ventricle relaxes.</li><li><b>Option B:</b> The bicuspid valve, also known as the mitral valve, is located between the left atrium and the left ventricle. It consists of two cusps or leaflets and prevents the backflow of blood from the left ventricle into the left atrium when the ventricle contracts.</li><li><b>Option C:</b> The mitral valve is another name for the bicuspid valve, which is located on the left side of the heart between the left atrium and the left ventricle.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 13</h3>
                <p><b>Which part of the cardiac conduction system receives dual blood supply from both atrioventricular nodal arteries?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. SA node</li><li>2. Bundle of His</li><li>3. AV node</li><li>4. Purkinje fibers</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The AV (atrioventricular) node is the part of the cardiac conduction system that receives dual blood supply from both the right and left atrioventricular nodal arteries.</li><li>This dual blood supply is essential for the AV node’s function, as it ensures adequate oxygen and nutrient delivery to this critical component of the conduction system.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> Receives blood supply primarily from the right coronary artery and occasionally from the left circumflex artery but not from the atrioventricular nodal arteries.</li><li>Option B and D: Blood supply from the septal perforating branches of the anterior and posterior interventricular arteries. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 14</h3>
                <p><b>What is the primary reason for the spontaneous depolarization of SA node cells?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Activation of fast Na<sup>+</sup> channels</li><li>2. High resting potential</li><li>3. Leakage of calcium ions</li><li>4. Fluctuating Na+ ion permeability</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoListParagraphCxSpFirst"><span lang="EN-US">&#183;<span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#10;</span></span><span lang="EN-US">The&#10;primary reason for the spontaneous depolarization of SA (sinoatrial) node&#10;cells, which allows them to act as the heart's natural pacemaker, is the&#10;leakage of calcium ions (Ca<sup>2+</sup>) into the cells.</span></p><p class="MsoListParagraphCxSpLast"><span lang="EN-US">&#183;<span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#10;</span></span><span lang="EN-US">Unlike&#10;typical cardiac cells, SA node cells have a unique combination of ion channels&#10;that allow for a slow inward current of calcium ions during the diastolic&#10;phase, leading to the gradual depolarization and initiation of the next action&#10;potential.</span></p><p class="MsoNormal"><b><span lang="EN-US">Other Options:</span></b></p><p>&#10;&#10;&#10;&#10;&#10;&#10;<b><span lang="EN-US">Option B:</span></b><span lang="EN-US"> A high resting&#10;potential in SA node cells contributes to their ability to spontaneously depolarize,&#10;but it is not the primary reason.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 15</h3>
                <p><b>In a clinical setting, a patient’s irregular heart rhythm suggests dysfunction in the heart’s pacemaker cells. Which ion channel is important primarily for the pacemaker activity in the SA node?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Potassium channels</li><li>2. Fast sodium channels</li><li>3. Slow calcium channels</li><li>4. Chloride channels.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>In the SA node, potassium (K+) channels play a crucial role in pacemaker activity. Specifically, during the repolarization phase of the action potential, potassium channels open, allowing potassium ions to flow out of the cell, which helps restore the cell’s negative membrane potential and contributes to the diastolic depolarization phase that leads to the next action potential. </li><li>Dysfunction in these potassium channels can lead to irregularities in pacemaker activity.</li></ul><b>Other options:</b><ul ><li><b>Option B:</b> They are primarily involved in the rapid depolarization phase of action potential in cardiac cells.</li><li><b>Option C:</b> Slow calcium (Ca2+) channels are indeed crucial for the pacemaker activity in the SA node. These channels allow a slow inward current of calcium ions during the diastolic phase, leading to the gradual depolarization and initiation of the next action potential. However, potassium channels are more directly associated with pacemaker activity.</li><li><b>Option D:</b> They are not primarily responsible.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 16</h3>
                <p><b>During an admission assessment, the nurse observes that the patient has xanthomas present on both eyelids. Based on this finding, which laboratory value should be checked by the nurse?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Triglyceride level</li><li>2. Homocysteine level</li><li>3. Cardiac enzymes—CPK-MB, troponin, and myoglobin</li><li>4. Cholesterol panel</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Option (d) is the correct choice because xanthomas, which are yellowish cholesterol deposits that can appear on the skin, often indicate elevated cholesterol levels in the blood. These deposits are a sign of underlying lipid metabolism disorders, particularly high levels of cholesterol.</li><li><b>Option (a)</b>, the triglyceride level, measures the amount of fat in the bloodstream but does not specifically relate to the presence of xanthomas. While triglyceride levels can be elevated in certain conditions, xanthomas are more closely associated with cholesterol.</li><li><b>Option (b)</b>, the homocysteine level, is relevant as elevated levels are considered an independent risk factor for atherosclerosis and cardiovascular disease, but it is not directly related to the presence of xanthomas.</li><li><b>Option (c)</b>, cardiac enzymes such as CPK-MB, troponin, and myoglobin, are used to assess for myocardial infarction (MI) and would not provide information related to xanthomas or lipid levels.In summary, given the presence of xanthomas, the nurse should focus on checking the cholesterol panel to evaluate the client’s lipid levels and assess any potential risk factors for cardiovascular disease.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 17</h3>
                <p><b>Which class of medications is most likely to increase the risk of digitalis toxicity in a patient?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Salicylate analgesics</li><li>2. Tetracycline antibiotics</li><li>3. Diuretics</li><li>4. Barbiturates</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option (c) is correct because many diuretics lead to increased excretion of potassium from the body. This can result in hypokalemia (low potassium levels), which significantly heightens the risk of digitalis (digoxin) toxicity. Digoxin has a narrow therapeutic window, meaning that the difference between a therapeutic dose and a toxic dose is small. When potassium levels are low, the heart’s sensitivity to digoxin increases, which can lead to toxicity even at normal doses.</li><li>Patients on diuretics need to be monitored closely for potassium levels, especially if they are also prescribed digoxin. Hypokalemia can cause symptoms such as cardiac arrhythmias, which can be exacerbated by digoxin.</li><li>The other options do not contribute to an increased risk of digoxin toxicity:</li><li><b>Option (a)</b>, salicylate analgesics, are primarily used for pain relief and do not have a known interaction that increases digoxin toxicity.</li><li><b>Option (b)</b>, tetracycline antibiotics, are used to treat bacterial infections and do not affect potassium levels or increase the risk of digoxin toxicity.</li><li><b>Option (d)</b>, barbiturates, are sedative medications that primarily affect the central nervous system and do not have a direct link to increased digoxin toxicity.</li></ul><p>In summary, diuretics are the class of medications most likely to increase the risk of digitalis toxicity due to their effect on potassium levels. Healthcare providers must ensure proper monitoring and management of electrolytes in patients receiving both diuretics and digoxin to prevent toxicity and associated complications.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 18</h3>
                <p><b>A 64-year-old woman visits the outpatient department due to swelling in her lower extremities, an issue she has never experienced before. She denies having any shortness of breath, cough, or palpitations. Her existing medical conditions comprise hypertension, type 2 diabetes mellitus, and chronic bronchitis. She smokes 1.5 packs of cigarettes daily but does not consume alcohol or illicit drugs. She carries a shopping bag filled with medications, including various antihypertensive and antidiabetic drugs, but is unsure about which ones she is currently taking. Her blood pressure registers at 142/92 mmHg, and her pulse is 66/min. Physical examination reveals even swelling in her lower extremities but is otherwise unremarkable. What is the most likely potential cause of this patient’s condition?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Enalapril</li><li>2. Glyburide</li><li>3. Amlodipine</li><li>4. Ipratropium</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li>Peripheral edema is a commonly observed side effect linked with calcium channel blocker (CCB) treatment, with an approximate incidence of 25% after six months of therapy.&#160;</li>&#10;<li>This edema is likely due to the selective dilation of precapillary vessels (arteriolar dilation), resulting in elevated capillary hydrostatic pressure and the leakage of fluid into the interstitium.&#160;</li>&#10;<li>Dihydropyridine (DHP) CCBs such as amlodipine and nifedipine are potent arteriolar dilators and tend to induce more peripheral edema compared to non-DHP CCBs like diltiazem and verapamil.&#160;</li>&#10;<li>Other significant side effects associated with DHP CCBs include headache, flushing, and dizziness.</li>&#10;<li>Renin-angiotensin system blockers, such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers, prompt post-capillary venodilation and can help normalize the increased capillary hydrostatic pressure.&#160;</li>&#10;<li>Clinical studies have shown that the combination of CCBs with ACE inhibitors was linked to a notably reduced risk of peripheral edema in comparison to CCB monotherapy.</li>&#10;</ul><p><strong>Other Options:</strong></p><p><strong>Option A:</strong></p><ul>&#10;<li>Approximately 0.1%&#8211;0.7% of patients treated with ACE inhibitors (e.g., Enalapril) may experience angioedema.&#160;</li>&#10;<li>This condition typically results in non-pitting swelling of the subcutaneous or submucosal tissue and primarily affects areas such as the lips, tongue, face, and upper airway.&#160;</li>&#10;<li>It's important to note that ACE inhibitors do not induce peripheral or dependent edema.</li>&#10;</ul><p><strong>Option B:</strong></p><ul>&#10;<li>Glyburide can cause dermatologic side effects including photosensitivity reactions, maculopapular eruptions, purpura, or urticaria.&#160;&#160;</li>&#10;<li>It is not associated with peripheral edema.</li>&#10;</ul><p><strong>Option D:</strong></p><p>&#10;&#10;&#10;&#10;&#10;&#10;&#10;</p><ul>&#10;<li>In rare instances, ipratropium may result in angioedema, but it does not induce peripheral edema.&#160;</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 19</h3>
                <p><b>A nurse is caring for a patient receiving digoxin. Which of the following symptoms should alert the nurse to possible digoxin toxicity?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Hyperkalemia</li><li>2. Increased hunger</li><li>3. Constipation</li><li>4. Visual disturbances</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p>Option (d) is the correct choice because visual disturbances are a well-known indicator of digoxin toxicity. Patients experiencing digoxin toxicity may report symptoms such as blurred vision, double vision (diplopia), or changes in color perception, which are linked to the medication's effects on the visual pathways in the brain. These symptoms warrant immediate attention, as they can signify that the digoxin levels in the body are too high, potentially leading to serious complications.</p>&#10;<p>In addition to visual disturbances, other signs of digoxin toxicity include:</p>&#10;<ul>&#10;<li><strong>Fatigue:</strong> Patients may feel unusually tired or weak.</li>&#10;<li><strong>Loss of appetite:</strong> A decrease in appetite or aversion to food can occur.</li>&#10;<li><strong>Nausea and vomiting:</strong> Gastrointestinal symptoms such as nausea may manifest.</li>&#10;<li><strong>Confusion:</strong> Changes in mental status, including confusion or disorientation, can also be present.</li>&#10;<li><strong>Bradycardia:</strong> A slow heart rate (bradycardia) is a critical sign of digoxin toxicity and may lead to more severe cardiac complications if not addressed promptly.</li>&#10;</ul>&#10;<p>The other options are not typically associated with digoxin toxicity:</p>&#10;<ul>&#10;<li><strong>Option (a)</strong>, hyperkalemia (elevated potassium levels), is actually more of a concern when considering the interactions of digoxin with certain diuretics and other medications. While low potassium levels (hypokalemia) increase the risk of digoxin toxicity, hyperkalemia itself is not a direct symptom of toxicity.</li>&#10;<li><strong>Option (b)</strong>, increased hunger, is not relevant to digoxin toxicity and is not commonly associated with the use of this medication.</li>&#10;<li><strong>Option (c)</strong>, constipation, can occur in patients taking various medications, including some diuretics or opioids, but it is not a recognized symptom of digoxin toxicity.</li>&#10;</ul>&#10;<p>In conclusion, awareness of the signs and symptoms of digoxin toxicity, particularly visual disturbances, is crucial for nurses to ensure prompt intervention and management of the patient's condition. Monitoring for these symptoms helps maintain patient safety and the effectiveness of digoxin therapy.</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 20</h3>
                <p><b>A pregnant patient was diagnosed to have hypertension for the first time at 22 weeks of gestation. She was prescribed methyldopa for management of the same. Which of the following is the correct mechanism of action of the drug?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Alpha 1 agonist effect</li><li>2. Alpha 2 agonist effect</li><li>3. Alpha 1 antagonistic effect</li><li>4. Beta 2 agonist effect</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li>Methyldopa acts as an alpha-2 agonist. It stimulates alpha-2 receptors which are autoreceptors. Therefore, these act as sympathomimetic drugs having sympatholytic activity.</li>&#10;<li>Methyldopa acts as an antihypertensive (due to vasodilatory properties) and is safe to be used in pregnancy. It causes hemolysis as a side effect.</li>&#10;</ul><p>Examples of alpha-2 agonists: -</p><ul>&#10;<li>Clonidine</li>&#10;<li>Apraclonidine</li>&#10;<li>Brimonidine</li>&#10;<li>Lofexidine</li>&#10;<li>Tizanidine</li>&#10;<li>Dexmedetomidine</li>&#10;<li>Methyldopa</li>&#10;<li>Guanabenz</li>&#10;<li>Guanfacine</li>&#10;</ul><p><strong>Other options:</strong></p><p>&#10;&#10;&#10;&#10;</p><ul>&#10;<li><strong>Option A:</strong> Alpha-1 agonists stimulate alpha-1 receptors located on blood vessels, radial muscles of the eye, prostatic urethra and liver. They have predominant vasoconstrictor activity. Ex: Phenylephrine, xylometazoline, oxymetazoline, midodrine, mephentermine, methoxamine.</li>&#10;<li><strong>Option C:</strong> Alpha-1 antagonists inhibit alpha-1 receptors located on blood vessels, radial muscles of the eye, prostatic urethra and liver. They have sympatholytic activity. Ex: Prazosin, terazosin, doxazosin.</li>&#10;<li><strong>Option D:</strong> Beta-2 agonists stimulate beta-2 receptors. These cause relaxations of smooth muscles and contraction of skeletal muscles and cardiac muscles. Ex: Salbutamol, salmeterol, formoterol, indacaterol.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 21</h3>
                <p><b>A patient visits the clinic with complaints of unexplained bruising and blood-tinged urine. Which type of medication is most important to ask if the patient is taking?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Antibiotic</li><li>2. Antipruritic</li><li>3. Antianemic</li><li>4. Anticoagulant</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option (d) is the correct choice because anticoagulant medications, such as warfarin, heparin, and others, are known to increase the risk of bleeding. One of the common side effects of these medications is abnormal bleeding, which can manifest in various ways, including easy bruising and hematuria (blood-tinged urine). The presence of these symptoms raises the suspicion that the patient may be experiencing side effects related to anticoagulation therapy, potentially indicating a need for dosage adjustment or further evaluation to prevent serious complications.</li><li>Unexplained bruising may occur due to the inhibition of clotting factors, which impairs the body’s ability to form blood clots effectively. Blood-tinged urine can result from bleeding in the urinary tract, which may occur as a consequence of anticoagulant therapy. Given these potential risks, it is crucial for the nurse or healthcare provider to inquire specifically about the patient’s use of anticoagulants.</li><li>In contrast, the other options do not typically relate to the symptoms presented by the patient:</li><li><b>Option (a)</b>, antibiotics, are primarily used to treat infections and are not commonly associated with bleeding or bruising unless the patient has an adverse reaction or specific condition that predisposes them to bleeding.</li><li><b>Option (b)</b>, antipruritics, are medications used to relieve itching and do not have a known association with bruising or blood in the urine.</li><li><b>Option (c)</b>, antianemics, which are used to treat anemia, may sometimes lead to gastrointestinal bleeding if they contain iron, but they are not commonly linked with easy bruising or hematuria. </li></ul><p>In summary, when a patient presents with unexplained bruising and blood-tinged urine, asking about the use of anticoagulant medications is crucial for determining the underlying cause of these symptoms and for guiding appropriate management and intervention.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 22</h3>
                <p><b>A physician has prescribed an antihypertensive medication for a patient. As a nurse, which instruction should be given to the patient?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Limit fluid intake to 1200 mL daily.</li><li>2. Increase activity levels but avoid foods high in magnesium.</li><li>3. Take a laxative along with the antihypertensive medication.</li><li>4. Change positions slowly and sit up for a few minutes before standing from a lying position.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option (d) is the correct choice because many antihypertensive medications can lead to orthostatic hypotension, a condition characterized by a significant drop in blood pressure upon standing. This phenomenon occurs when blood vessels do not constrict properly to maintain blood flow to the brain as the patient changes position from lying down to standing up. As a result, patients may experience dizziness, light headedness, or even fainting.</li><li>By advising patients to change positions slowly and take a moment to sit up before standing, the nurse helps reduce the risk of these adverse effects. This precaution allows the body to adjust gradually to the change in position and helps maintain adequate blood pressure, minimizing the risk of injury from falls. </li></ul><p>In contrast, the other options are not appropriate instructions regarding the management of antihypertensive medication: </li></ul> <ul ><li><b>Option (a)</b> suggests limiting fluid intake to 1200 mL daily. While fluid management may be important in certain clinical situations (such as heart failure), it is not a standard recommendation for patients taking antihypertensive medications unless specifically directed by a healthcare provider. Adequate hydration is often encouraged to support overall health.</li><li><b>Option (b)</b> states that patients should increase their activity levels but avoid foods high in magnesium. This recommendation is not directly related to antihypertensive medications. In fact, magnesium is important for cardiovascular health, and patients should not avoid magnesium-rich foods unless contraindicated for other medical reasons.</li><li><b>Option (c)</b> advises taking a laxative alongside the antihypertensive medication. This is not relevant to antihypertensive therapy. While constipation can be a side effect of some medications, it is not a typical concern with antihypertensive agents, and a laxative should only be used when necessary and as directed by a healthcare provider.In summary, educating patients on the potential for orthostatic hypotension when taking antihypertensive medications is vital for their safety. This knowledge helps patients manage their treatment effectively and reduces the risk of complications associated with sudden changes in blood pressure.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 23</h3>
                <p><b>The following ECG shows a characteristic finding of a clinical condition. Which of the following drugs acting on the cardiovascular system is contraindicated in this condition?</b><p><img src="data:image/jpeg;base64,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"><b></b></p></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Verapamil</li><li>2. Digoxine</li><li>3. Metoprolol</li><li>4. All of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The given ECG shows a delta wave, characteristic of <b>Wolff Parkinson White syndrome.</b> In this condition, an accessory electrical pathway called ‘bundle of Kent’ is present in between the atria and the ventricles. This accessory electrical pathway causes atrial signals to travel faster to the ventricle bypassing the delayed conduction through the AV node.</li><li>AV nodal blocking agents further enhance the transmission of signals through the accessory pathway and thus aggravate the arrhythmia.</li><li>Further, they enhance chances of re-entry by blocking the AV nodal pathway and stimulating conduction through the accessory pathway.</li></ul><b>Other options:</b><ul ><li>List of AV nodal blocking agents:</li><li>Calcium channel blockers like verapamil, diltiazem</li><li>Beta blockers like metoprolol, propranolol, esmolol</li><li>Digoxin</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 24</h3>
                <p><b>Patient education is a crucial aspect of nursing care. When educating a patient taking captopril, which common adverse effect of angiotensin-converting enzyme (ACE) inhibitors should be discussed?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Persistent cough</li><li>2. Increased appetite</li><li>3. Hypertension</li><li>4. Sedation</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option (a) is the correct choice because a persistent cough is a well-documented and common adverse effect associated with angiotensin-converting enzyme (ACE) inhibitors, including captopril. This side effect occurs in a significant number of patients and can be bothersome enough to lead some to discontinue the medication. The cough is thought to result from the accumulation of bradykinin, a substance that is normally broken down by angiotensin-converting enzyme. When the enzyme is inhibited by medications like captopril, bradykinin levels can rise, leading to irritation of the respiratory tract and a resultant cough. </li></ul><p>Conversely, the other options do not accurately represent typical adverse effects of ACE inhibitors:<ul ><li><b>Option (b)</b>, increased appetite, is not a recognized side effect of captopril or other ACE inhibitors. Patients may experience changes in appetite for various reasons, but this is not specifically linked to this class of medication.</li><li><b>Option (c)</b> is incorrect because ACE inhibitors like captopril are primarily used to treat hypertension, and their goal is to lower blood pressure rather than increase it. They are effective in managing high blood pressure and can also provide benefits for heart failure and kidney protection.</li><li><b>Option (d)</b>, sedation, is also not a typical side effect of ACE inhibitors. While some medications can cause sedation, ACE inhibitors are generally well-tolerated and do not commonly affect the central nervous system in this manner.</li></ul><p>In summary, when educating patients about captopril and other ACE inhibitors, it is essential to inform them about the potential for a persistent cough as an adverse effect. This knowledge empowers patients to recognize side effects and communicate effectively with their healthcare providers, ensuring better management of their treatment.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 25</h3>
                <p><b>A patient has been prescribed both heparin and warfarin. When administering these anticoagulants together, what rationale should the nurse consider?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. It takes 12–24 hours for oral anticoagulants to take effect.</li><li>2. Heparin is more effective when combined with warfarin.</li><li>3. Administering an oral anticoagulant with heparin reduces the need for frequent heparin doses.</li><li>4. The patient is less likely to experience adverse effects.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option (a) is correct because oral anticoagulants, such as warfarin, typically take 12 to 24 hours to exhibit their therapeutic effects after administration. This delay occurs because warfarin works by inhibiting vitamin K-dependent clotting factors, which are produced in the liver and require time to deplete. Consequently, patients often receive heparin, which acts immediately as an anticoagulant, to provide short-term protection against thromboembolic events while waiting for warfarin to reach its effective therapeutic levels.</li><li>Once the warfarin reaches the desired INR (International Normalized Ratio) range, the heparin can be gradually discontinued. This protocol ensures continuous anticoagulation during the transitional period, as patients at risk for thrombus formation require immediate intervention that oral anticoagulants alone cannot provide.The other options are not accurate in describing the rationale for using both medications together:</li><li><b>Option (b)</b> is misleading; while heparin and warfarin can be used concurrently, it does not imply that heparin is inherently more effective when combined with warfarin. Each medication has its own indications and mechanisms of action, and they are used together primarily to bridge therapy until warfarin is effective.</li><li><b>Option (c)</b> incorrectly suggests that using warfarin allows for a reduction in the frequency of heparin doses. In practice, patients often continue to receive heparin at regular intervals until the INR indicates that warfarin is therapeutic, rather than reducing the frequency of heparin administration.</li><li><b>Option (d)</b> inaccurately states that the patient is less likely to experience adverse effects when taking both medications together. Both heparin and warfarin have their own risk profiles for adverse effects, including bleeding complications, and their concurrent use may increase the risk of such events.</li></ul><p>In summary, understanding the pharmacokinetics of anticoagulants is crucial for safe and effective patient management, especially in situations where overlapping therapy is required.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 26</h3>
                <p><b>Drug of choice for the treatment of digoxin induced ventricular arrhythmias is?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Atropine</li><li>2. Lidocaine</li><li>3. Amiodarone</li><li>4. Procainamide</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The drug of choice for the treatment of digoxin-induced ventricular arrhythmias is Lidocaine.Lidocaine: </li><li>Lidocaine is a class 1B antiarrhythmic agent that works by blocking sodium channels in cardiac tissues.</li><li>By doing so, it reduces the rate of depolarization and conduction velocity, which can help suppress abnormal electrical activity in the heart and restore normal rhythm.</li><li>In the case of digoxin-induced ventricular arrhythmias, lidocaine can be used to treat ventricular tachycardia and other arrhythmias that may arise as a result of increased intracellular calcium levels caused by digoxin toxicity. Clinical Note: It is important to note that lidocaine should be used with caution in patients with impaired cardiac function or hepatic dysfunction.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> Atropine is not used to treat ventricular arrhythmias induced by digoxin. Atropine is a medication used to treat bradycardia (slow heart rate) and is not effective for the treatment of ventricular arrhythmias.</li><li><b>Option C:</b> Amiodarone is a medication that can be used to treat certain types of ventricular arrhythmias. However, it is not the drug of choice for digoxin-induced ventricular arrhythmias. Digoxin-induced arrhythmias are typically treated with digoxin immune Fab (also known as digoxin-specific antibody fragments).</li><li><b>Option D:</b> Procainamide is a medication that can be used to treat certain types of ventricular arrhythmias. However, it is not the drug of choice for digoxin-induced ventricular arrhythmias. Digoxin-induced arrhythmias are typically treated with digoxin immune Fab.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 27</h3>
                <p><b>A patient with a thrombus in her left leg has been prescribed Coumadin (warfarin) 7.5 mg orally each day. The patient’s prothrombin time (PT) is 20 and her international normalized ratio (INR) is 2.4. The nurse has 5 mg scored tablets of Coumadin available. What should the nurse plan to do?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Administer ½ tablet because the PT and INR are in a safe range.</li><li>2. Administer one tablet because the PT and INR are in a safe range.</li><li>3. Administer 1 ½ tablets because the PT and INR are in a safe range.</li><li>4. Do not administer Coumadin because the PT and INR are too high.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li>Option (c) is correct because the patient&#8217;s prothrombin time (PT) and international normalized ratio (INR) are within the therapeutic range for someone receiving anticoagulant therapy with warfarin. The therapeutic INR range for most conditions requiring anticoagulation is typically between 2.0 and 3.0. The patient's INR of 2.4 indicates that she is at an appropriate level of anticoagulation, meaning the medication is effective without posing an immediate risk of bleeding complications.</li>&#10;<li>To calculate the appropriate dose of Coumadin to administer, the nurse needs to determine how many 5 mg tablets are required to achieve the prescribed dose of 7.5 mg:</li>&#10;<li>The available tablet strength is 5 mg. To find out how many tablets to administer, the calculation is as follows:</li>&#10;</ul><p>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 7.5&#8201;mg = 5&#8201;mg&#8201;per&#160;tablet &#215; X&#8201;tablets</p><p>This can be rearranged to solve for xxx:</p><p>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 5X=7.5</p><p>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; X = 7.5/ 5=1.55</p><p><br></p><p>Thus, the nurse should administer 1 &#189; tablets to provide the patient with the correct dose of 7.5 mg.</p><p><br></p><p>The other options are not appropriate based on the patient's current PT and INR levels:</p><ul>&#10;<li><strong>Option (a)</strong>, administering &#189; tablet, would only provide 2.5 mg, which is insufficient for the prescribed dose.</li>&#10;<li><strong>Option (b)</strong>, administering one tablet, would give 5 mg, which is also less than the required dose.</li>&#10;<li><strong>Option (d)</strong>, not administering Coumadin due to PT and INR being too high, is incorrect since the values are actually within a safe range for anticoagulation therapy.</li>&#10;</ul><p>&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;</p><p>In summary, the nurse should plan to administer 1 &#189; tablets of Coumadin to achieve the therapeutic dose while ensuring the patient's INR remains within the desired range, thus providing effective anticoagulation and minimizing the risk of complications.</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 28</h3>
                <p><b>The physician has prescribed nitroglycerin (Nitro Bid) 0.4 mg to be taken sublingually (SL) immediately. Which action would show that the nurse administered this medication correctly?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Placing the tablet under the patient’s tongue and instructing them to allow it to dissolve.</li><li>2. Giving the tablet to the client with 8 oz of water after checking blood pressure and heart rate.</li><li>3. Providing the tablet with 4 oz of juice to help mask the bitter taste.</li><li>4. Placing the tablet under the client’s tongue and instructing them to chew slowly to enhance absorption.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option (a) is the correct method for administering nitroglycerin (Nitro Bid) as it was prescribed to be given sublingually (SL). Sublingual administration is specifically designed for rapid absorption, which is achieved by placing the tablet under the tongue and allowing it to dissolve completely. This technique allows the medication to be absorbed directly into the bloodstream through the mucous membranes under the tongue, which facilitates a quicker therapeutic effect. This rapid action is especially important for nitroglycerin, which is commonly used to relieve acute chest pain (angina) by dilating blood vessels and improving blood flow to the heart.</li></ul><p>The other options are incorrect for sublingual nitroglycerin administration. <ul ><li>Option (b) suggests swallowing the tablet with water, which would mean the drug would pass through the digestive system, delaying its effect and reducing its efficacy in an acute situation. </li><li>Option (c) also involves swallowing the tablet with juice, which could mask the taste but would also prevent the rapid absorption needed to relieve symptoms promptly. </li><li>Option (d) instructs the patient to chew the tablet, which is not appropriate for sublingual medications; chewing could lead to irregular absorption and may reduce the medication’s effectiveness in managing symptoms swiftly. </li></ul><p>Therefore, placing the tablet under the tongue and allowing it to dissolve as per option (a) is essential to achieving the intended therapeutic effect in a timely manner.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 29</h3>
                <p><b>A patient who has been recently diagnosed with hypertension cannot control his blood pressures by lifestyle modifications. It is desired to initiate an ACE inhibitor in this patient. All of the following tests need to be done prior to initiation of drug therapy, except?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Urine pregnancy test</li><li>2. Renal artery Doppler</li><li>3. Serum potassium concentrations</li><li>4. Serum calcium concentrations</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p class="MsoListParagraphCxSpFirst"><span lang="EN-US">&#183;<span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#10;</span></span><span lang="EN-US">ACE&#10;inhibitors act by <b>inhibiting angiotensin&#10;converting enzymes</b>, thereby preventing the conversion of angiotensin 1 to&#10;angiotensin 2. As a result, the RAAS pathway gets blocked, leading to a drop in&#10;the blood pressure values.</span></p><p class="MsoListParagraphCxSpLast"><span lang="EN-US">&#183;<span>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#10;</span></span><span lang="EN-US">Ex:&#10;captopril, Lisinopril, Enalapril, Ramipril.</span></p><p class="MsoNormal"><b><span lang="EN-US">Contraindications of ACE inhibitors:</span></b></p><ul type="disc">&#10; <li class="MsoNormalCxSpMiddle"><b><span lang="EN-US">Pregnancy-</span></b><span lang="EN-US"> ACE inhibitors are teratogenic. They cause neural tube defects in&#10;     the first trimester and can result in Potter's sequence in the second and&#10;     third trimester.</span></li>&#10; <li class="MsoNormalCxSpMiddle"><span lang="EN-US">Bilateral renal artery stenosis and renal&#10;     failure, due to baseline low values of GFR.</span></li>&#10; <li class="MsoNormalCxSpMiddle"><span lang="EN-US">Hyperkalemia, since ACE inhibitors themselves&#10;     cause hyperkalemia.</span></li>&#10;</ul><p class="MsoNormal"><span lang="EN-US">&#160;<b>Side&#10;effects of ACE inhibitors:</b></span></p><ul type="disc">&#10; <li class="MsoNormalCxSpMiddle"><span lang="EN-US">Cough</span></li>&#10; <li class="MsoNormalCxSpMiddle"><span lang="EN-US">Angioedema</span></li>&#10; <li class="MsoNormalCxSpMiddle"><span lang="EN-US">Dysgeusia</span></li>&#10; <li class="MsoNormalCxSpMiddle"><span lang="EN-US">Rash</span></li>&#10; <li class="MsoNormalCxSpMiddle"><span lang="EN-US">Pruritus </span></li>&#10;</ul><p class="MsoNormal"><b><span lang="EN-US">Other options:</span></b></p><p class="MsoNormal"><b><span lang="EN-US">Option A:</span></b><span lang="EN-US">&#160; Urine pregnancy test needs to be&#10;done to rule out pregnancy. ACE inhibitors are teratogenic. They cause neural&#10;tube defects in the first trimester and can result in Potter's sequence in the&#10;second and third trimester.</span></p><p class="MsoNormal"><b><span lang="EN-US">Option B:</span></b><span lang="EN-US"> Renal artery Doppler needs to be done to rule out bilateral renal&#10;artery stenosis. </span></p><p>&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;</p><p class="MsoNormal"><b><span lang="EN-US">Option C:</span></b><span lang="EN-US"> Serum potassium concentrations are checked since ACE inhibitors have a&#10;risk of causing hyperkalemia as a side effect.</span></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 30</h3>
                <p><b>The nurse identifies a need for additional patient education when a client following a low-cholesterol diet for cardiac health, selects the following menu options:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Stewed chicken, green beans, and noodles</li><li>2. Liver and onions, a salad with ranch dressing, and milk</li><li>3. Ham and bean soup, a salad with vinaigrette dressing, and cornbread</li><li>4. Pork roast, brown rice, and beets</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option (b) is the correct choice because liver and other organ meats are high in cholesterol and saturated fats, which can be detrimental to a cardiac low-cholesterol diet. For patients with heart conditions or those trying to lower their cholesterol levels, it is generally advised to limit or avoid foods that are rich in cholesterol, such as organ meats, fatty cuts of meat, and full-fat dairy products.</li><li>A cardiac low-cholesterol diet emphasizes the importance of choosing lean proteins, whole grains, fruits, vegetables, and healthy fats. Here’s a brief overview of the </li></ul><b>Other options:</b><ul ><li><b>Option (a)</b>: Stewed chicken, green beans, and noodles represent a more suitable choice for a low-cholesterol diet. Skinless chicken is a lean protein, and green beans are low in calories and cholesterol-free.</li><li><b>Option (c)</b>: Ham and bean soup, salad with vinaigrette dressing, and cornbread can also be appropriate, provided the ham is lean and the vinaigrette is low in saturated fat. Beans are a good source of protein and fiber, making this a generally healthy option.</li><li><b>Option (d)</b>: Pork roast, brown rice, and beets may be acceptable if the pork is lean. Brown rice and beets are both heart-healthy and low in cholesterol. </li></ul><p>In conclusion, the selection of liver and onions indicates a need for further education regarding dietary restrictions for individuals on a cardiac low-cholesterol diet. It is essential for the client to understand which foods are high in cholesterol and how to make healthier choices to support cardiovascular health.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 31</h3>
                <p><b>Following is a list of ACE inhibitors. Which of them need to be activated in the human body to perform its action?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Captopril</li><li>2. Enalaprilat</li><li>3. Lisinopril</li><li>4. Ramipril</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Ramipril is a prodrug that requires activation in the human body.</li><li>Most of the ACE inhibitors are prodrugs.</li><li>ACE inhibitors act by inhibiting angiotensin converting enzymes, thereby preventing the conversion of angiotensin 1 to angiotensin 2. As a result, the RAAS pathway gets blocked, leading to a drop in the blood pressure values.</li><li>Ex: captopril, Lisinopril, Enalapril, Ramipril.</li></ul><b>Other options:</b><ul ><li>Option A, B and C are: The list of ACE inhibitors that are administered in their active form:</li><li>Captopril (oral formulation)</li><li>Lisinopril (oral formulation)</li><li>Enalaprilat (I/V formulation)</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 32</h3>
                <p><b>The nurse is administering low molecular weight heparin, enoxaparin. Which of the following nursing interventions is incorrect when giving this medication?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Using a TB syringe</li><li>2. Injecting the medication using the Z-track method</li><li>3. Not rubbing the injection site after administration</li><li>4. Administering the medication in the anterolateral abdominal wall</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option (b) is the correct choice as the Z-track method is specifically utilized for intramuscular (IM) injections to prevent the medication from leaking back into the subcutaneous tissue. Enoxaparin, a low molecular weight heparin, is typically administered subcutaneously, which does not require the Z-track technique. Instead, the standard approach involves injecting the medication into the subcutaneous tissue, usually in the anterolateral abdominal wall, to ensure proper absorption and effectiveness.The other options are appropriate nursing interventions for administering enoxaparin.</li><li><b>Option (a)</b>, using a TB syringe, is not typically recommended. A syringe with a larger volume capacity (e.g., 1 mL or 3 mL) is more commonly used for this medication.</li><li><b>Option (c)</b>, not rubbing the injection site after administration, is correct as rubbing can cause irritation and increase the risk of bruising at the injection site.</li><li><b>Option (d)</b>, administering the medication in the anterolateral abdominal wall, is an appropriate site for subcutaneous injections of enoxaparin, as this area allows for better absorption.In summary, while administering enoxaparin, the nurse should avoid using the Z-track method and adhere to the correct protocols for subcutaneous injection.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 33</h3>
                <p><b>Which medication is an inhaled selective prostacyclin receptor agonist indicated for the treatment of PAH?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Sildenafil</li><li>2. Ambrisentan</li><li>3. Iloprost</li><li>4. Tadalafil</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Iloprost is an inhaled selective prostacyclin receptor agonist that is indicated for the treatment of pulmonary arterial hypertension (PAH).</li><li>It is a synthetic analog of prostacyclin (PGI2), a potent vasodilator and inhibitor of platelet aggregation. By binding to prostacyclin receptors on smooth muscle cells of the pulmonary arteries, Iloprost promotes vasodilation and reduces pulmonary artery pressure, improving symptoms and exercise capacity in patients with PAH.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> Sildenafil is a phosphodiesterase-5 (PDE-5) inhibitor, not a prostacyclin receptor agonist. It works by increasing cyclic guanosine monophosphate (cGMP), leading to vasodilation in the pulmonary arteries.</li><li><b>Option B:</b> Ambrisentan is an endothelin receptor antagonist (ERA), not a prostacyclin receptor agonist. It blocks the action of endothelin, a potent vasoconstrictor, leading to vasodilation and decreased pulmonary artery pressure.</li><li><b>Option D:</b> Tadalafil is also a phosphodiesterase-5 (PDE-5) inhibitor, similar to sildenafil, and works through the same mechanism to increase cGMP and promote vasodilation in the pulmonary arteries. It is not a prostacyclin receptor agonist.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 34</h3>
                <p><b>A patient arrives in the emergency room complaining of “his heart racing.” The cardiac monitor reveals atrial tachycardia with a ventricular rate of 190 bpm. The nurse anticipates that the physician will order adenosine to be administered. Before administering the medication, which of the following actions should the nurse take?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Determine when the patient recently ate</li><li>2. Ask the laboratory to draw serum BUN and creatinine levels</li><li>3. Ask the patient client if he/she has a history of asthma</li><li>4. Have the patient sign a consent</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Option (c) is the correct choice because adenosine can induce bronchospasms in patients who have a history of asthma. It is essential to assess the patient for this condition prior to administration, as it could pose a significant risk and necessitate alternative treatment options.<ul ><li><b>Option (a)</b>, determining when the patient last or recently ate, is not relevant to the administration of adenosine and does not impact the immediate treatment for atrial tachycardia.</li><li><b>Option (b)</b>, asking the laboratory to draw serum BUN and creatinine levels, is not a priority at this moment. While renal function is important, it does not directly affect the use of adenosine in the treatment of atrial tachycardia.</li><li><b>Option (d)</b>, having the client sign a consent, is important for many medical procedures and treatments, but in emergency situations, implied consent may apply. The immediate concern is the patient ‘s safety regarding the potential for bronchospasm. </li></ul><p>In summary, the nurse should prioritize asking about the patient’s history of asthma before administering adenosine, as this information is crucial for ensuring the patient’s safety during treatment.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 35</h3>
                <p><b>Metoprolol tartrate has been prescribed for a patient who has experienced a myocardial infarction. What therapeutic outcome should the nurse anticipate from administering this medication?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Increased urinary output</li><li>2. Decreased coronary artery spasms</li><li>3. Increased cardiac output</li><li>4. Decreased resting heart rate</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Option (d) is the correct answer because metoprolol tartrate is a beta-adrenergic blocker that primarily works by slowing the heart rate. This reduction in heart rate is beneficial for patients who have had a myocardial infarction, as it decreases myocardial oxygen demand and helps protect the heart.<ul ><li><b>Option (a)</b>, increased urinary output, is not a direct effect of metoprolol. While improved cardiac function may lead to better perfusion and potentially increased urine output, this is not the primary therapeutic goal of the medication.</li><li><b>Option (b)</b>, decreased coronary artery spasms, may occur, but metoprolol is not primarily indicated for this purpose. Its primary action is related to heart rate and contractility rather than addressing coronary artery spasms directly.</li><li><b>Option (c)</b>, increased cardiac output, is typically not expected with beta-blockers like metoprolol, as they often decrease the force of contraction and heart rate, which may lead to a lower cardiac output in the short term. </li></ul><p>In summary, when administering metoprolol tartrate to a patient post-myocardial infarction, the nurse should expect to see a decreased resting heart rate as the primary therapeutic result.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 36</h3>
                <p><b>In pregnant patients with chronic hypertension, which class of anti-hypertensive drugs is commonly used for blood pressure control?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Beta blockers</li><li>2. Calcium channel blockers</li><li>3. Methyldopa</li><li>4. ACE inhibitors</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Methyldopa is commonly used for blood pressure control in pregnant patients with chronic hypertension. </li><li>It is considered safe during pregnancy and is often recommended as a first-line treatment for hypertension in pregnant women. </li><li>Methyldopa acts centrally by being converted into alpha-methyl norepinephrine, which acts as a false neurotransmitter, reducing sympathetic outflow and leading to decreased peripheral resistance and lowered blood pressure. </li><li>Its safety profile during pregnancy makes it a preferred choice for managing hypertension in this population.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> Although some beta blockers have been used in pregnancy for certain indications, they are generally not the first choice for hypertension management in pregnant patients due to concerns about potential adverse effects on fetal growth and development.</li><li><b>Option B:</b> Certain calcium channel blockers, such as nifedipine, have been used in pregnancy for specific indications, but their use for blood pressure control in chronic hypertension during pregnancy may be limited due to limited safety data and concerns about potential effects on fetal development.</li><li><b>Option C:</b> ACE inhibitors are strictly contraindicated during pregnancy as they can cause severe fetal malformations and are associated with significant fetal and neonatal risks. They should be avoided in pregnant patients with hypertension.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 37</h3>
                <p><b>A patient’s cardiac monitor displays the following readings: HR 42/min, rhythm regular, PR interval 0.16 seconds, and QRS duration 0.06 seconds. The patient is experiencing dizziness, nausea, and chest pain rated as 3 on a scale of 1 to 10, with 10 being the worst pain. What is the most appropriate drug to treat this dysrhythmia?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Lidocaine</li><li>2. Adenosine</li><li>3. Atropine sulfate</li><li>4. Epinephrine</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Option (c) is the correct choice because atropine sulfate is effective in treating bradycardia by blocking vagal impulses to the heart, which helps to increase the heart rate. In this case, the patient is experiencing symptomatic bradycardia (heart rate of 42 beats per minute), which can lead to symptoms such as dizziness, nausea, and chest pain.<ul ><li><b>Option (a)</b>, Lidocaine, is primarily used for the management of ventricular dysrhythmias and is not indicated for bradycardia.</li><li><b>Option (b)</b>, Adenosine, is typically used to restore normal sinus rhythm in cases of supraventricular tachycardia, not bradycardia.</li><li><b>Option (d)</b>, Epinephrine, is a catecholamine used for conditions such as anaphylaxis and severe bronchospasms. While it can increase heart rate, it is not the first-line treatment for symptomatic bradycardia. </li></ul><p>In summary, the appropriate treatment for this patient experiencing symptomatic bradycardia is atropine sulfate, as it effectively increases the heart rate by inhibiting vagal tone.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 38</h3>
                <p><b>Which anti-hypertensive drug is known for its nitric oxide-enhancing vasodilatory effects?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Hydralazine</li><li>2. Verapamil</li><li>3. Diltiazem</li><li>4. Metoprolol</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Hydralazine is an anti-hypertensive drug known for its nitric oxide-enhancing vasodilatory effects. It directly relaxes smooth muscle in the blood vessels, leading to vasodilation and a decrease in blood pressure.</li><li>One of the mechanisms by which hydralazine exerts its vasodilatory effect is by increasing the release of nitric oxide (NO), which is a potent vasodilator.</li></ul><b>Other options:</b><ul ><li><b>Option B:</b> Verapamil is a calcium channel blocker. It works by inhibiting the influx of calcium ions into smooth muscle cells, leading to vasodilation and decreased heart rate. However, its mechanism of action is not directly related to enhancing nitric oxide (NO) production.</li><li><b>Option C:</b> Diltiazem is also a calcium channel blocker. It works in a similar manner by blocking calcium channels in the heart and blood vessels.</li><li><b>Option D:</b> Metoprolol is a beta blocker. It primarily works by blocking the effects of beta-adrenergic stimulation, leading to decreased heart rate and reduced contractility of the heart. It does not have a direct effect on nitric oxide production.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 39</h3>
                <p><b>The nurse is administering a beta-blocker to a patient who has been admitted due to a myocardial infarction (MI). When the patient’s wife inquires about the purpose of the medication, the nurse should base their response on the following fact that the medication will:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Reduce the amount of oxygen needed by the heart muscle</li><li>2. Decrease the risk of a blood clot</li><li>3. Enhance the affinity of oxygen for hemoglobin</li><li>4. Increase the volume of blood in the coronary arteries</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Beta-blockers are a class of medications that play a crucial role in the management of myocardial infarctions by primarily reducing the oxygen demand of the heart. They achieve this effect by blocking the beta-adrenergic receptors in the heart, which leads to several physiological changes:<ul ><li>Decreased Heart Rate: Beta-blockers slow down the heart rate, which allows the heart to pump more efficiently and reduces the workload on the myocardium (heart muscle). A lower heart rate decreases the overall oxygen requirement of the heart.</li><li>Reduced Contractility: By decreasing the force of each heartbeat (contractility), beta-blockers further diminish the heart’s oxygen demand, making them particularly useful in the setting of an MI, where the heart muscle is already under stress.</li><li>Lower Blood Pressure: Beta-blockers help lower blood pressure, which reduces the effort, the heart must exert to circulate blood throughout the body. This reduction in afterload contributes to a decrease in the heart’s oxygen needs. </li></ul><p>While other options present relevant aspects of cardiovascular care, they do not directly align with the primary mechanism of action of beta-blockers in the context of an MI: <ul ><li><b>Option b)</b> Decrease the risk of a blood clot: This function is primarily attributed to antiplatelet agents (like aspirin) rather than beta-blockers. While beta-blockers may indirectly reduce the risk of complications, their primary role is not in clot prevention.</li><li><b>Option c)</b> Enhance the affinity of oxygen for hemoglobin: This concept relates to the oxygen-hemoglobin dissociation curve and is more relevant to conditions affecting oxygen transport rather than the action of beta-blockers. </li><li><b>Option d)</b> Increase the volume of blood in the coronary arteries: Beta-blockers do not increase blood volume in the coronary arteries; rather, they help manage myocardial oxygen demand. </li></ul><p>In summary, the most accurate response to the patient’s wife’s question is that the beta-blocker will reduce the amount of oxygen needed by the heart muscle. This understanding is essential, as it highlights the critical role of beta-blockers in the immediate management of patients experiencing an MI by alleviating strain on the heart and improving outcomes.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 40</h3>
                <p><b>A patient who has recently been diagnosed with thrombocytopenia due to a thiazide diuretic and inquires about the duration of this condition will resolve after discontinuation of this drug. What is the most appropriate response for the nurse to provide?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 1–2 weeks</li><li>2. 2–4 weeks</li><li>3. 1–6 months</li><li>4. It is unpredictable</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>When addressing a patient’s concern about the duration of thrombocytopenia resulting from a thiazide diuretic, the nurse should inform the patient that drug-induced thrombocytopenia typically resolves within 1 to 2 weeks after the offending medication is discontinued. This is because the body generally recovers its platelet count once the trigger (in this case, the thiazide diuretic) is removed from the treatment regimen.<ul ><li><b>Understanding Drug-Induced Thrombocytopenia:</b> This condition occurs when certain medications, like thiazide diuretics, cause a decrease in the platelet count. Upon cessation of the medication, the bone marrow typically resumes normal platelet production, leading to a gradual recovery. </li><li><b>Differentiating Other Types of Thrombocytopenia:</b> The duration mentioned in option (a) is specifically related to drug-induced cases. In contrast, conditions such as <b>idiopathic thrombocytopenic purpura (ITP)</b> may have varying durations and can last longer, sometimes up to several months, but these conditions are different from the acute, drug-related type.</li><li><b>Reassurance:</b> By providing this information, the nurse can help reassure the patient that the condition is generally self-limiting and can be resolved quickly with appropriate action—namely, discontinuing the thiazide diuretic. </li></ul><p>In summary, the correct response to the patient’s question about the duration of thrombocytopenia related to thiazide diuretics is <b>1–2 weeks</b> after stopping the medication. This timeframe allows for adequate recovery and normalization of platelet levels in most cases.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 41</h3>
                <p><b>A 65-year-old woman with CHF and severe hypotension is admitted to the intensive care unit. Her blood pressure is critically low, and she requires immediate support. Which medication, a potent vasoconstrictor that acts on alpha-1 adrenergic receptors, is used in emergencies to restore blood pressure and improve perfusion?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Milrinone</li><li>2. Dobutamine</li><li>3. Dopamine</li><li>4. Norepinephrine</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Norepinephrine is a potent vasoconstrictor that acts on alpha-1 adrenergic receptors. </li><li>It is commonly used in emergencies to restore blood pressure and improve perfusion in situations of severe hypotension, shock, and inadequate tissue perfusion. </li><li>Norepinephrine increases peripheral vascular resistance, which helps elevate blood pressure and maintain organ perfusion.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> Milrinone is a phosphodiesterase inhibitor that has positive inotropic and vasodilatory effects. It is primarily used in acute heart failure situations to improve cardiac contractility and reduce afterload. However, it is not the first-line choice for rapidly raising blood pressure and improving perfusion. </li><li><b>Option B:</b> Dobutamine is a medication with positive inotropic effects and some vasodilatory properties. It is often used to increase cardiac output in situations of heart failure, but it may not be the best choice for rapidly increasing blood pressure and vasoconstriction.</li><li><b>Option C:</b> Dopamine is a catecholamine that can act on various receptors at different doses, including dopamine receptors, beta-1 adrenergic receptors, and alpha-1 adrenergic receptors. At lower doses, dopamine can cause vasodilation and increase blood flow to certain organs, but at higher doses, it can also lead to vasoconstriction. While it can be used in certain situations of shock, norepinephrine is generally preferred for its stronger vasoconstrictor effects. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 42</h3>
                <p><b>A patient diagnosed with stage 2 hypertension is currently on hydrochlorothiazide and lisinopril. The healthcare provider has now added Prazosin to the treatment regimen. What is the most important teaching point for the nurse to convey to this patient?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Weigh yourself every morning to monitor for fluid retention.</li><li>2. Change positions slowly and avoid prolonged standing.</li><li>3. Use sugarless gum or candy to help relieve dry mouth.</li><li>4. Take your pulse daily to check for any slowing of the heart rate.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><b>Option a. Weigh yourself every morning to monitor for fluid retention. </b><ul ><li>While monitoring weight is important for patients on diuretics like hydrochlorothiazide to check for fluid retention, it is not the primary concern when adding prazosin. The focus here should be on preventing orthostatic hypotension, which poses a more immediate risk to the patient’s safety. </li></ul><b>Option b. Change positions slowly and avoid prolonged standing: </b><ul ><li>This is the correct answer. Prazosin is an alpha-adrenergic blocker that can lead to orthostatic hypotension, characterized by a significant drop in blood pressure upon standing. This can cause dizziness, weakness, and fainting. Teaching the patient to rise slowly from sitting or lying positions and to avoid standing for long periods is essential for minimizing these risks.</li></ul><b>Option c. Use sugarless gum or candy to help relieve dry mouth. </b><ul ><li>Dry mouth can occur with certain medications, including diuretics, but it is not the primary concern when Prazosin is introduced. Addressing the risk of orthostatic hypotension is more critical than managing dry mouth symptoms.</li></ul><b>Option d. Take your pulse daily to check for any slowing of the heart rate.</b><ul ><li>While it is important to monitor the pulse for some medications, this is not the most crucial instruction for this patient. Prazosin primarily affects blood pressure rather than heart rate. Although bradycardia can occur with some antihypertensives, the immediate concern should be the risk of orthostatic hypotension associated with position changes.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 43</h3>
                <p><b>In addition to its anti-inflammatory effects, which NSAID is specifically recommended for the prevention of cardiovascular events due to its antiplatelet activity?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Naproxen</li><li>2. Ibuprofen</li><li>3. Ketorolac</li><li>4. Aspirin</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Aspirin is unique among NSAIDs in that it irreversibly inhibits the enzyme cyclooxygenase (COX), thus preventing the formation of thromboxane A2 in platelets.</li><li>Thromboxane A2 is a potent inducer of platelet aggregation, and by inhibiting its synthesis, aspirin has antiplatelet activity.</li><li>Due to its antiplatelet effects, aspirin is commonly recommended for the prevention of cardiovascular events, such as myocardial infarction and stroke, in individuals at risk.</li><li>Other NSAIDs, including naproxen, ibuprofen, and ketorolac, do not have the same antiplatelet activity as aspirin.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> While naproxen has anti-inflammatory effects, it does not have the same antiplatelet activity as aspirin. Naproxen is not typically recommended for cardiovascular event prevention.</li><li><b>Option B:</b> Like naproxen, ibuprofen is primarily known for its anti-inflammatory effects but does not possess significant antiplatelet activity. It is not recommended for cardiovascular event prevention in the same way as aspirin.</li><li><b>Option C:</b> Ketorolac is a potent NSAID with strong anti-inflammatory effects, but it is not used for the prevention of cardiovascular events. Its use is generally limited to the short-term management of moderate to severe pain.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 44</h3>
                <p><b>The patient has utilized sublingual nitroglycerin and various long-acting nitrates but now presents with an ejection fraction of 38% and is considered at high risk for a cardiac event. Which medication should be added first for vasodilation and to reduce ventricular remodeling?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Clopidogrel</li><li>2. Captopril</li><li>3. Diltiazem</li><li>4. Metoprolol</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><b>Option a) Clopidogrel </b><ul ><li>Clopidogrel is an antiplatelet medication commonly used to prevent thrombotic events, especially in patients who cannot tolerate aspirin. While it plays a vital role in reducing the risk of heart attacks and strokes, it does not have the properties needed for vasodilation or the prevention of ventricular remodeling. Therefore, it is not the appropriate choice for this patient’s needs.</li></ul><b>Option b) Captopril </b><ul ><li>Captopril is an angiotensin-converting enzyme (ACE) inhibitor that effectively causes vasodilation, reduces blood pressure, and minimizes the workload on the heart. Importantly, it also prevents ventricular remodeling, a process that can lead to further heart failure and complications. Given the patient’s low ejection fraction and high cardiac event risk, Captopril is the most suitable option.</li></ul><b>Option c) Diltiazem </b><ul ><li>Diltiazem is a calcium channel blocker that can help with coronary vasospasm and may improve exercise tolerance in patients with angina. However, it does not specifically address the prevention of ventricular remodeling and is not primarily used for the type of heart failure indicated by the patient’s low ejection fraction. Thus, it is less effective in this context.</li></ul><b>Option d) Metoprolol</b><ul ><li>Metoprolol is a β-adrenergic blocker that can help reduce heart rate and myocardial oxygen demand, which may be beneficial in heart failure. However, its primary role is to manage symptoms related to heart failure and ischemic heart disease rather than directly preventing ventricular remodeling or providing vasodilation. While it may be part of a broader treatment strategy, it is not the first choice in this situation.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 45</h3>
                <p><b>A patient with supraventricular tachycardia is prescribed an antiarrhythmic medication that slows conduction through the AV node. The patient subsequently reports constipation and dizziness. Which of the following drugs is most likely responsible for these symptoms?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Lidocaine</li><li>2. Flecainide</li><li>3. Verapamil</li><li>4. Sotalol</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>Verapamil is a calcium channel blocker and belongs to Class IV of antiarrhythmic drugs. </li><li>It works by blocking L-type calcium channels, primarily in the cardiac conduction system and smooth muscle cells. </li><li>By inhibiting calcium influx into cells, verapamil reduces heart rate and conduction through the atrioventricular (AV) node, making it effective for treating supraventricular tachycardias. </li><li>However, its effects on smooth muscle cells can lead to side effects such as constipation and dizziness.</li></ul><b>Other options:</b><ul><li><b>Option A:</b><span> Lidocaine is a Class Ib antiarrhythmic drug primarily used to treat ventricular arrhythmias. It does not typically cause constipation and dizziness as side effects.</span></li><li><b>Option B:</b> Flecainide is a Class Ic antiarrhythmic drug that primarily affects conduction in the His-Purkinje system and is used to treat supraventricular arrhythmias. It is not known for causing constipation and dizziness as side effects.</li><li><b>Option D:</b> Sotalol is a non-selective beta-blocker that also has Class III antiarrhythmic properties due to its potassium channel-blocking effects.</li><li>It prolongs the action potential duration and refractory period in both atria and ventricles. While sotalol can cause gastrointestinal symptoms as side effects, constipation is not a common symptom.</li><li>Dizziness can be a side effect of beta-blockers, but it is not as strongly associated with sotalol as with calcium channel blockers like verapamil.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 46</h3>
                <p><b>A 40-year-old patient with newly diagnosed hypertension is prescribed an angiotensin-converting enzyme (ACE) inhibitor. Which of the following adverse effects is commonly associated with this medication class?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Hyperkalemia</li><li>2. Hypoglycemia</li><li>3. Hyperlipidemia</li><li>4. Hyponatremia</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>ACE inhibitors can lead to an increase in serum potassium levels (hyperkalemia). </li><li>This occurs because ACE inhibitors interfere with the renin-angiotensin-aldosterone system, which normally stimulates aldosterone secretion in the adrenal glands. </li><li>Aldosterone promotes the retention of sodium and water while increasing the excretion of potassium. </li><li>When ACE inhibitors block the production of angiotensin II, which normally stimulates aldosterone release, potassium excretion is reduced, potentially leading to elevated levels of potassium in the blood.</li></ul><b>Other options:</b><ul ><li><b>Option B:</b> ACE inhibitors are not typically associated with hypoglycemia. However, some medications used to manage diabetes (such as insulin or certain oral hypoglycemic agents) can cause hypoglycemia.</li><li><b>Option C:</b> ACE inhibitors are not commonly associated with hyperlipidemia. Blood lipid levels are more influenced by factors such as diet, genetics, and other medications.</li><li><b>Option D:</b> ACE inhibitors are not commonly associated with hyponatremia. Hyponatremia can result from various causes, including excessive fluid intake or certain medical conditions affecting sodium balance.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 47</h3>
                <p><b>A 55-year-old woman with a history of hypertension and hyperlipidemia is admitted with a non-ST-segment elevation myocardial infarction (NSTEMI). What class of medications should be initiated to inhibit platelet aggregation and prevent further clot formation?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Propranolol</li><li>2. Alteplase</li><li>3. Aspirin</li><li>4. Enalapril</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Aspirin is a platelet aggregation inhibitor and an antiplatelet medication commonly used in patients with acute coronary syndrome, including NSTEMI. </li><li>It works by irreversibly inhibiting cyclooxygenase (COX) enzymes, which are involved in the synthesis of thromboxane A2, a potent platelet aggregator and vasoconstrictor. </li><li>By inhibiting thromboxane A2 production, aspirin reduces platelet aggregation and the risk of clot formation in coronary arteries.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> Propranolol is a beta-blocker and is often used to reduce heart rate and blood pressure in patients with acute coronary syndrome. However, it does not directly inhibit platelet aggregation.</li><li><b>Option B:</b> Alteplase is a thrombolytic agent used to dissolve blood clots that have already formed. It is not used as a first-line treatment for NSTEMI.</li><li><b>Option D:</b> Enalapril is an angiotensin-converting enzyme (ACE) inhibitor commonly used in heart failure and hypertension. </li></ul><p>While it has cardiovascular benefits, it is not used primarily to inhibit platelet aggregation and prevent clot formation in the acute setting of NSTEMI.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 48</h3>
                <p><b>A patient complains of ringing sensation in the ear since the past one week. She was started on a class 1a antiarrhythmic drug a month back. Which of the following drugs may have caused this side effect?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Procainamide</li><li>2. Chloroquine</li><li>3. Quinidine</li><li>4. Flecainide</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Quinidine is a Class Ia antiarrhythmic drug that can cause various side effects, including tinnitus (ringing sensation in the ear). </li><li>Tinnitus is an auditory perception of sound in the absence of an external stimulus and can be a side effect of medications affecting the auditory system. </li><li>Quinidine’s effects on ion channels can lead to disturbances in the inner ear, resulting in auditory symptoms such as tinnitus.</li></ul><b>Other options:</b><ul ><li><b>Option A:</b> Procainamide is another Class Ia antiarrhythmic drug that can cause auditory disturbances, but it is not specifically known for causing tinnitus.</li><li><b>Option B:</b> Chloroquine is an antimalarial drug that can cause auditory disturbances, including hearing loss or tinnitus, but it is not an antiarrhythmic drug.</li><li><b>Option D:</b> Flecainide is a Class Ic antiarrhythmic drug that primarily affects the His-Purkinje system and is not typically associated with tinnitus as a side effect.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 49</h3>
                <p><b>During an assessment of a newborn, a nurse observes several clinical signs, including high blood pressure, strong brachial pulses, weak pedal pulses, increased jugular venous distention (JVD), and the presence of a cardiac murmur. Considering these findings, which condition is most likely to be suspected by nurse?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Congestive heart failure</li><li>2. Coarctation of the aorta</li><li>3. Mitral valve prolapse</li><li>4. Transposition of the great vessels</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Option (b) is correct because coarctation of the aorta involves a narrowing of the aorta, which restricts blood flow. This condition typically results in elevated blood pressure in the upper body (indicated by the bounding brachial pulses) due to increased resistance, while the lower body (indicated by diminished pedal pulses) experiences decreased blood flow, leading to lower blood pressure. The elevated jugular venous distention (JVD) suggests increased pressure in the venous system, and the presence of a cardiac murmur can indicate collateral circulation or other hemodynamic changes due to the narrowed aorta.<ul ><li><b>Option (a)</b>, congestive heart failure, could also present with some overlapping symptoms, but the specific combination of elevated blood pressure, bounding pulses in the upper body, and diminished pulses in the lower body is more characteristic of coarctation of the aorta.</li><li><b>Option (c)</b>, mitral valve prolapse, typically presents with different symptoms such as a mid-systolic click or regurgitant murmur, and it does not specifically cause the upper versus lower extremity pulse disparity seen in this case.</li><li><b>Option (d)</b>, transposition of the great vessels, is characterized by a different set of symptoms and typically presents with severe cyanosis and distress shortly after birth due to inadequate oxygenation of blood.</li></ul><p>In summary, the clinical findings in this newborn infant strongly suggest coarctation of the aorta, making option (b) the most appropriate choice.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 50</h3>
                <p><b>A 4-year-old male child was brought to the pediatric OPD with a history of recurrent episodes of gum bleeding and one episode of hematuria in the past four weeks. After detailed evaluation, the child was diagnosed to have Christmas disease. Which of the following is expected to be deficient or absent in this child?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Clotting factor I</li><li>2. Plasma thromboplastin antecedent</li><li>3. Plasma thromboplastin component</li><li>4. Clotting factor VIII</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li><strong>Christmas disease</strong>is also called as&#160;<strong>Hemophilia B</strong>, which is associated with the&#160;<strong>deficiency of the clotting factor IX.</strong></li>&#10;<li>The&#160;<strong>factor IX</strong>is also called as anti-hemophilic factor B or&#160;<strong>Christmas factor</strong>&#160;or&#160;<strong>plasma thromboplastin component (PTC).</strong></li>&#10;<li>The&#160;<strong>factor XI</strong>is called anti-hemophilic factor C or&#160;<strong>plasma thromboplastin antecedent</strong>&#160;(PTC), whose deficiency will result in&#160;<strong>hemophilia C.</strong></li>&#10;<li>The&#160;<strong>factor VIII</strong>is called anti-hemophilic factor A or antihemophilic globulin (AHG), whose deficiency will result in&#160;<strong>hemophilia A.</strong></li>&#10;<li>The&#160;<strong>factor I</strong>is called fibrinogen, whose deficiency will result in&#160;</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 51</h3>
                <p><b>Which assessment finding in a neonate should the nurse recognize as a potential indicator of coarctation of the aorta?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Triphasic color changes in the upper extremities</li><li>2. Pulsating abdominal mass with a systolic bruit and cool lower extremities</li><li>3. Decreased distal pulses, thick, malformed nails, cyanotic upper extremity digits</li><li>4. Bounding pulses in the arms and absent pulses in the groin and legs</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>The correct interpretation is d) Bounding pulses in the arms and absent pulses in the groin and legs. Coarctation of the aorta is a congenital condition characterized by a narrowing of the aorta, typically occurring just after the left subclavian artery. This narrowing can lead to differential blood flow between the upper and lower parts of the body. As a result, the neonate may exhibit strong or bounding pulses in the upper extremities (arms) due to increased blood pressure in these areas, while the lower extremities (groin and legs) may present with decreased or absent pulses because of reduced blood flow. This difference in pulse quality can often manifest hours to days after birth, especially following the closure of the ductus arteriosus, which further decreases blood flow to the lower body.<p>Now let’s explore why the other options are less indicative of coarctation of the aorta:<ul ><li><b>Option a) Triphasic color changes in the upper extremities:</b> Triphasic color changes are not associated with coarctation of the aorta; rather, they are more characteristic of conditions like Raynaud’s disease, which involves vasospasm and ischemia in response to cold or stress.</li><li><b>Option b) Pulsating abdominal mass with a systolic bruit and cool lower extremities:</b> These findings suggest an abdominal aortic aneurysm rather than coarctation of the aorta. An abdominal aortic aneurysm can cause a pulsating mass due to the dilation of the aorta, and the coolness in the lower extremities could indicate compromised blood flow.</li><li><b>Option c) Decreased distal pulses, thick, malformed nails, cyanotic upper extremity digits:</b> This presentation is more consistent with thromboangiitis obliterans (Buerger’s disease), a condition that affects blood flow to the extremities due to inflammation of the blood vessels, leading to tissue ischemia. </li></ul><p><b>Summary:</b> In conclusion, the finding of <b>bounding pulses in the arms and absent pulses in the groin and legs</b> is a hallmark sign of severe coarctation of the aorta in neonates. Recognizing these distinct differences in peripheral circulation is critical for timely diagnosis and intervention in this potentially life-threatening condition.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 52</h3>
                <p><b>A 9-year-old female child is brought to the hospital for a blood transfusion. She was diagnosed with thalassemia in early childhood. After 15 minutes of the current blood transfusion, she suddenly developed a fever, chills, and body aches. Blood transfusion is immediately stopped. What should have been done to decrease the rate of reactions during blood transfusion?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Leucocyte depletion</li><li>2. Antibiotics</li><li>3. Irradiation</li><li>4. Washed RBCs</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li>In multi-transfused patients, removing leucocytes from blood has been shown to decrease&#160;<strong>febrile non-hemolytic&#160;transfusion&#160;reactions,&#160;platelet&#160;refractoriness, and&#160;HLA&#160;alloimmunization</strong>.</li>&#10;<li>Transmission of<strong>leukotropic viruses</strong>&#160;such as&#160;<strong>EBV</strong>&#160;and&#160;<strong>CMV</strong>&#160;can be prevented by leucodepletion.</li>&#10;<li>Removing leucocytes below a level&#160;<strong>&#8804; 5 &#215; 10<sup>6</sup></strong>in a blood component helps to prevent blood transfusion reactions.</li>&#10;<li>Leucodepletion can be achieved with the help of&#160;<strong>leuko-filters</strong>.</li>&#10;<li><strong>Leukofilter&#160;</strong>&#8594; prevent&#160;<strong>WBC from entering the recipient's body, so chances&#160;</strong>of&#160;transfusion&#160;reaction will be minimal.</li>&#10;<li>Leucodepletion can be done by</li>&#10;<li><strong>Irradiation</strong></li>&#10;<li><strong>Filters&#160;(easier and convenient)</strong></li>&#10;</ul><p><strong>Other options</strong></p><p><strong>Option B: Antibiotics</strong></p><ul>&#10;<li>Antibiotic is only indicated if&#160;septic&#160;transfusion&#160;reactions&#160;develop.</li>&#10;<li>Typically, this reaction occurs due to&#160;contamination&#160;of the donor blood components by bacteria, including&#160;Staphylococcus&#160;aureus&#160;and&#160;Staphylococcus epidermidis.</li>&#10;</ul><p><strong>Option C: Irradiation</strong></p><ul>&#10;<li>Irradiation can also&#160;deplete&#160;leucocytes, but it is expensive and can't be used routinely.</li>&#10;</ul><p><strong>Option D: Washed RBCs</strong></p><ul>&#10;<li>Triple-washed RBCs were a method to&#160;deplete&#160;leucocytes, used earlier but was not very effective.</li>&#10;</ul><p><strong>Learning objective</strong></p><p>&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;&#10;</p><ul>&#10;<li>Leucodepletion can minimize blood transfusion-related reactions.</li>&#10;<li>Leukofilters are used in leucodepletion to prevent the entry of&#160;WBC&#160;into the recipient's body.</li>&#10;<li><strong>Leukotropic viruses</strong>such as&#160;<strong>EBV</strong>&#160;and&#160;<strong>CMV can be prevented by leucodepletion.</strong></li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 53</h3>
                <p><b>A child is set to undergo a bone marrow aspiration as part of the diagnostic evaluation for acute lymphocytic leukemia. Where will the procedure be performed on the child’s body?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Sternum</li><li>2. Scapula</li><li>3. Iliac crest</li><li>4. Sacrum</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>When explaining the <b>bone marrow aspiration</b> procedure to the child’s caregivers, it’s essential to note that this procedure is typically performed on the <b>iliac crest</b> in pediatric patients. The iliac crest, located on the upper part of the pelvis, is preferred for several reasons:<ul ><li><b>Accessibility:</b> The iliac crest provides easy access to the bone marrow without the complications that might arise from other sites. This site is also relatively safe and has a good volume of bone marrow, making it suitable for aspiration.</li><li><b>Safety Considerations:</b> In children, the iliac crest is less likely to result in injury to vital organs or blood vessels compared to other sites like the sternum or sacrum.</li><li><b>Adult Considerations:</b> While adults may also have bone marrow aspirations done from the iliac crest, they can also have the procedure performed on the sternum. However, due to anatomical differences and the risks involved, the iliac crest remains the preferred site for children.</li></ul><p>In summary, the procedure for bone marrow aspiration in a child diagnosed with acute lymphocytic leukemia is performed on the iliac crest. This understanding is crucial for providing accurate information and reassurance to the patient and their family.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 54</h3>
                <p><b>What instruction should be given to the parent of a child diagnosed with hemophilia?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Administer prophylactic factor at bedtime.</li><li>2. Store factor in the refrigerator.</li><li>3. Give ibuprofen for joint pain.</li><li>4. Plan frequent rest periods throughout the day.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>When providing guidance to the parent of a child with hemophilia, it’s essential to focus on effective management of the condition and the proper handling of clotting factor replacement therapy.<ul ><li><b>Storing Factor:</b> The correct direction is to <b>store the factor in the refrigerator</b> (option b). Proper storage is crucial to maintain the effectiveness of the factor concentrates used to manage hemophilia. These medications need to be kept at a cool temperature to preserve their stability and potency until needed for treatment.</li><li><b>Administering Prophylactic Factor:</b> While prophylactic factor is essential in the management of hemophilia, it is typically administered in the morning rather than at bedtime (option a). This is due to the short half-life of many factor concentrates, which necessitates timing the doses to maximize effectiveness during the day.</li><li><b>Using Ibuprofen:</b> Advising the parent to give <b>ibuprofen for joint pain</b> (option c) is inappropriate. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that can increase the risk of bleeding, making it unsuitable for children with hemophilia. Instead, acetaminophen is typically recommended for pain relief in these patients.</li><li><b>Planning Rest Periods:</b> While it’s important for all children to have adequate rest, the suggestion to <b>plan frequent rest periods throughout the day</b> (option d) is not a specific requirement for children with hemophilia. Children with hemophilia can generally engage in normal activities, though they should avoid high-risk sports or activities that might lead to injury. </li></ul><p>In summary, storing the factor in the refrigerator is a crucial instruction for parents, as it ensures that the medication remains effective and readily available for use in managing their child’s hemophilia.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 55</h3>
                <p><b>Which statement made by the parent of a child diagnosed with thalassemia minor suggests a misunderstanding about the condition?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. My child’s Mediterranean heritage increases the risk of this disease.</li><li>2. My child will require ongoing treatment for life but is expected to have a normal lifespan.</li><li>3. My child will be anemic but will not show symptoms that necessitate treatment.</li><li>4. The issue is that there are not enough red blood cells produced, and some of them are destroyed.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>In evaluating the parent’s understanding of thalassemia minor, it’s essential to clarify several points about the disease:<ul ><li><b>Understanding Thalassemia Minor:</b> Thalassemia minor, also known as beta-thalassemia trait, is generally considered a mild form of thalassemia. Individuals with this condition typically have a reduced level of hemoglobin due to a genetic defect that affects the production of beta globin chains in hemoglobin.</li><li><b>Asymptomatic Nature:</b> Unlike thalassemia major, thalassemia minor is often asymptomatic and does not require any specific treatment. Many individuals with thalassemia minor do not experience significant health issues and can lead normal, healthy lives. Therefore, the statement made by the parent that the child will need lifelong treatment is incorrect and indicates a misunderstanding of the condition.</li><li><b>Normal Lifespan:</b> While it is true that individuals with thalassemia minor generally have a normal lifespan, the implication that they will require while ongoing treatment is misleading. This statement reflects a need for further education on the condition and its management.</li><li><b>Cultural and Genetic Factors:</b> The other statements made by the parent are accurate. Being of Mediterranean descent (option a) indeed increases the risk of thalassemia due to its genetic prevalence in that population. The child being anemic but asymptomatic (option c) is also true, as those with thalassemia minor typically do not exhibit symptoms requiring treatment. Lastly, the explanation regarding <b>the production and destruction of red blood cells</b> (option d) accurately describes the underlying issue in thalassemia minor. </li></ul><p>In conclusion, while the parent has some understanding of thalassemia minor, the statement regarding the need for lifelong treatment highlights a significant misconception that warrants further explanation and education about the condition.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 56</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A patient diagnosed with arteriosclerosis obliterans has the goal of increasing arterial blood supply to the extremities. Which nursing intervention would be most appropriate to support this goal?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Elevate the extremities above the level of the heart for 15 minutes four times a day.</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Have the client perform Buerger-Allen exercises four times a day.</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Maintain the client on bed rest with legs in a neutral position.</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Position the client in high-Fowler&rsquo;s position with legs straight.</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Option (b) is the correct choice because Buerger-Allen exercises are specifically designed to improve blood flow to the extremities. These exercises involve alternating between elevating the legs to promote venous drainage and then lowering them to encourage arterial blood flow, effectively stimulating circulation in the legs. This method is particularly beneficial for clients with peripheral arterial disease, as it helps to enhance the arterial supply.</p>
<ul>
<li><strong>Option (a)</strong>, elevating the extremities above heart level, is counterproductive in this situation as it drains static blood from the legs, which is useful for conditions like varicose veins but does not promote arterial flow.</li>
<li><strong>Option (c)</strong>, maintaining the patient on bed rest with legs in a neutral position, does not facilitate blood flow and can contribute to stagnation, which is not ideal for someone with reduced arterial supply.</li>
<li><strong>Option (d)</strong>, positioning the patient in High-Fowler&rsquo;s position with legs straight, also does not promote drainage or increase arterial blood flow to the extremities.</li>
</ul>
<p>In summary, to increase arterial blood supply to the legs in a patient with arteriosclerosis obliterans, implementing Buerger-Allen exercises is the most effective nursing intervention.</p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 57</h3>
                <p><b>What information should the nurse provide to a patient with sickle cell disease regarding hand and foot syndrome?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Without immediate treatment, necrosis and need for amputation can occur.</li><li>2. Incidence of hand and foot syndrome declines with age.</li><li>3. Prodromal signs of hand and foot disease are muscle spasms and mottling of the skin.</li><li>4. Episodes of hand and foot syndrome are self-limiting.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><b>Hand and foot syndrome,</b> also known as dactylitis, is a common complication of sickle cell disease, particularly in infants and young children. This condition is characterized by painful swelling and edema in the hands and feet due to vaso-occlusive episodes caused by sickled red blood cells obstructing blood flow.<ul ><li><b>Self-Limiting Nature:</b> The episodes are typically self-limiting, meaning they resolve on their own without requiring aggressive medical intervention. The pain and swelling can be managed with supportive care, such as hydration, analgesics, and rest, but they do not typically lead to serious complications like necrosis or amputation.</li><li><b>Misconceptions about Necrosis and Amputation:</b> Option (a) is incorrect because, although hand and foot syndrome can be painful and distressing, it generally does not progress to tissue necrosis or the need for amputation. Such severe outcomes are not characteristic of this syndrome.</li><li><b>Incidence with Age:</b> Option (b) is misleading; while the incidence of hand and foot syndrome may decrease with age as sickle cell patients develop adaptive mechanisms and their body changes, it is not a definitive statement. Some adults can still experience vaso-occlusive crises, including hand and foot syndrome.</li><li><b>Prodromal Signs:</b> Option (c) is also incorrect. Prodromal signs such as muscle spasms and mottling of the skin are not specifically associated with hand and foot syndrome. The primary symptoms are localized pain and swelling in the affected areas, and these symptoms can occur suddenly without specific warning signs.</li></ul><b> Summary:</b><p>In summary, the correct information for a client with sickle cell disease regarding hand and foot syndrome is that episodes are self-limiting (option d). This understanding can help patients manage their expectations and symptoms effectively, knowing that while painful, these episodes are typically transient and do not lead to severe complications.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 58</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A 45-year-old male patient undergoes an electrocardiogram (ECG) as part of a routine health check-up. The ECG report indicates a prolonged QT interval, what does the finding indicate?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ventricular depolarization</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ventricular depolarization and ventricular repolarization</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ventricular repolarization</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Septal activation</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The QT interval on an electrocardiogram (ECG) represents the time from the start of ventricular depolarization to the end of ventricular repolarization.</li>
<li>It encompasses both the electrical events of ventricular contraction (depolarization) and relaxation (repolarization).</li>
<li>Prolongation of the QT interval can predispose individuals to ventricular arrhythmias, including Torsades de Pointes, and is associated with an increased risk of sudden cardiac death.</li>
</ul>
<p><strong>Incorrect Options:</strong></p>
<ul>
<li>Option A - Ventricular depolarization: The QRS complex on an ECG represents ventricular depolarization, not the QT interval.</li>
<li>Option C - Ventricular repolarization: While the QT interval includes ventricular repolarization, it also includes ventricular depolarization.</li>
<li>Correct Option D - Septal activation: The Q wave on an ECG represents septal activation, not the QT interval.</li>
</ul>
<p><strong> Learning objective </strong></p>
<ul>
<li>The QT interval on an electrocardiogram (ECG) represents the time from the start of ventricular depolarization to the end of ventricular repolarization.</li>
<li>It encompasses both the electrical events of ventricular contraction (depolarization) and relaxation (repolarization).</li>
</ul>
<p><strong> Normal ECG</strong></p>
<p><img title="image009.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/b63107a9-bb46-49d5-a95a-e3c57a9cc6e1.png" alt="" width="368" height="305" /></p>
<ul>
<li>1 Small Box = 1 mm = 0.04 s</li>
<li>1 Big Box = 5 mm = 0.2 s</li>
<li>1 s = 5 Big Boxes</li>
</ul>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 35.9712%;" width="227">
<p><strong>ECG wave/interval</strong></p>
</td>
<td style="width: 64.0288%;" width="461">
<p><strong>Physiological correlates</strong></p>
</td>
</tr>
<tr>
<td style="width: 35.9712%;" width="227">
<p>P wave</p>
</td>
<td style="width: 64.0288%;" width="461">
<p>Atrial depolarization</p>
</td>
</tr>
<tr>
<td style="width: 35.9712%;" width="227">
<p>QRS complex (up to 0.10 s)</p>
</td>
<td style="width: 64.0288%;" width="461">
<p>Ventricular depolarization</p>
</td>
</tr>
<tr>
<td style="width: 35.9712%;" width="227">
<p>T wave</p>
</td>
<td style="width: 64.0288%;" width="461">
<p>Ventricular repolarization</p>
</td>
</tr>
<tr>
<td style="width: 35.9712%;" width="227">
<p>U wave</p>
</td>
<td style="width: 64.0288%;" width="461">
<p>Repolarization of ventricular myocytes with long action potential</p>
</td>
</tr>
<tr>
<td style="width: 35.9712%;" width="227">
<p>PR interval (0.12- 0.2 s)</p>
</td>
<td style="width: 64.0288%;" width="461">
<p>Atrial depolarization and conduction through AV node</p>
</td>
</tr>
<tr>
<td style="width: 35.9712%;" width="227">
<p>QT interval (up to 0.43 s)</p>
</td>
<td style="width: 64.0288%;" width="461">
<p>Ventricular depolarization and ventricular repolarization</p>
</td>
</tr>
<tr>
<td style="width: 35.9712%;" width="227">
<p>ST interval (Average 0.32 s)</p>
</td>
<td style="width: 64.0288%;" width="461">
<p>Plateau portion of ventricular action potential + Ventricular repolarization</p>
</td>
</tr>
<tr>
<td style="width: 35.9712%;" width="227">
<p>ST segment</p>
</td>
<td style="width: 64.0288%;" width="461">
<p>Plateau portion of ventricular action potential</p>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 59</h3>
                <p><b>A patient has just returned to the CTVS unit after undergoing a repair of an abdominal aortic aneurysm. Which position should the nurse place the patient in?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. High-Fowler’s</li><li>2. Sims</li><li>3. Semi-Fowler’s</li><li>4. Flat</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Option (d) is the correct choice because placing the patient in a flat position is essential after abdominal aortic aneurysm repair. This position helps prevent flexion of the graft, which is crucial for maintaining proper blood flow and reducing the risk of complications such as graft kinking or thrombosis.<ul ><li><b>Option (a)</b>, High-Fowler’s, involves sitting the patient up, which can increase flexion at the hips and put pressure on the surgical site, potentially compromising the graft.</li><li><b>Option (b)</b>, Sims position, is not appropriate as it involves turning the patient onto their side, which can also lead to flexion at the hips and may interfere with the surgical area.</li><li><b>Option (c)</b>, Semi-Fowler’s, allows for some elevation but still poses a risk for hip flexion and pressure on the abdomen, which is not ideal in the immediate postoperative period.</li></ul><p>In summary, following an abdominal aortic aneurysm repair, the nurse should place the patient in a flat position to prevent flexion of the graft and ensure optimal recovery.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 60</h3>
                <p><b>Essential hypertension is diagnosed when:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Blood pressure measurements are consistently high on three separate occasions.</li><li>2. Blood pressure measurements are high on one occasion.</li><li>3. Blood pressure measurements are high in the absence of other cardiovascular risk factors.</li><li>4. Blood pressure measurements are high in the presence of secondary causes.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Essential hypertension, also known as primary hypertension, is diagnosed when blood pressure measurements are consistently high on three separate occasions. </li><li>To establish the diagnosis of essential hypertension, healthcare providers typically measure blood pressure on multiple visits to rule out the possibility of isolated high readings due to temporary factors like stress or white coat hypertension.</li></ul><b>Other options:</b><ul ><li><b>Option B:</b> A single high blood pressure reading is not sufficient to diagnose essential hypertension. Elevated blood pressure on one occasion can be due to various factors and does not necessarily indicate hypertension.</li><li><b>Option C:</b> Essential hypertension is diagnosed based on consistent high blood pressure measurements, regardless of the presence or absence of other cardiovascular risk factors.</li><li><b>Option D:</b> Secondary hypertension refers to high blood pressure caused by an identifiable underlying medical condition or medication. </li></ul><p>Essential hypertension is diagnosed when secondary causes have been ruled out, and high blood pressure is consistently present without an identifiable cause.</li></ul></div></div>
            <div class="question">
                <h3>Question No: 61</h3>
                <p><b>A 25-year-old patient presents with recurrent episodes of palpitations and recurrent syncopal attacks. An electrocardiogram performed in the clinic shows normal findings. The physician advises the patient to undergo Holter monitoring which reveals paroxysmal supraventricular tachycardia. What is not correct about this condition?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Wide QRS complex</li><li>2. ST segment depression</li><li>3. R-R interval decreased</li><li>4. Hidden P waves</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul>&#10;<li>Paroxysmal&#160;supraventricular&#160;tachycardia presents with a narrow QRS complex on the ECG, as the&#160;arrhythmia&#160;originates above the&#160;bundle&#160;of His.</li>&#10;<li>Therefore, a wide QRS complex is not an&#160;ECG&#160;finding observed in PSVT.</li>&#10;<li>The other options, including&#160;ST segment&#160;depression, decreased R-R interval, and hidden P waves, are commonly seen in&#160;PSVT&#160;due to rapid atrial&#160;activation&#160;and&#160;aberrant&#160;atrioventricular&#160;conduction.</li>&#10;</ul>&#10;<p><strong>Incorrect Options:</strong></p>&#10;<p><strong>Options B, C and D:</strong></p>&#10;<ul>&#10;<li>These are the&#160;ECG&#160;findings seen in&#160;paroxysmal&#160;supraventricular&#160;tachycardia.</li>&#10;</ul>&#10;<p><strong>Learning objective</strong></p>&#10;<p>The&#160;ECG&#160;findings seen in&#160;Paroxysmal&#160;supraventricular&#160;tachycardia&#160;are as follows:</p>&#10;<ul>&#10;<li>Narrow QRS complex</li>&#10;<li>ST segment depression</li>&#10;<li>R-R interval decrease</li>&#10;</ul>&#10;<p><strong>Paroxysmal Supraventricular Tachycardia </strong></p>&#10;<ul>&#10;<li>Tachycardia (&gt; 100 beats / min) arising in the atria or AV junction</li>&#10;<li>Occurs most commonly in young adults</li>&#10;<li>The most common cause frequently is AV nodal re-entry anomaly</li>&#10;<li>Clinically: Sudden palpitations, dyspnea, or syncope</li>&#10;<li><strong>ECG:</strong> Narrow QRS complex, ST segment depression, R-R interval decrease, P waves hidden in T waves Hidden P waves</li>&#10;</ul>&#10;<p><img title="image011.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/86b5ccd8-b3ad-4b23-9d57-7b7d88e5cd37.png" alt="" width="200" height="52"></p>&#10;<ul>&#10;<li><strong>Treatment:</strong>&#10;<ul>&#10;<li>Acute episode&#10;<ul>&#10;<li>Systolic blood pressure &lt; 90 mmHg /un-recordable &#8211; DC shock</li>&#10;<li>Systolic blood pressure &#8805; 90mmHg &#8211; carotid sinus massage</li>&#10;</ul>&#10;</li>&#10;<li>Chemical cardioversion&#10;<ul>&#10;<li>IV adenosine (6-12mg)</li>&#10;</ul>&#10;</li>&#10;<li>Electrical cardioversion&#10;<ul>&#10;<li>Synchronized DC shock (120-200 J)</li>&#10;</ul>&#10;</li>&#10;</ul>&#10;</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 62</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>To prevent the postoperative complication of thrombophlebitis in a patient who has undergone mitral valve replacement, which activity should the nurse encourage the patient to engage in?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Perform dorsiflexion of the feet several times every hour while awake</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cough and take deep breaths every hour while awake</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sit up in a chair for several hours during the afternoon</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Eat a high-fiber, high-calorie diet</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Option (a) is the correct choice because performing dorsiflexion exercises of the feet helps promote venous return and prevent venous stasis, which is a key factor in the development of thrombophlebitis. By actively engaging the muscles in the legs, the patient can enhance blood circulation, reducing the risk of clot formation.</li>
<li><strong>Option (b),</strong> coughing and taking deep breaths, while important for preventing respiratory complications like pneumonia, does not specifically address the prevention of thrombophlebitis.</li>
<li><strong>Option (c),</strong> sitting up in a chair for several hours, can be beneficial for overall recovery and comfort but does not actively encourage leg movement or venous return.</li>
<li><strong>Option (d),</strong> eating a high-fiber, high-calorie diet, is important for overall healing and nutritional status but does not have a direct impact on preventing thrombophlebitis.</li>
</ul>
<p>In summary, encouraging the patient to perform dorsiflexion of the feet several times each hour is the most effective strategy for preventing thrombophlebitis following mitral valve replacement surgery.</p>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 63</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Prophylaxis advice to adult patients undergoing tooth extraction for dental caries against infective endocarditis is all of the following, except?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Prosthetic heart valves</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Atrial septal defect</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Unrepaired cyanotic heart disease</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Prior history of endocarditis</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Atrial septal defect is not considered a high-risk condition that warrants prophylaxis against infective endocarditis.</li>
<li>Bacterial or fungal infection of the valvular or endocardial surface of the heart is known as infective endocarditis.</li>
<li>Large friable vegetation on the heart valves composed of fibrin, inflammatory cells, and organisms are characteristic of the condition.</li>
<li>Predisposing conditions include mitral valve prolapse, ventricular septal defect, rheumatic heart diseases intravenous drug use, and prosthetic valves.</li>
<li>Prophylaxis against infective endocarditis is recommended during certain dental procedures and respiratory tract procedures.</li>
<li>In patients not allergic to penicillin, 2 g of amoxicillin can be given orally one hour before the procedure. Another option is to administer 2 g of ampicillin intravenously or intramuscularly 30 minutes before the procedure.</li>
<li>Though prophylaxis is not advised, it is recommended that skin and genitourinary tract infections be treated before undergoing the procedure at these sites.</li>
<li>The most common organisms responsible are <em>Staphylococcus aureus, streptococci,</em> and pneumococci.</li>
<li>The oral cavity is the portal for Viridans streptococci.</li>
<li>Staphylococci are responsible for early prosthetic valve endocarditis. In late prosthetic valve endocarditis, streptococci are commonly implicated.</li>
<li>Clinical features include subungual splinter hemorrhages, Osler nodes, Janeway lesions, and Roth spots.</li>
<li>Osler nodes, which are painful raised violaceous lesions commonly affecting the fingers, toes, and feet. It is immunologically mediated.</li>
<li>Symptoms such as dyspnea, cough, arthralgias, and flank pain can also arise due to embolization or immunologically mediated phenomena.</li>
<li>Antibiotics are the mainstay in management. In certain cases, surgical management is necessary.</li>
</ul>
<p>&nbsp;</p>
<p><strong><strong>Other options:</strong></strong></p>
<ul>
<li><strong>Option A:</strong> Prosthetic heart valves
<ul>
<li>Patients with prosthetic heart valves are at a higher risk of developing infective endocarditis, which is why prophylaxis is recommended before dental procedures.</li>
<li>Antibiotic prophylaxis is usually recommended for patients with prosthetic heart valves, regardless of the type of dental procedure they are undergoing.</li>
</ul>
<p><strong>Option C:</strong> Unrepaired cyanotic heart disease</p>
<ul>
<li>Patients with unrepaired cyanotic heart disease, such as Tetralogy of Fallot or transposition of the great vessels, are also at an increased risk of developing infective endocarditis.</li>
<li>Antibiotic prophylaxis is usually recommended for these patients before dental procedures.</li>
</ul>
<p><strong>Option D:</strong> Prior history of endocarditis</p>
<ul>
<li>Patients who have previously had infective endocarditis are at a higher risk of developing it again.</li>
<li>Antibiotic prophylaxis is usually recommended for these patients before dental procedures, especially if the previous infection occurred within the past year or if they have prosthetic heart valves.</li>
</ul>
</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 64</h3>
                <p><b>A nurse is caring for a patient who has just arrived on the Cath-Lab unit after undergoing cardiac catheterization. Which assessment should the nurse prioritize immediately?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Heart and lung sounds</li><li>2. Pain at the catheter insertion site</li><li>3. Pulses distal to the insertion site</li><li>4. Urine output</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option (c) is the correct choice because assessing the pulses distal to the catheter insertion site is crucial immediately after cardiac catheterization. This assessment helps to determine the adequacy of blood flow and circulation to the extremities. A lack of pulse or diminished circulation can indicate complications such as a clot or occlusion, which requires prompt intervention to prevent further complications.</li><li><b>Option (a),</b> assessing heart and lung sounds, while important, can be done after ensuring that circulation is intact since it does not directly indicate immediate complications related to the procedure.</li><li><b>Option (b),</b> assessing pain at the catheter insertion site, is important for identifying potential complications like hematoma or infection, but it is secondary to assessing circulation.</li><li><b>Option (d),</b> monitoring urine output, is a part of overall assessment but is less critical than ensuring blood flow to the extremities immediately following the procedure.In conclusion, the most immediate assessment after cardiac catheterization is to evaluate the pulses distal to the insertion site, as it directly relates to the client’s circulation and safety.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 65</h3>
                <p><b>After conducting an assessment, the nurse concludes that a client is showing signs of left heart failure. Which of the following signs and symptoms are characteristic of this condition?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Tachypnea, loss of appetite, ST elevation on the ECG</li><li>2. Hemoptysis, cogwheel murmur, mid-sternal chest pain</li><li>3. Ascites, oliguria, fatigue</li><li>4. Orthopnoea, bibasilar crackles, gallop rhythm</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>In left heart failure, the heart struggles to manage the volume of blood returning from the lungs. As a result, blood begins to back up into the pulmonary circulation, leading to pulmonary congestion. This is primarily due to increased pressure in the left atrium and subsequent pressure in the pulmonary veins. The consequences of this congestion manifest in a variety of respiratory symptoms, which are critical for diagnosis.<ul ><li><b>Orthopnea:</b> This symptom refers to the difficulty in breathing that occurs when lying flat. Patients with left heart failure often find it easier to breathe when sitting or propped up because gravity helps reduce the amount of blood pooling in the lungs. When they lie flat, the increased venous return exacerbates pulmonary congestion, leading to breathlessness.</li><li><b>Bibasilar Crackles:</b> These are abnormal lung sounds that can be heard upon auscultation. Crackles, or rales, are typically indicative of fluid accumulation in the alveoli, which is common in left heart failure due to pulmonary congestion. The presence of these crackles, particularly at the bases of the lungs (bibasilar), suggests that there is significant fluid build-up, which hampers effective gas exchange.</li><li><b>Gallop Rhythm:</b> This refers to an abnormal heart sound characterized by an extra heart sound that follows the normal “lub-dub” (S1 and S2) sounds. It may be described as “S3” or “S4” depending on its timing. An S3 gallop is often associated with rapid ventricular filling due to increased blood volume returning to the heart, which is common in heart failure scenarios.</li></ul><p><b>Evaluation of Other Options</b><ul><li><b>Option (a):</b> This combination includes tachypnea (rapid breathing), loss of appetite, and ST segment elevation on the ECG. While tachypnea may be present in left heart failure due to respiratory distress, loss of appetite is a nonspecific symptom and does not directly indicate heart failure. ST elevation usually suggests myocardial ischemia or infarction rather than heart failure specifically.</li><li><b>Option (b):</b> The symptoms mentioned here—hemoptysis (coughing up blood), cogwheel murmur, and mid-sternal chest pain—are not characteristic of left heart failure. Instead, they could indicate other serious conditions such as pulmonary embolism or other cardiac issues. The cogwheel murmur is not commonly associated with heart failure and is more indicative of specific valvular heart disease.</li><li><b>Option (c):</b> Ascites (fluid in the abdominal cavity), oliguria (decreased urine output), and fatigue are more representative of right heart failure, where fluid overload leads to systemic congestion. In left heart failure, symptoms primarily arise from pulmonary congestion rather than systemic venous pressure.</li></ul><p><b>Conclusion:</b><ul><li>In summary, option (d) is the most indicative of left heart failure due to the direct relationship between the left ventricular dysfunction and the resulting pulmonary congestion. Understanding these specific symptoms is crucial for timely diagnosis and management of left heart failure, which can significantly impact patient outcomes if not addressed appropriately. Therefore, recognizing orthopnea, bibasilar crackles, and gallop rhythm as critical signs of left heart failure underscores the nurse’s role in effective patient assessment and intervention planning.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 66</h3>
                <p><b>A 45-year-old patient with acute coronary syndrome undergoes percutaneous coronary intervention (PCI). The patient is administered abciximab intravenously to inhibit platelet aggregation during the procedure. What potential benefit does the use of abciximab provide to patients undergoing PCI?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Reduction of inflammation at the site of intervention</li><li>2. Enhanced platelet synthesis</li><li>3. Prevention of stent thrombosis</li><li>4. Decreased blood pressure</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Abciximab is a glycoprotein IIb/IIIa receptor antagonist that is used during percutaneous coronary intervention (PCI) to inhibit platelet aggregation and prevent acute thrombosis, especially in the context of stent placement.<p><b>Here’s how abciximab benefits patients undergoing PCI:</b><ul ><li>During PCI, a stent is often placed to help open a narrowed or blocked coronary artery. </li><li>The process of inserting a stent can cause endothelial injury and platelet activation. </li><li>Platelets play a key role in clot formation, and their aggregation can lead to the development of thrombi (clots) within the stent, a condition known as stent thrombosis. </li><li>Stent thrombosis can be life-threatening and may result in a myocardial infarction.</li><li>Abciximab works by inhibiting the glycoprotein IIb/IIIa receptors on the surface of platelets. </li><li>These receptors play a critical role in platelet aggregation and clot formation. </li><li>By blocking these receptors, abciximab reduces the risk of platelet aggregation within the stent, preventing stent thrombosis and ensuring the patency (openness) of the stent. </li><li>This is a critical benefit during and immediately after PCI to enhance the success of the procedure and reduce the risk of complications.</li></ul><p><b>Other options:</b><ul><li><b>Option A:</b> Abciximab is primarily used to inhibit platelet aggregation and prevent thrombosis; it does not target the reduction of inflammation at the site of intervention.</li><li><b>Option B:</b> Abciximab does not enhance platelet synthesis; rather, it inhibits platelet activation and aggregation.</li><li><b>Option D:</b> Abciximab does not typically affect blood pressure. Its main purpose during PCI is to prevent stent thrombosis and acute clot formation in the coronary arteries.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 67</h3>
                <p><b>A patient has been diagnosed with pericardial effusion. In this context, the nurse should prepare the patient for which of the following procedures?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Myotomy</li><li>2. Pericardiectomy</li><li>3. Pericardiostomy</li><li>4. Dynamic cardiomyoplasty</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Pericardiostomy, which involves creating an opening in the pericardium to facilitate the drainage of excess fluid accumulated in the pericardial space—a condition known as pericardial effusion. This procedure is essential as it helps relieve pressure on the heart, allowing it to function more effectively.<p><b>Understanding Pericardial Effusion:</b> Pericardial effusion refers to the accumulation of fluid in the pericardial cavity, the space between the heart and the pericardium (the fibrous sac surrounding the heart). This condition can arise due to various causes, including infections, inflammatory diseases, cancer, or post-surgical complications. The build-up of fluid can lead to increased pressure on the heart, resulting in symptoms such as shortness of breath, chest pain, and in severe cases, cardiac tamponade—a life-threatening condition.<p><b>Other Options Explained:</b><ul ><li><b>Myotomy: This procedure involves making an incision in a muscle, typically related to correcting problems with muscles affecting swallowing or other muscular functions. It is not relevant to managing pericardial effusion.</li><li><b>Pericardiectomy: This surgical procedure involves the excision of a part or all of the pericardium. While it can be used for chronic conditions like constrictive pericarditis, it is not the first-line procedure for immediate drainage of pericardial effusion.</li><li><b>Dynamic cardiomyoplasty: This is a more complex surgical technique aimed at enhancing heart function by using skeletal muscle to assist the failing heart. It is not used to treat pericardial effusion.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 68</h3>
                <p><b>Which of the following instructions would be unsuitable to provide to a client after undergoing coronary artery bypass graft (CABG) surgery?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. No driving for 6–8 weeks</li><li>2. Avoid smoking or tobacco use for 4–6 weeks</li><li>3. No heavy lifting for 6–8 weeks</li><li>4. Can resume sexual intercourse in 3–4 weeks</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The correct answer is b) Avoid smoking or tobacco use for 4–6 weeks. While it is important for patients to refrain from smoking or using tobacco during their recovery period, the recommendation should be more stringent. Smoking cessation should be viewed as a long-term lifestyle change rather than a temporary measure. Tobacco use can significantly impair cardiovascular health and the healing process, particularly after a procedure such as CABG, where the heart and blood vessels are directly impacted. Therefore, advising the client to stop smoking entirely, rather than just for a limited time, is crucial for their recovery and overall well-being.</li></ul><p><b>Understanding the other options:</b><ul><li><b>Option a) No driving for 6–8 weeks:</b> This instruction is appropriate. After CABG surgery, patients often experience pain, fatigue, and reduced strength, which can hinder their ability to drive safely. Allowing 6–8 weeks for recovery helps ensure they can handle the physical and mental demands of driving.</li><li><b>Option c) No heavy lifting for 6–8 weeks:</b> This is also an appropriate instruction. Lifting heavy objects can put undue strain on the chest, which is still healing after surgery. Avoiding heavy lifting during this period helps prevent complications, such as strain on the surgical site.</li><li><b>Option d) Can resume sexual intercourse in 3–4 weeks:</b> This instruction is generally acceptable as well. Many healthcare providers recommend that patients can return to sexual activity about 3 to 4 weeks after CABG, assuming their recovery is progressing well. It’s crucial, however, for patients to discuss any concerns or personal circumstances with their healthcare provider before resuming sexual activity.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 69</h3>
                <p><b>A 50-year-old patient has slight limitation of physical activity. He is comfortable at rest but ordinary physical activity results in fatigue, palpitation and dyspnea. His NYHA grade of dyspnea is?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Grade 1</li><li>2. Grade 2</li><li>3. Grade 3</li><li>4. Grade 4</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Based on history, the given patient comes under Grade 2 of New York Heart Association Functional Classification.<p><b>NYHA Grading:</b><ul ><li>Grade 1: No limitation of physical activity; No symptoms with ordinary exertion.</li><li>Grade 2: Slight limitation of physical activity; Ordinary activity causes symptoms.</li><li>Grade 3: Marked limitation of physical activity; Less than ordinary activity causes symptoms, but asymptomatic at rest.</li><li>Grade 4: Inability to carry out any physical activity without discomfort; Symptomatic at rest</li></ul><p><b>Other options:</b><ul><li><b>Option A:</b> Grade 1: No limitation of physical activity; No symptoms with ordinary exertion.</li><li><b>Option C:</b> Grade 3: Marked limitation of physical activity; Less than ordinary activity causes symptoms, but asymptomatic at rest.</li><li><b>Option D:</b> Grade 4: Inability to carry out any physical activity without discomfort; Symptomatic at rest.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 70</h3>
                <p><b>Which of the following instructions should a nurse provide to a patient scheduled for a cardiac nuclear scan?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Avoid coffee, tea, and cocoa the morning of the test</li><li>2. Follow a clear liquid diet for 24 hours before the test</li><li>3. Wear comfortable clothing and walking shoes</li><li>4. Continue taking all prescribed medications prior to the test</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>This recommendation is important for a cardiac nuclear scan as it may involve physical activity, such as walking on a treadmill or performing other exercises during the procedure. Comfortable clothing allows for ease of movement, and appropriate footwear enhances stability and comfort, which is particularly relevant if the patient needs to engage in physical activity as part of the testing process.<p>Let’s examine the other options to clarify why they are not appropriate for this scenario:<ul ><li><b>Option a) Avoid coffee, tea, and cocoa the morning of the test:</b> While it is common to advise patients to avoid caffeine before certain cardiac tests due to its potential effects on heart rate and blood pressure, this specific instruction may vary based on the facility’s protocols or the type of scan being performed. It is not universally required for all cardiac nuclear scans, so this instruction is not definitive. </li><li><b>Option b) Follow a clear liquid diet for 24 hours before the test:</b> A clear liquid diet may be necessary for specific tests, but it is not typically required for a cardiac nuclear scan. Most guidelines allow patients to eat a light meal unless otherwise instructed. This instruction is not appropriate for all clients undergoing this procedure.</li><li><b>Option d) Continue taking all prescribed medications prior to the test:</b> While many medications can be taken as prescribed, certain medications may need to be withheld prior to the scan, especially those that could affect heart function or blood pressure. This instruction is not universally applicable and should be clarified with the healthcare provider prior to the test.</li></ul><p><b>Summary:</b> In summary, the most relevant and universally applicable instruction for a patient preparing for a cardiac nuclear scan is to wear comfortable clothing and walking shoes (option c). This guidance ensures the client is physically prepared for any necessary activity during the test while providing a comfortable experience overall.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 71</h3>
                <p><b>The nurse would expect to administer morphine sulfate, oxygen, nitroglycerin, and aspirin to a patient experiencing which condition?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Raynaud’s disease</li><li>2. Myocardial infarction</li><li>3. Valvular heart disease</li><li>4. Kawasaki disease</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><p>The acronym <strong>MONA</strong> refers to the immediate treatment protocol used for patients presenting with a <strong>myocardial infarction (MI)</strong>, which includes:</p>&#10;<ul>&#10;<li><strong>Morphine sulfate</strong>: This medication is administered to alleviate severe chest pain and discomfort. Morphine also helps reduce anxiety, decreases oxygen demand by lowering heart workload, and may aid in dilating coronary arteries.</li>&#10;<li><strong>Oxygen</strong>: Supplemental oxygen is provided to increase oxygen delivery to the myocardium, especially in cases of hypoxia due to reduced blood flow. Ensuring adequate oxygenation is crucial during an MI to minimize cardiac tissue damage.</li>&#10;<li><strong>Nitroglycerin</strong>: This vasodilator helps relieve chest pain by relaxing the smooth muscle in the coronary arteries and improving blood flow to the heart muscle. It also reduces preload and afterload, decreasing the heart's oxygen demand.</li>&#10;<li><strong>Aspirin</strong>: Administered to inhibit platelet aggregation, aspirin helps prevent the formation of new clots and the growth of existing ones, reducing the risk of further obstruction in coronary arteries during an MI.</li>&#10;</ul>&#10;<p>Each component of the MONA protocol plays a vital role in managing a myocardial infarction and addressing the associated symptoms and complications.</p>&#10;<p><strong>Discussion of Other Options:</strong></p>&#10;<ul>&#10;<li><strong>Option a) Raynaud&#8217;s disease</strong>: The treatment for Raynaud&#8217;s primarily involves avoiding triggers, medications such as vasodilators, calcium channel blockers, and sometimes analgesics, not the MONA protocol.</li>&#10;<li><strong>Option c) Valvular heart disease</strong>: Management may include medications like digitalis, diuretics, ACE inhibitors, and potential surgical interventions. It does not typically involve the MONA approach.</li>&#10;<li><strong>Option d) Kawasaki disease</strong>: This condition requires treatment with salicylate therapy and intravenous gamma globulin, focusing on reducing inflammation and preventing coronary artery complications.</li>&#10;</ul>&#10;<p><strong>Summary:</strong></p>&#10;<p>In conclusion, the combination of morphine sulfate, oxygen, nitroglycerin, and aspirin is specifically indicated for patients experiencing a myocardial infarction. This treatment approach aims to relieve pain, restore oxygen supply, and prevent further cardiac damage, highlighting the urgency and specificity of care required in such critical situations.</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 72</h3>
                <p><b>A 42-year-old man presents with sudden onset chest pain, tingling sensation and numbness along the jaw, and profuse perspiration. After preliminary examination in the Casualty department, the patient’s blood pressure was measured as 90/50 mmHg, and pulse as 46 beats per minute. Inferior leads of ECG showcase ST-segment elevation. Which of the following findings would be found in the patient?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Increased PCWP</li><li>2. Decreased CVP</li><li>3. Increased Cardiac Index</li><li>4. Decreased SVR</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Sudden-onset chest pain, radiation to the jaw, perspiration, and ST-segment elevation in contiguous ECG leads is suggestive of an ST-elevation Myocardial Infarction (STEMI).</li><li>Hypotension and bradycardia are suggestive of MI-induced acute left ventricular (LV) failure and Cardiogenic Shock.</li><li>Systolic failure leads to increased LV end-diastolic pressure, further transmitted backward to increase pulmonary capillary wedge pressure (PCWP) and pulmonary edema.</li><li>The increased pressure also impairs right ventricular function, causing increased central venous pressure (not decreased).</li><li>Low cardiac output leads to hypotension with decreased coronary perfusion pressure, thereafter leading to compensatory peripheral vasoconstriction to increase systemic vascular resistance in an effort to maintain homeostasis.</li></ul><p><b>Other options:</b><ul><li><b>Option B:</b> Decreased central venous pressure (CVP) which is representative of Right-Sided Preload is only decreased in distributive shock.</li><li><b>Option C:</b> Increased cardiac index which is representative of Left Ventricular Output is only increased in Distributive Shock, or neurogenic shock due to impaired sympathetic reflexes.</li><li><b>Option D:</b> Decreased systemic vascular resistance (SVR) which is representative of Afterload is only decreased in Distributive Shock.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 73</h3>
                <p><b>For a patient experiencing a sickle cell crisis, the nurse should prioritize frequent assessments of:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Amount of fluid intake</li><li>2. Level of pain</li><li>3. Prolonged erection in males</li><li>4. Lower leg ulcers</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>In a sickle cell crisis, pain is the primary and most acute symptom. This pain results from the sickle-shaped red blood cells blocking blood flow through small blood vessels, leading to tissue ischemia and necrosis. Therefore, regularly assessing the level of pain allows the nurse to gauge the severity of the crisis and make appropriate adjustments to the treatment plan.</li></ul><p><b>Discussion of </li></ul><p><b>Other options:</b><ul><li></b><ul><li><b>Option a) Amount of fluid intake:</b> While monitoring fluid intake is important in managing sickle cell disease, especially to prevent dehydration and promote better blood flow, it is secondary to assessing pain during a crisis.</li><li><b>Option c) Prolonged erection in males:</b> This is a complication that can occur with sickle cell disease but is not a common or acute symptom during a crisis. It may occur due to priapism, but this is a chronic issue rather than a primary concern during a crisis.</li><li><b>Option d) Lower leg ulcers:</b> Like prolonged erection, lower leg ulcers are associated with chronic complications of sickle cell disease. These ulcers result from poor circulation over time, not from an acute crisis.</li></ul><p><b>Summary:</b> In summary, during a sickle cell crisis, the most critical assessment for the nurse is the level of pain, as it directly reflects the patient’s condition and guides further interventions to manage the crisis effectively.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 74</h3>
                <p><b>How should a nurse interpret the sudden appearance of pallor and symptoms of low blood pressure in a patient with sickle cell disease?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. The patient is experiencing bleeding.</li><li>2. A vaso-occlusive crisis may be starting.</li><li>3. The patient is undergoing a sequestration crisis.</li><li>4. There has been systemic vasodilation.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>In clients with sickle cell disease, the sudden onset of paleness and hypotension can indicate a sequestration crisis. This condition occurs when sickled red blood cells become trapped in the spleen or other organs, leading to a pooling of blood and a significant drop in circulating blood volume.</li><li><b>Sequestration Crisis:</b> During a sequestration crisis, the spleen becomes enlarged due to trapped sickled cells, leading to hypovolemia (decreased blood volume). This can result in symptoms such as paleness (pallor) and hypotension. The body’s inability to adequately perfuse tissues due to low blood volume can lead to further complications, including shock if not promptly addressed.</li><li><b>Bleeding:</b> While option (a) is a possibility in any patient exhibiting sudden hypotension and pallor, in the context of sickle cell disease, the sequestration crisis is more common and represents a significant risk due to the nature of the disease.</li><li><b>Vaso-Occlusive Crisis:</b> Option (b) refers to a different type of crisis characterized by pain and tissue ischemia due to blocked blood flow. While this can occur in sickle cell disease, it typically presents with localized pain rather than the systemic symptoms of hypotension and paleness.</li><li><b>Systemic Vasodilation:</b> Option (d) is incorrect because systemic vasodilation would generally lead to decreased blood pressure but would not typically result in paleness unless it was part of a larger shock response.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 75</h3>
                <p><b>Which of the following conditions presents with the Water hammer pulse?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Aortic stenosis</li><li>2. Aortic regurgitation</li><li>3. Aortic stenosis and aortic regurgitation</li><li>4. Mitral regurgitation</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The condition that presents with the Water hammer pulse is option B, which is Aortic regurgitation.</li><li>A Water hammer pulse is a forceful, bounding pulse that feels like a hammer striking against the fingers when palpated. </li><li>It is caused by a sudden increase in blood flow into the arteries, followed by a sudden drop in pressure when the aortic valve closes.</li><li>This condition is also known as the Corrigan pulse or the collapsing pulse.</li><li>Aortic regurgitation is a condition where the aortic valve fails to close completely, causing blood to leak back into the left ventricle during diastole. </li><li>As a result, there is an increased volume of blood flowing into the arteries during systole, leading to a sudden rise in blood pressure and a bounding, forceful pulse. </li><li>This pulse is known as the Water hammer pulse.</li></ul><p><b>Other options:</b><ul><li><b>Option A:</b> Aortic stenosis, on the other hand, presents with a weak, delayed, or absent pulse due to obstruction of blood flow from the left ventricle to the aorta. Aortic stenosis does not present with a Water hammer pulse.</li><li><b>Option C:</b> Which is a combination of aortic stenosis and aortic regurgitation, may present with a weak or delayed pulse due to the stenosis and a bounding pulse due to the regurgitation. However, the specific pulse associated with this combination of conditions is not the Water hammer pulse.</li><li><b>Option D:</b> Which is mitral regurgitation, presents with a weak, delayed, or absent pulse due to decreased stroke volume from the left ventricle. It does not present with a Water hammer pulse.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 76</h3>
                <p><b>During a health education session with a patient recently diagnosed with polycythemia vera, the patient inquires about the reasons behind the increased risk of blood clots associated with this condition. What should be the primary focus of the nurse’s response?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Viscosity is increased</li><li>2. Blood volume is decreased</li><li>3. Arterial diameter is narrowed</li><li>4. Platelet activity is decreased</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>The primary reason for the heightened risk of blood clots in patients with polycythemia vera is the increased viscosity of the blood (option a). In this condition, there is an overproduction of red blood cells, leading to a thicker and stickier blood consistency. This increased viscosity slows down blood flow, particularly in smaller vessels, and promotes the formation of clots.</li><li><b>Increased Viscosity:</b> The excessive number of red blood cells elevates the overall viscosity of the blood, making it more prone to clotting. This can lead to complications such as thrombosis, which can result in serious cardiovascular events.</li><li><b>Blood Volume:</b> Contrary to option (b), blood volume is actually increased in polycythemia vera due to the elevated red blood cell count. This increase contributes to the higher viscosity rather than leading to a decrease in blood volume.</li><li><b>Arterial Diameter:</b> Option (c) is not applicable to polycythemia vera; the arterial structure remains unchanged by this disease. The narrowing of arterial diameter is not a direct consequence of the increased red blood cell mass.</li><li><b>Platelet Activity:</b> In terms of option (d), platelet activity is not decreased; in fact, many patients with polycythemia vera may have elevated platelet counts, which can further contribute to clotting risks.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 77</h3>
                <p><b>What essential information should the nurse provide to a patient who has just been diagnosed with pernicious anemia?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Symptoms will begin to disappear once you start eating a diet high in iron.</li><li>2. You should expect intermittent episodes of nausea and sweating once therapy begins.</li><li>3. Injections of vitamin B12 will be necessary for the rest of your life.</li><li>4. It is important to avoid foods that increase peristalsis and cause loose stools.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>When educating a patient about pernicious anemia, it is crucial to emphasize that lifelong vitamin B12 injections are required. This is because pernicious anemia is characterized by the body’s inability to absorb vitamin B12 from the gastrointestinal tract due to a deficiency of intrinsic factor, which is necessary for B12 absorption in the ileum. Therefore, to ensure adequate levels of this vital nutrient, injections are needed to bypass the gastrointestinal absorption process.<ul ><li><b>Vitamin B12 Injections:</b> The need for continuous injections arises from the underlying condition. While some patients may also be prescribed oral or nasal vitamin B12, the primary treatment remains injectable therapy to ensure that they receive sufficient amounts of the vitamin.</li><li><b>Diet and Iron:</b> Option (a) is misleading; while dietary changes are important for managing other types of anemia, a diet high in iron will not address the symptoms of pernicious anemia because the underlying issue is not iron deficiency.</li><li><b>Side Effects: In response to option (b), it is inaccurate to suggest that patients will experience nausea and diaphoresis with vitamin B12 therapy, as these symptoms are not typical side effects of B12 administration.</li><li><b>Dietary Considerations:</b> Option (d) is also incorrect; the degree of peristalsis and stool consistency is not directly related to pernicious anemia. Therefore, patients do not need to avoid foods that might increase peristalsis or cause loose stools as a management strategy for this condition.</li></ul><p><b>Summary:</b> In summary, the most critical piece of information for patients diagnosed with pernicious anemia is the necessity for lifelong vitamin B12 injections to compensate for their inability to absorb the vitamin from their diet. Proper education about the condition and its management will empower patients to understand their treatment plan and adhere to the necessary therapies.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 78</h3>
                <p><b>A 69-year-old man was presented with a history of progressively worsening dyspnea on exertion. He is known diabetic and hypertensive, on regular medications. On examination, JVP was raised and positive hepatojugular reflux, crackles at the lung bases, hepatomegaly, ascites, pedal edema was found. Provisional diagnosis would be?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Portal hypertension</li><li>2. Hypertrophic cardiomyopathy</li><li>3. Mitral regurgitation</li><li>4. Heart failure</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The clinical example provided is indicative of heart failure.</li><li>Because the ventricle is unable to fill with blood or evacuate blood, heart failure is a complex clinical condition that develops. <p><b>Heart failure’s etiology includes:</b><ul ><li>Hypertension (most prevalent cause) (most common cause)</li><li>Type 2 diabetes</li><li>Cardiovascular disease</li><li>Cardiomyopathies</li><li>Kidney illness that is ongoing</li><li>High output conditions such</li><li>Thyrotoxicosis, </li><li>Severe anemia</li><li>BeriberiSigns and symptoms of heart failure are:</b>Right heart failure:</b> Due to congestion in the systemic circulation:</li></ul><p><b>Symptoms and signs:</b><ul><li>Raised JVP</li><li>Congestive hepatomegaly</li><li>Positive</li><li>Hepatojugular reflux</li><li>Ascites</li><li>Bilateral pitting edema</li><li>Weight gain- Due to edema</li><li>Fatigue- Due to pumping of blood to lungs leading to oxygenation of the blood.Left heart failure:</b> Due to congestion in the lungs:</li></ul><p><b>Symptoms and signs:</b><ul><li>Dyspnea on exertion</li><li>Orthopnea</li><li>Paroxysmal nocturnal</li><li>Dyspnea (characteristic of LVF)</li><li>Pulmonary rales</li><li>Increased</li><li>PCWP</li><li>Fatigue- Due to cardiac output.</li></ul><p><b>Other options:</b><ul><li><b>Option A:</b> Portal hypertension, can cause ascites, pedal edema, and hepatomegaly, but it usually does not cause crackles in the lungs or positive hepatojugular reflux. Additionally, the presence of a raised JVP and dyspnea on exertion are more indicative of heart failure.</li><li><b>Option B:</b> Hypertrophic cardiomyopathy, can cause dyspnea on exertion, but it usually does not cause ascites, pedal edema, or crackles in the lungs. Additionally, the presence of a raised JVP, positive hepatojugular reflux, and hepatomegaly are not typical findings in hypertrophic cardiomyopathy.</li><li><b>Option C:</b> Mitral regurgitation, can cause dyspnea on exertion and may lead to pulmonary congestion and crackles in the lungs, but it usually does not cause hepatomegaly or ascites. The presence of a raised JVP, positive hepatojugular reflux, and pedal edema are more indicative of right-sided heart failure, which can be caused by mitral regurgitation.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 79</h3>
                <p><b>What is an appropriate nursing intervention for a patient with a lymphocyte count of 19,000/mm³?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Institution of DVT precautions</li><li>2. Institution of protective isolation</li><li>3. Institution of bleeding precautions</li><li>4. Institution of seizure precautions</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>In evaluating the lymphocyte count of 19,000/mm³, it is important to consider the implications of this value. While the normal range for lymphocyte counts typically falls between 1,000 and 4,800/mm³, a count of 19,000/mm³ is significantly elevated, indicating lymphocytosis.<ul ><li><b>Bleeding Precautions:</b> The most critical intervention in this case is the institution of bleeding precautions. Elevated lymphocyte counts can be associated with conditions that may lead to thrombocytopenia (low platelet count) and, subsequently, an increased risk of spontaneous bleeding. Although lymphocytes themselves do not directly influence coagulation, a count over 20,000/mm³ is concerning for possible complications related to underlying conditions, such as hematological disorders. Therefore, implementing bleeding precautions is essential to prevent any potential bleeding complications.</li><li><b>DVT Precautions:</b> While Deep Vein Thrombosis (DVT) precautions are important for patients with limited mobility, they are not directly indicated by a high lymphocyte count. DVT precautions are more relevant in patients who are immobilized or have risk factors for venous thromboembolism.</li><li><b>Protective Isolation:</b> This is typically required for patients with neutropenia, where the neutrophil count is low, increasing the risk of infection. In this scenario, the lymphocyte count does not indicate neutropenia.</li><li><b>Seizure Precautions:</b> These are necessary for patients with a history of seizures or those at high risk of seizures, but there is no direct correlation with lymphocyte count.</li></ul><p>In summary, for a patient with a lymphocyte count of 19,000/mm³, the appropriate nursing intervention is the institution of bleeding precautions to mitigate the risk of potential bleeding complications associated with hematological issues.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 80</h3>
                <p><b>When planning care for a patient with aplastic anemia, which nursing order should be included?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Test urine and stool for occult blod.</li><li>2. Monitor for signs of pulmonary edema.</li><li>3. Encourage flossing after each meal.</li><li>4. Prevent chilling.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>When caring for a patient diagnosed with aplastic anemia, it is crucial to prioritize interventions that address the specific risks associated with this condition. Aplastic anemia is characterized by a reduction in the production of red blood cells, white blood cells, and platelets, leading to a number of complications.<ul ><li><b>Testing for Occult Blood:</b> The correct nursing order is to test urine and stool for occult blood (option a). This is important because the low platelet count associated with aplastic anemia increases the risk of bleeding. By checking for occult blood, the nurse can identify any internal bleeding that may require further intervention. </li><li><b>Monitoring for Pulmonary Edema:</b> While monitoring for signs of pulmonary edema (option b) is important in patients with heart failure or those receiving certain treatments, it is not specifically relevant to the general care plan for aplastic anemia.</li><li><b>Encouraging Flossing:</b> Encouraging the patient to floss after each meal (option c) is contraindicated due to the risk of bleeding. Patients with aplastic anemia should avoid procedures that could cause trauma or bleeding to the gums, making this option inappropriate.</li><li><b>Preventing Chilling:</b> Preventing chilling (option d) is typically advised for patients with cold-induced autoimmune anemia, but it does not specifically apply to patients with aplastic anemia. </li></ul><p>In summary, the nursing order to test urine and stool for occult blood is essential for a patient with aplastic anemia, as it helps detect potential bleeding complications associated with the condition’s impact on blood cell production.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 81</h3>
                <p><b>After a hip replacement surgery, if patients present with swelling of the legs in association with pain on palpation; PR-70 beats per min and no history of hemoptysis or significant weight loss or no previous history of pulmonary embolism; based on Well’s score what is the risk level for development of pulmonary embolism?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Low</li><li>2. Moderate</li><li>3. High</li><li>4. Cannot comment without d-dimer values</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>According to Well’s criteria, the patient has a high risk of getting a pulmonary embolism.Ways to calculate Well’s score:</li><li>Clinical DVT symptoms = 3</li><li>Alternative diagnosis not made = 3</li><li>70 beats per minute is the heart rate (< 100) = 0</li><li>Surgery during the last four weeks = 1.5</li><li>No previous PE = 0</li><li>No Hemoptysis = 0</li><li>No cancer (no substantial weight loss) = 0Score overall: 7.5A patient’s chance of suffering pulmonary embolism is increased if their Well’s score is more than 6.Rule out criterion for pulmonary embolism (PERC):</b>To quickly rule out pulmonary embolism in patients with minimal clinical probability, use this OPD/casualty tool. There are eight clinical variables in it. If the patient satisfies all eight requirements, no additional research is required. The variables consist of:</b></li><li>Age <50 years</li><li>100 bpm for heart rate.</li><li>SpO2 >95%</li><li>There is no lone leg swelling.</li><li>No hemoptysis</li><li>No recent injuries or operations.</li><li>No history of venous thromboembolism.</li><li>Hormone therapy is not allowed.</li></ul><p><b>Other options:</b><ul><li><b>Option A:</b> A low risk level for development of pulmonary embolism is typically associated with a Well’s score of less than 2. In this scenario, the patient has undergone a hip replacement surgery and presents with swelling of the legs, which can be a sign of deep vein thrombosis (DVT), a risk factor for pulmonary embolism. Therefore, a Well’s score of less than 2 would not be appropriate in this case.</li><li><b>Option B:</b> A moderate risk level for development of pulmonary embolism is typically associated with a Well’s score of 2-6. In this scenario, the patient has undergone a hip replacement surgery and presents with swelling of the legs, which can be a sign of DVT, a risk factor for pulmonary embolism. Therefore, a Well’s score of 2-6 would be appropriate in this case.</li><li><b>Option D:</b> While a d-dimer test is often used in conjunction with the Well’s score to assess the risk of pulmonary embolism, it is not necessary to calculate the Well’s score itself. In this scenario, the patient has undergone a hip replacement surgery and presents with swelling of the legs, which can be a sign of DVT, a risk factor for pulmonary embolism. Therefore, it is appropriate to calculate the Well’s score based on the available information.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 82</h3>
                <p><b>Using light pressure with the index and middle fingers, the nurse is unable to palpate any of the patient’s superficial lymph nodes. How should the nurse respond to this assessment?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Record this finding as normal.</li><li>2. Reassess the lymph nodes using deeper pressure.</li><li>3. Ask the patient about any history of radiation therapy.</li><li>4. Notify the health care provider that x-rays of the nodes will be necessary.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option a. Record this finding as normal:</b> This is the correct response. Superficial lymph nodes, such as those located in the cervical, axillary, and inguinal regions, are typically evaluated through light palpation. It is important to note that while small, mobile, firm, and non-tender lymph nodes can sometimes be palpated, many individuals will not have palpable lymph nodes under normal circumstances. The absence of palpable nodes, especially in healthy individuals, can be a normal finding and should be documented as such.</li><li><b>Option b. Reassess the lymph nodes using deeper pressure:</b> This option is not appropriate. Superficial lymph nodes are assessed using light palpation, and applying deeper pressure is not necessary or appropriate for evaluating these nodes. If deeper nodes need to be assessed, such as those in the abdomen or retroperitoneal area, that typically requires advanced imaging techniques rather than manual palpation. Therefore, using deeper pressure on superficial nodes is not recommended and could potentially cause discomfort.</li><li><b>Option c. Ask the patient about any history of radiation therapy:</b> While a history of radiation therapy could affect lymph node status, the lack of palpable lymph nodes in itself does not warrant this inquiry. Such a history would be more relevant if there were other concerning symptoms or abnormal findings. In a healthy individual or a patient without significant symptoms, the absence of palpable nodes is not indicative of a problem.</li><li><b>Option d. Notify the health care provider that x-rays of the nodes will be necessary:</b> This option is inappropriate in this context. The absence of palpable lymph nodes, particularly when assessed appropriately with light pressure, does not necessitate further imaging like x-rays. X-ray imaging of lymph nodes is not typically performed as lymph nodes are better evaluated through ultrasound or other imaging modalities if clinically indicated.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 83</h3>
                <p><b>When educating a patient about a bone marrow examination, what should the nurse clarify?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. The procedure will be performed under general anesthesia because it is very painful.</li><li>2. The patient will not feel any pain after the area at the puncture site is anesthetized.</li><li>3. The patient will experience a brief, very sharp pain during the aspiration of the bone marrow.</li><li>4. There will be no pain during the procedure, but an ache may be felt several days afterward.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Option a. The procedure will be performed under general anesthesia because it is very painful: This statement is inaccurate. A bone marrow examination is typically performed using local anesthesia rather than general anesthesia. While the procedure can cause discomfort, it does not usually warrant the use of general anesthesia, as patients are generally awake and alert during the procedure.</li><li><b>Option b. The patient will not feel any pain after the area at the puncture site is anesthetized:</b> This statement is misleading. While local anesthesia is applied to numb the puncture site, the patient will likely still experience pain during the aspiration itself. Local anesthesia minimizes discomfort at the site, but it does not eliminate all sensations during the procedure, particularly the sharp pain associated with the aspiration of the bone marrow.</li><li><b>Option c. The patient will experience a brief, very sharp pain during the aspiration of the bone marrow:</b> This is the correct answer. During the bone marrow aspiration, patients typically experience a brief, sharp pain as the needle is inserted and the bone marrow is aspirated. The pain is generally described as a sudden, intense sensation that lasts only a few seconds. After the aspiration, patients usually do not experience prolonged pain.</li><li><b>Option d. There will be no pain during the procedure, but an ache may be felt several days afterward:</b> This statement is not accurate. Although some patients may report feeling an ache in the days following the procedure, they will certainly experience pain during the aspiration phase. The procedure itself does involve a notable degree of discomfort, which is primarily due to the aspiration, not just afterward.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 84</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A 59-year-old man was brought to ED with an episode of acute onset dizziness and loss of consciousness which lasted for a few seconds followed by a regain of full consciousness. No similar episodes in the past. True statement regarding this scenario is?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tilt-table testing</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>If ECG is normal, CT scan should be done</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>ECG to rule out atrial fibrillation</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vestibular Neuritis is a possible condition that can cause these symptoms</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Syncope may be suspected if there is a transient loss of consciousness. Since this was the first episode, the preliminary assessment would include:</li>
</ul>
<p><strong>History</strong></p>
<ul>
<li>To rule out orthostatic hypotension, a physical exam is mostly used to measure blood pressure when standing and while lying flat.</li>
<li>An ECG while at rest to check for heart arrhythmia.</li>
</ul>
<p><strong>Other options:</strong></p>
<ul>
<li><strong>Option A:</strong> Patients with repeated syncopal attacks who are thought to have vasovagal syncope undergo tilt-table testing. Those who experience recurrent, inexplicable syncopal attacks undergo a psychiatric examination.</li>
<li><strong>Option B:</strong> No more tests are required if the ECG is normal. Other investigations, such as electrophysiological studies and continuous ECG monitoring, may be performed if the ECG is indicative of a cardiac arrhythmia.</li>
<li><strong>Option D:</strong> Vertigo, in which patients frequently report feeling lightheaded and their heads spinning, is linked to vestibular neuritis.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 85</h3>
                <p><b>A lymph node biopsy is most commonly performed to diagnose:</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Leukemia</li><li>2. The cause of lymphedema</li><li>3. Hemorrhagic tendencies</li><li>4. Neoplastic cells in lymph nodes</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option a. leukemia:</b> While leukemia can cause infiltration of lymph nodes, a lymph node biopsy is not primarily performed to diagnose leukemia itself. Instead, leukemia is typically diagnosed through blood tests and bone marrow examinations. A lymph node biopsy focuses more on examining the tissue of the lymph nodes for neoplastic changes rather than detecting leukemia.</li><li><b>Option b. the cause of lymphedema:</b> Lymphedema is characterized by the swelling due to the accumulation of lymph fluid, usually caused by blockages in the lymphatic system. A lymph node biopsy is not used to diagnose the cause of lymphedema. Instead, imaging studies and clinical assessments are more appropriate for identifying the underlying reasons for lymphedema.</li><li><b>Option c. hemorrhagic tendencies:</b> Hemorrhagic tendencies refer to the increased tendency to bleed, which can be caused by various conditions, including clotting factor deficiencies or platelet disorders. A lymph node biopsy does not help in diagnosing bleeding disorders, as these are typically evaluated through blood tests, such as complete blood counts and coagulation studies.</li><li><b>Option d. neoplastic cells in lymph nodes:</b> This is the correct answer. A lymph node biopsy is most often performed to assess for neoplastic cells, which may indicate malignancies such as lymphomas or metastatic cancer from other body sites. By examining the biopsy sample, healthcare providers can determine whether malignant cells are present, aiding in diagnosis and subsequent treatment planning.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 86</h3>
                <p><b>A patient with a hemoglobin (Hb) level of 7.8 g/dL (78 g/L) has cardiac palpitations, a heart rate of 102 bpm, and an increased reticulocyte count. At this severity of anemia, what other manifestation would the nurse expect the patient to exhibit?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Pallor</li><li>2. Dyspnea</li><li>3. A smooth tongue</li><li>4. Sensitivity to cold</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option a. Pallor:</b> Pallor is commonly associated with anemia due to the reduction of hemoglobin in the blood, which can affect the color of the skin and mucous membranes. However, pallor is more prominently observed in severe anemia (usually when Hgb is below 6 g/dL). In this case, with a hemoglobin level of 7.8 g/dL, while pallor may still be present, it is not the most defining characteristic of moderate anemia.</li><li><b>Option b. Dyspnea:</b> Dyspnea, or shortness of breath, is a key manifestation seen in moderate anemia, especially when accompanied by cardiac symptoms like palpitations and elevated heart rate. The body struggles to deliver adequate oxygen to tissues, resulting in increased respiratory demand. Given the patient’s Hgb level and other symptoms, dyspnea is the most likely additional manifestation to expect in this scenario.</li><li><b>Option c. A smooth tongue:</b> A smooth, glossy tongue, known as glossitis, is often associated with certain types of anemia, such as iron deficiency or vitamin B12 deficiency, but is not a specific indicator of anemia severity. It is more common in chronic or severe forms of anemia and would not typically be expected solely based on the Hgb level of 7.8 g/dL.</li><li><b>Option d. Sensitivity to cold:</b> Sensitivity to cold can occur in anemic patients due to reduced blood flow and oxygen delivery, but it is generally more associated with severe anemia (Hb levels significantly lower than 6 g/dL). While some patients may experience cold intolerance at moderate anemia, it is not as directly correlated as dyspnea.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 87</h3>
                <p><b>A 18-year-old female patient with recurrent infections of respiratory tract. ECG is given, what will be the most probable diagnosis?</b><p><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAeAB4AAD/2wBDAAMCAgMCAgMDAwMEAwMEBQgFBQQEBQoHBwYIDAoMDAsKCwsNDhIQDQ4RDgsLEBYQERMUFRUVDA8XGBYUGBIUFRT/2wBDAQMEBAUEBQkFBQkUDQsNFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBT/wAARCAC7AjwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD7cvvipr9lt3X5bPPEEf8A8TVX/hc2tgDN5Jk8/wDHvH/8TXL620nnIIsZ2nrWa/2w7PlX7te3yQ/lR9D7On/KvuO8b4xa4oLG8faoyf8AR4//AImo1+M2vNz9rk29c/Z4/wD4muGumvPIn+Rf9WKmja8MKAIuPLo5IfyoPZ0/5V9x2n/C5td3EG8kAxn/AI94/wD4mnf8Ll1vcU+2vuAyR9nj/wDia4ktdbuUX7gqBmuzqU/yL9wUckP5UP2dP+Vfcd9/wuLXApY3r4/694//AImmP8ZtbjUlr1xg4/494/8A4muHma68sjaucr/Omah9q8l/lX76/wBKOSH8qF7On/KvuO6/4XNrnP8Apr/+A8f/AMTSt8Y9eGMXj/8AgPH/APE1w7fazGRsU/MKl/0vDfIv36OSH8qH7On/ACr7jsF+NOut0vHPOP8Aj3j/APiaefjFr4UH7Y5z/wBO8f8A8TXBWX2sKcqv+sParKNd4T5V+8f60ckP5UT7On/KvuOy/wCFza9wPtj5P/TvH/8AE08fGLXiuftj/wDgPH/8TXBN9r+1W+AvQ/zq3/pflqNq/dNHJD+VB7On/KvuOxb4za4qkm8fgZ/494//AImj/hc2uFci8f1/494//ia4K4+2C3c7V/1dSw/a2hHyrnZRyQ/lQeyp/wAqO4/4XJrv/P44/wC3eP8A+Jpq/GfXGdh9sf5f+neP/wCJrjtt383yr0X+lV4ftfnXHyr1FHJD+VB7On/KjvP+Fya7/wA/j/8AgPH/APE01vjPriso+2Pycf8AHvH/APE1xTfbMv8AKv3hUNwbsTRfKv36OSH8qD2VP+VHff8AC5NdYnF4/wD4Dx//ABNM/wCFza7/AM/b/wDgPH/8TXGL9rXHyr96k3XX9xf4v60ckP5UHs6f8q+47OP40a5IAftj8/8ATvH/APE09vjHr2ARdyYx/wA+8f8A8TXBWv2vy4/lXvVnN2VUbV4U0ckP5UP2dP8AlX3HYj4z67v2m7kzjP8Ax7x//E0//hceunkXj4/694//AImuD8y7FyflX/V1MrXnzDav3fSjkh/Kg9nT/lX3HaTfGfXIlLfbJP8AwHj/APiacvxk11lz9sk/8B4//ia4TUWultz8q9V/pUm662cKvajkh/Khezp/yr7juG+Meuhc/bH/APAeP/4mmR/GjXJFJF5J1x/x7x//ABNcYxuyrAqv3qr2X2vY4Cr/AKyjkh/Kg9nT/lX3Het8ZNdGMXjn/t3j/wDiaa/xo1tdv+mSEt/07x//ABNcbi6GDtX7xqrMbrzoPlXnP86OSH8qD2cP5V9x33/C5tcZeLuT/wAB4/8A4mmN8ZteVcm8cDGf+PeP/wCJrjlW72L8q9DVe8N2tqSVX7lHJD+VB7OH8q+47sfGbXGUEXj+v/HvH/8AE0v/AAuXXOf9MkB/694//ia4a2a78lSEX7lPLXbM3yKPlH8xRyQ/lQ/Z0/5V9x2n/C59c3FftkmR/wBO8f8A8TTv+Fy65/z9yf8AgPH/APE1wKtd/bJxtXt29qtMbwA/IvUUckP5UV7On/KvuOyf40a4rhTeSDJx/wAe8f8A8TTv+Fya6Ot4/wD4Dx//ABNefXjXf2qH5V/1lXN13kfIv3qOSH8qJ9nT/lX3HaL8ZtdYH/TJP/AeP/4mkj+M+uOoP2x+f+neP/4muKBuypOxR96orNrpo4/lXvRyQ/lQvZ0/5V9x3v8AwuTXMD/S36Z/494//iaYvxn1zdj7Y/TP/HvH/wDE1xu67wPkX7pqsrXf2rGxfuUckP5UHs6f8q+471vjLrna7f1/494//iaST4za4gybx/8AwHj/APia4pjd7m+Rfu1BfNdiJjsX+H+lHJD+VB7On/KvuO9/4XNre3P2uT/wHj/+Jp3/AAuPXP8An8k/8B4//ia4Zvtfln5V7UrC8AJKr96lyQ/lQ/Z0/wCVfcdpH8aNcfP+myE5x/x7x/8AxNSf8Lk1z/n8k64/494//ia8+sftZkk+Vf8AWVaxd7s7Vxvo5IfyoPZ0/wCVfcdq3xm1tSB9sk5OP+PeP/4mlHxl1sj/AI/JP/AeP/4muBujdieH5V+8anT7XxhF60ckP5UL2dP+Vfcdr/wufXNuftj9P+feP/4mkj+NGuMmftjn/t3j/wDia4d/tfkj5F+6abZ/a2t0IVc4o5IfyoXs6f8AKvuO8/4XJrv/AD9ydM/8e8f/AMTTP+F0a75hX7Y/Az/x7x//ABNcdm7zjav3Kq7bz7ZJ8q/cFHJD+VC9nT/lX3He/wDC5dd2n/TJP/AeP/4mmS/GjXY8ZvJOuP8Aj3j/APia41mu/LfKr27VBdfa9yfKv+sFHJD+VFezp/yr7jvv+Fya5tH+lydcf8e8f/xNH/C5Nc73j+n/AB7x/wDxNcSxu14Kr970oIvD/CuNx7UckP5UV7On/KvuOyX40a4wyL1+uP8Aj3j/APiakX4ya5j/AI/JP/AeP/4muAsvtRT7in5z/OrSfa/l+Ve9HJD+VC9nT/lX3HY/8Lo1zcB9sfkZ/wCPeP8A+Jp3/C5tc/5+5P8AwHj/APia4GT7Wt0gCr/q6tRfa9nKL900ckP5UL2dP+VHZt8aNbVSftr8DP8Ax7x//E0v/C5tc25+1v6/8e8f/wATXB3X2tYZDsX7g/mKlQ3nk/cX7oo5IfyoPZ0/5Udw3xl1zdxeSe/+jx//ABNMHxo1xmYC9fg4P+jx/wDxNca32tmb5F6iqtvJdefOCi/f9KOSH8qF7On/ACr7jvl+MmvMf+Px/wDwHj/+JpG+M+urtBvJMscf8e8f/wATXFo92ucIv3qrXrXnnW/yD75/rRyQ/lQ/Z0/5Ud//AMLk10kAXr8/9O8f/wATV6D4neIJ4w66hwfWCP8A+JrzqMXhaM7FHNbem/8AHqu772afs4fyoFSp/wAq+4z9fVWuI8yeV8prPaOP5M3Tfd9aueJJDE0TCAz/ACngViyXzfL/AMS1vu+9WbSLt1HGYLj/AElv9V60scMe2P8A0ts+X61nzag3k3AOmtjy/ep1uv3SEacx+T3pElqSNN3/AB8t9wd6gaFBqM/+lN/qx3qOW7b/AKBzfcHrULXjfbpSNOb7g9aANFoY/JY/am/h71HfQxmF/wDSj/rF7/Sq7Xb+TIf7PbHHr61FfXRaJj/Z7ffX19qANEwx/MftR+8O9SeTHhv9KP3/AFrOa7bac6e33h6077YfmH9nNjf70ASW0Mfln/Sz/rD3qzDDGVQm6b7x7/WsyzvN0Z/4l7f6w+tSrdurIBp7Y3H1oAlZIheQj7S3Q9/erCxxkL/pTfdPes2S+/0qDOnNnafX1qZbwkL/AMS1uh9aAJ7iGP7O/wDpR/1frToYo/KH+lN9z1qhPdN9nk/4lzY8v3p8d23lD/iXN933oAvtHHhv9KPRe/0qKKKPzrj/AEo9R3qubx/m/wCJc3QevtUMd23mz/8AEubqPWgDTaOMM/8ApTfeHeobuGPzoj9qb/WetVzdPuf/AIlzfeHrUd1dN5kedOb/AFnvQBqeTHwftR+960GOLy8/aWH3u/1qkt4w2/8AEub73vSLeNtOdObHzevvQS9yexhjMSf6U3fvVlI49oP2o/dPesmzu28pP+Jc3f1qX7Y3lj/iXN90+tBJN5MTXjD7U3+r9anMaDOLpvu+tZAvHF4f+Jc3+r96uG8fB/4lzfd96AJNRhRrc/6U3Ve/0qb7PF5Y/wBKbt3rNvLp/s7f8S5uq+vtUv2p9p/4l7dvWgaZoeTH83+lMfm9ar2axbZB9pb/AFnrUX28q/8AyDWHze9VrS9ZvNH9nNjzPegq5q+XH8v+lH7x71Vkhj86D/Sz37+9RJcyYX/iXN94+tV2umFxD/xLm7+vrQFzZEcexf8ASj0Peqt3HH9lP+lE/J6003jCNf8AiWt39aq3F4Wtj/xLWHyH1oGaFrEhtl/0oj5fWpDEm5s3R+6O/wBKzYbxhbp/xLm+771J9sfLZ05vuj19qBWRLEkbXlwPtLdu/tVqSNOR9qPUd6yI7xvtM5/s5u3rVg3jMx/4lrdR60BYlu4UF1Bi6J/eetWjHHuH+lHr61lXN032qL/iXN9/3qf7W27/AJBzfe96AsW/JTb/AMfTfxd6h0+FPLQfam796ga8bb/yDm/i9aisbxhGn/Eubv60EtGmIkyAbo/dPeoPJT7Z/wAfTf6sd6gF6+4f8S5vun1qL7Y/2v8A5B7fc96BWNOSGMFv9KbO31qLUIU+zk/aW/h7/Sq8l4/zf8S5vu+9RX145tj/AMS5v4fX2oGaPkx+Sf8ASm7d6c0ce0/6Ux+Yd6ofbH8r/kHN29ad9qf5v+Jc33vegsks4o1d/wDSWH7z1q0safN/pbff9ayrW7bc/wDxLmPz+9TtdOuT/ZzD5/egCW4iiM0J+0t9496nWOMBf9KYcnvWfLdHzIf+Jc33j61It2zbf+Jc3X3oAstFH5JzdN9w96ZYxp9nX/ST931qu123lt/xLm+6fWo7O7b7OmNOY/L70EGk0KeYP9KP3PWoNi/bpc3R+4O9QC9fd/yDW+571B9sb7dJ/wAS1vuD1oA1ZIUKv/pJ7d6hvIk3Rj7Uf9YO9QyXj/N/xLW6D1qC+um3If7Ob749aBo05Y0b/l6P3h3pzRps/wCPo/ePeqDXj7R/xLW+97043jeX/wAg1vvH1oKH2EMfk/8AH0fvnv71ZWFMp/pZ6HvWTp983l4/s1vvH19asresQn/Eubv60ASvCn2qPF0f9X61OsabQDdN9096yXvXF1H/AMS5vue9W1vH2/8AINb7vvQKxJdQR/Z5P9KbO0d/cVKsafZ/+Poj5R3qhdXjfZ3H9nN9wevqKVbx/J/5BzfdHrQKxo+Ugd8XZxx3qnbon2ibN2f9Z60Lduxc/wBnNjj1qpb3DGab/iXN/rPegRsRxxsx/wBLOd/rVa9WNZYAbtvvnv8AWmR3DBsnTm+/71VvbxvtFvnTm++fX3oBbmoiqvlkXTdfWtzS8fY153e9cut0x2Eaa33veuo0cbrFDt2f7NNGiKesiX7REIiB8p61Rk+0gRjCE7fWr2vRo9xHvkMQ2npWW0MLMn+lt931psbJrprv7Lc/LH/qvWljN2IozhPuetV7uOL7Pcf6U3+rp8cERhj/ANLb7nrUkk00l4WI+QfIO9Vt16b6X7n3B3pzW8JY/wClt9wd6iWCH+0Jf9Lb7goJuW2N4sTg7MHHf3qO+a7EbD5Pvr3+lJcQw7H/ANKb+Hv71FqEEPlki6b76/0oGmXj9rYcbPvDvSP9s3Nyn3/Wq3lR4OLtvvDvT2gj+fN0xO/1oGRWX2vaeE/1h71bja73L9zG496z7WCLaf8AS2/1h71Yjt4hg/bG+8e9ADZmu2vIflXoe/vVpPte0Z2/dPes54ohdQf6W3Q9/erfkxlVxdt9096AHXTXX2Z/uf6v1pIvtRtxgpnb61Xu4Ivsr/6U3+r9afawwmAZum+560EFjF582fL6L3+lQW/2vz7n7nUd6eYYsN/pTdF7/Sq8cMPnXH+lN1HegC632vJOU+8O9RXZuvMi+5/rPWka3i2t/pbfeHeq1xFD5sObpv8AWetBZpKLvaOEPzetNIvPLPCfxd/rUSwxBVP2pvvetI0UXl/8fbfxd/rQKwaf9r8hM7O/ep1+1iMcp9096pWNvE0EZ+1N371K1rGYx/pTfdPegVhv+l/bT9z/AFfrVk/bOfuD5fWs5YY1vD/pTf6v1q00cXP+lN931oEF99s8k/c6r3+lS/6ZsP3O3eqWoQx+SR9qbqvf6VKLePb/AMfbdu9AFvbdt18vO/1qvYi73SD93/rPWlkggi3E3hA3dSaqWEMTFyLxiDIcEGgDU23XH3PvHvVKT7Z9qh+5370/yY8D/Sm+8e9VpLWM3UP+lN37/WgaNEfbPLXmPv3qvdfbFtWz5f8Aq/WhIItq5um796r3kUK25/0pvuetBRZtvtn2ZP8AV/d9an/0vc33D8o7/SqNvDF9nT/Sm+761YWGL5/9Jb7o70ARK139sn+5jjvVn/S+f9X1HeqEUMP2mb/SW7d6naGLtdN1HegB10139rh+59/1qxm88wfc+961QuIYvtUWbpvv+tWPJiMgH2puvrQBMy3eDyn8XeoLP7Z5Sfc796RoYduPtbfxd6hsYYvITF22Oe9BLLi/a/l+59096h/0v7X/AAf6v1pFghDL/pTfdPeofs8X2r/j7bGz1oJNCT7X83Kfd9ar6h9s8g/c/h7/AEoeGHcf9KbG31qDUYIvs/8Ax9Nj5e/0oGW3+2eUP9X271IPtmDnZ971qnNBF5I/0pu3epvJi2kfamJ3etBY2zN40kn3P9Z61NJ9s3Y+T7/rVOzhi8x83Tff9anNvEWP+lt9/wBaAFm+2LJD9z7x71Iou9y4KdfWqk0MXmxf6U33z3qb7PFuT/S2HPrQA+T7Z5Tfc+6e9MsheNbpjZ931pklvCqH/S2PyHvUdjDEsA/0tvu+tBLLa/bM9Y/u+tQst59ucfJ9wd6RbeIsP9Lb7vrUPkxG/kH2tvuDv7UCLzfbBv5ToO9QXy3jMn3PvjvRJDEN/wDpbdB3qC+hj3J/pbffHegEXm+2KBkp971pxF5t6p989/rVZoIiv/H033vWlaCL/n7b7x70FjbFrvYcBPvnvVhBebU+5371RsIYvLP+kt989/erEcUJRf8ASm796AGTfa/tUWNn3PWrS/bAv8H3fWs9raL7VH/pTf6v1q15UO3m6b7vrQAXTXn2eT7n3B39xTl+2GH+D7o71VuY4mt5P9Kb7g7+4qSO3iaEZum+6O9AFr/TF3/cPI71Tt/thmm+5/rPWpWhhXf/AKU3Ud6q2tvD50/+lN/rPWglml/pm4ZKff8AWqt4t550H+r++e/1p3kRbv8Aj6b7/rVW8hiWe3/0tvvnv9aBI0f9LVUxs6+tbel7vsabh83fFc6tvExT/S2zn1rodKQfY0wxb3po0Rm+ICEuIyyGQbTwKzPOg+TNs/3a0fET3XnRm1Cltp+9WSW1f93kR/d9abGyW6mtzDcD7O/+r9Kes1uIU/0d/uelR3R1b7PccR/6r1oSTV/KQYj/ANX61JI9poFc/uH+4O1V2u7aG8ndoGCiMHOKkL6uz4xH9z1rN1yTVVttRJWPiH1+tBBoW+pWd9bPKkLSISAGH1p2pTQGNsWzj51/pXM/D+51VvCsRCpgv1JrotQk1by2/wBWfnXv9KBosGaBUP8Aoz/eFPa4gwf9GfO+oJH1fyycR/eHepGk1fByI/v+tBRDZXEBU5tn/wBYe1Wllt8L/oz/AHjVCzk1byzxH/rD3q2r6t8v+r6nvQBBLNB9rt/9Gfof51aS4gCL/oz9DVOSTV/tVvxH0Pf3qz5mrbVwI+h70AR3csLW7/6M/wDq6fHNbrAMWz/cFRXD6v8AZJM+Xjy/Wkh/tdoV/wBWPl9aCAv7yC1sbqb7PJ+7i3flWR4T1hNYsZbh7dss2KteJJdWh0HUCTHjyDnn2rnfhXcalN4eLIUPznvQLqds80HI+zv94VBdyQeZCRbv/rKsSHVmLE+X94d6p3X9q+ZHgIP3nrQaF2OaDav+jyfeokmg24+zvj5v61EravgcR43eopsj6tt/5Z/xd/rQA6xmg8lP9Hcdal86Eqv+jP8AdNVLF9W+zpxH371MG1fYvEf3T3oAZ5sH2w/6O/8Aq6s+db/N/o7/AHaobtX+2HiP7nrVnfq2G4j+760CC+mt/Ib/AEd+q/0p6yQlc/Z37VWvm1Y27cR9V7/SpVbVtn8HUd6AsZfja6jt/Dt9KsLqVI5pPBl5DNoNq7QOxJyTWd8T7rVofBupl/L28dD7ipfhzcaq3hOwZVj2EdzSRB06zQbh/o7/AHj2qvJND9ogP2d+9SCTVc9E+961WkfVvtEHCd+/vTKsXVngKqPs8neoLt7f7MxNu/8Aq/SpN+rgLxH0Peq91Jq5t2B8vHlnvQDJLWSA2qkW7/dqZriFQ3+jv90f0qtavq32dMCP7vrUsj6tzkR/dHf6UCI4J7f7RP8A6O/arDT2/P8AoznkVUjOqi4n4j7dxVgtq4zxH1HegLjLyaD7VD/o7j56mWaDeP8AR2+96VTvH1Y3UPEf3/Wpg2riQcRn5vWgLlhri2CY+zP/ABVXsJIPJX/R370sjax28vHzd6gsJNXESf6vqe9BZba4t1K/6M/3TUQlg+2EfZ3/ANWKVm1csOI/unvUAk1b7Z0j/wBWO9AmW2uIGZv9HfhazNW16yhuo7RrZ/MkCkfpWlu1bcxIj+761534pvtTj+IenQEpuMYOM+1J6EHorzQ+Vg2z9ql863+YfZ3+9UBk1doxkRnp3FPZ9W54j+960yiGzuLffJ/o7n95VjzoNzEW7/f9KoWMmreZJxH/AKz1q2ZNW3HiP7/rQCI554PMi/0d/vmp47i3bbm3fqaqXDat5kPEf3z3qeNtW+X5Y+p70FCyTQeWT9nf7hptnJB9nX/R3+76UyR9WEZwIx8p70lnJq5tk4j6HvQSy1HJADzbv9yqv2m3GoTH7M/3R2qZW1cnpH9z1qsDq32yX/V/dHegRckuLf5z9lfoKg1CaDcn+jP98U531cb/APV4wO9Q30mrGRB+7++O9Ai000O3/j2f71Bmgyc2z4DGmM2rdvL+9602VtY8mbiP+I9fagZDpt5azxkxwsyhyDj61a86DagW3fHPauN+Hd5qt1Z3pTYQLhwcn3rsI21b5OE6HvQUiPzoPtSZtpP9XVkywbV/0Z/u1RdtY+2Rf6v7nrVktrG4D93931oAZcyQLbyH7O/3B29xUkMkPknNs/3RUF62rfZ5P9X9wd/cVLHJq7W+AI/ujvQSSySW+W/0d+oqraz26vOfsz/6ypmbV9zZ8vqO9V7dtXaWcfu/v+tAF1ZoG5+zSffqnezQeZARbSffb+tTrJq6nH7v7/rVa5k1cyQD93989/rQCLsNxAFj/wBGcc10OlsWs0KrgVzMb6x+74jxn1rpdLV2s0MjYfvimjRGfrmxp4w8nl/KelZkiwZQfaW+761pa8Ql1Duj8z5TWa7xGSP/AEb+H0psbFulg8i4H2k/6r1ojjhMaEXBxs9aS8MQt7g/Zv8AlnUsckIt0xbHOypJG+XF5mPtB/1frWJ4v8qHStXcXByLf19jWy00QkJ+yn7gFYHjiSNtE1gfZyM2/wDQ0Ey2M/4UyQXPgG1drg793rXV30cKx/8AHwfvr3+lcf8ACHyYfAFmPs5c7hXY380TRt/op++v9KAjsS+XBsI+0n7w71JJHDz/AKSfv+tQySQhTi1I+YU9pItp/wBFJ+egoq2MUOxv9JP+sPerirBhP9JP3j3+tU7GSHa3+in/AFhq0kkPy/6IfvH+tAEEkcP2u3/0k9D396srHAQv+knoe9VZJIftlv8A6Meh/nVjzItq/wCinoaAIrtYVtZMXJ/1frT4Y4Taj/STnb61BdSR/Z3/ANFI/d1NbyRC3H+in7lBBmeLxDH4Y1Ui4JItj39q5T4J+VN4R3NMVbzD3rqfF0lvJ4a1RTbEZtyAfwrmPgu0MfhZ1NuXxIaJbk9T0JkgDOPtJ+8O9VLtYjJF/pB/1nrVlpoGdv8ART94VWvJoVkhH2U/6yg1LKRw7F/0g/e9abJHDtP+kn+LvRHLFtH+in71JJJFtz9lP8X9aAIrGODyU/0k9+9TiOHav+kkfKe9QWM0PlR/6KR1qYSR4X/RSflNBSIPLhW8b/ST9z1qz5cHzf6Sfu+tVPMi+2N/op/1dWfNh+b/AEU/doJI76OH7O3+knqvf6VKiwrGf9IPUd6hv5IvIb/RT1X+lSeZD5Z/0U547UAcj8YFjbwXfhJySSOM+4q38NVhPg3TkM7KQPWq/wAVWibwfebbcq24fzqf4bTRf8IjYg25Y/SpW5n1OoEdvt/4+T9496pPDD9ogP2lu/f3q2nk4/49j96q8kkC3EH+inv/ADpo0LXlw7U/0k9D3qrdRRC3bNyfuetWfOh2ri1PQ1WuZIvszH7IcbKYiS1SEW6YuT931qSSOBsn7Q33R39xUVvND9nT/RT9yntJF83+in7o/mKBWIY44ftM2Lk9u9WGji3MPtJHI71Uhmj+1Tf6KT0q20sTMf8ARSORQFiC7hh+1Q/6Qfv+tTeXD5i/6SfvetQ3ckf2qL/RT9+p/Ni3D/RCPmoFZgyQ7f8Aj4P8XeoNPhh8tP8ASD1Pep/Mh282h/iqCwli8lf9FbvQWWGSEY/0g/dPeqypB9rJ+0H/AFfrUxki2qfsx+6ahWSD7V/x6n/V0AWmWDcf9IP3fWvIfGCj/hcWlhZyU8le/tXrpkg3E/ZT92vLPFMcTfFGwlFucLGoqZGZ6gI4lhb/AEk9u9PMcHP+knO71pryQ+X/AMex7UvmREH/AEUj5qooqWMcG+TNyf8AWetXvLt8n/ST9/1qjYvF5kn+i8eZVzdDuJ+y/wAdAIhuI4DJD/pJ+8e9Pjjh4/0k9fWo7iSLzIf9FI+c1NHJCNv+inqaChjxQeWf9JP3D3ptqkP2dMXJ+760skkPln/RT900y1ki+zoPsp+7QIsKsP8Az9H7nrVULF9ul/0k/dHep1kiyP8ART9yq2+L7dL/AKKc7RQTYuNHD8/+k8YHequoJCJE/wBJP3x3qw0kXzf6KegqC+aEyRn7KfvigdicpDkf6UfvetJeCCO1uW+1HhHPX2NKzQ/8+p+9VXWLiBNLvD9mI+Rv5UCOD+DEkVzpuol7hgftcmOf9qvR4Uh+UfaT0PevMvgn5cen3gMGc3Dn9a9PSSBVU/ZDnmgpbFSSKFbmI/aSfk9at7IWXP2k/d9arTTQm5j/ANEP3KnWSHAH2U42+lAmQXUcX2d83J+6O/uKmjihEP8Ax8nG0d6hvpoVt3xan7g/mKkW4h+zcWp+6KBEjJBuk/0knkd6rWccPm3H+kH7/rT/ADosti2PUVBayR+dOPspHz0BYt+VC2P9JP3/AFqpeRwrLbf6Sf8AWN3+tXIpIs82x+/VW+aEzW/+jfxt/WgouRiHan+knr61u6Vj7GmGzWCskO1P9FJ5rZ0uVfsaYXaPSmikV9a81rqPZtHynrVCRrr93yn3fapvEUYupIlaZoflPK1kHTYv3f8Ap8n3abHIv3pu/s83Kf6v2qWNrvyk5T/V+1Zt7psX2ab/AE2T/V05dPi8mP8A02T/AFdSSaLfa/7yfcHpXPeNGuX0nUlJTDQY7ehrQbT4h/y/SfcrnfF+nxrp94Pt0hPl9KTM2w+F32mPwXbKpUBWHpXV37XexuU++vp7Vxfw50uNvCyZvXTDjiulvtOj2Nm9k++v9Ka2HFmnI90VJyn3h6U9muh3T7/tWW2nxbTm+k+8KlbT4s/8fsn36CyWye7IY5X/AFh9KuK10AvKfePp71h2OnxbW/06T/WGrS6fH8v+nSfeNAE0jXf2y3+ZOh9PWrayXXy8p0PpWM+nxG7t/wDTpOh/nVhdPi+XN9J0NAFq8kuvsr8p/q/anQzXXkDBT7o9Kzp9Lha3f/T5P9XSrpkQhGL+T7tBL3IfGK3beH7/ACU2mHHaub+DouF8PzqpXAlPXFbXivT410G7H22Q5jAxXL/C2zjTS7tDeOpEtEtyOp6VI138+Cn3h6VBcNdmaLlP9Z7VUjs4WZgb6T7wpl5psXmRH7dJ/rKDU1w95gcp972pkj3fl9U/i9PeqSafFtH+nSH5qbJp8Pl/8fsn8VAFqxe78mPlO/pU4ku9q8p90+lZVjp0QgTF7J3qddPhwub2T7poHEk3XZvW5X/V+1Wt13tblPu+1Y66fD9sb/TZP9XVn+zotjf6dJ92gRZ1CS7+znlOq+ntUgku9hOU7elZl/YQ/Z2/02Tqv9Kl/s+HYf8ATpO1AnuYvxMW7m8N3AbZgt2xT/hu12nhW1ClOGPpVXx5p8J0R1+2SOS3So/h3ZRv4ZizeSLiQio6mfU7bde/Lyn3vaqkjXn2qDlO/p60wafF8oN9J941Um02JbmE/bpO/wDWrNTYzdgLynQ+lR3TXn2V+U/1ftWcLOL5f9Ok6Gkn0+P7K3+nSf6ugDRtzdfZ1+ZPu+1PkN2C2GX7o9Pasy302EW65vpPu1I+nQ/N/p0n3R/SgCxC939onyU7enpVpmu8k5TqPSseHTYftE/+nSdv5VLLp8I3f6dJ1FAFu5luxeRcofn9qsbrssOU+97Vh3FnF9sh/wBOk+/Vo6dDuGL+T71AGjuu1X+D+L0qGwa7MKnKYyfSqkmnx7M/bpP4qj0/Tovs6/6dJ3oA1B9q+UZT7p9Kg/0v7URlP9WPSqx06EbT9uk+6ahXT4vtX/H9J9ygDYK3hLcp932rzTxELr/hOLeQ7dwKr2rvxYRKx/06T7tea6zDBJ4qUi6kOJgualq5mepf6W0O4lO3pUmbz5uU+97Vm/2fEIj/AKdJ2qT+z4sN/p0n3qopsksWvN0n3P8AWe1WS14rHlPv+1Y9jYxeZIPtsn+sq02nw5P+nSffoGWLhrsyQ5KffPpU8bXa7eU6n0rIuLGLzIv9Nk++amisIxt/02TrQMuyteeWeU+4fSo7N7xoUHyfd9qpyafD5R/06T7hptlZReSn+mSfdoA1Vkuweqfd9qrhbxr6U7k+6PSoP7NiLD/TJPuVCtjD9tlH22T7ooA15Gu8MNydB6VWvmvA0fzJ/rB6VWl0uL5z9tk6Cql9pse6P/TZPvigDbla8AGSn3/as/xI1yuiXpJX7relJJp8f/P7J96szxTYxjQbphfPndjFBLZzfwaW7jt7hAFxvY/rXpXmXa7RlO/pXmvwz01IppkF26jk13C6bC+3/TpO9C0BOyJpGvGuosFPue1Ws3igfMn3fasZ9LhS6jBv5PuVaOnwlR/p0n3aBFm8+2G3k5T7g9PUU6P7Z5B5T7o9Kz7rT4vs8n+nSfcH8xTo9Ni8n/j+k+6KB2NAi8G75k6j0qC3+1LNPyn3/aoJNNhDPi+k6iq8OmxeZMft0n36CjYjN2rclPv+1Vb37V5kBBT77envUH2GPjN7J9+q11Yx+Zbj7bJ99v60AbULXbqnKAZ9q2NM3fZFyFzmuZj0+FVQ/bZOtdLpMBWxQKd4/vU0NGTq0wjmjDRmT5TVTzo28v8A0Vvu1d1rzBJEYsZ2moUW7ZYz8uNlNjZFevD9lm/0Vv8AV0qyw+RH/orfcp12btbeb7p/d1Kkly1tGSqD5KkkrtPBuP8AorfcFc345kiWznItyNygfpXUM1yrjATGyuY8fG5e3C/L8xxUyMpEfw/kjTw6B9nJ+cV0epTRrGSbYn51/pWF4HW5bw/LtCjbKBz9a3tSkuvLIGxvnX+lNbDRI00A4Nq3Udqe0sJyRatjfQrXUinKp1FYeo+M5rHxJb6UIVcSMN8nZPSmaXRoWM0OD/orf6w1djmh+X/RW+8aZZrdiFiAmfMPFTK12u3IT7xoAoyXEP22AfZW6H+dWRLDx/ordDUbPctfQcJ0P86n8y6XHEfQ0AVbiSL7NIRat/q6fC0LW6k2rH5aLqW7Fq+QmPLqa1e6a3UKE+5QSzF8VSRnRbgC2ZeFH6iuZ+G/krb36m3JPm11vihbptLk3beSo/UVzvgBLmKTU1CrxIP5UEdTqR5KyMfszfeFOvJIWaL/AEZj+8qVTdySH5UxuFOvPtUUkeQn+soNRUkhUD/Rm+9TZpodn/Hq38Xb61S1bxMmimNbhkDO3C1orNPc2sc0ZjeNgSGFAFayki8lP9GbvVhZIcLm1Y/KabZi6aCPATvUu+8RE4T7poGmUhJCbxsWrf6urHmQ7WP2Zvu1As919sbIT/V1cRrnkbU+7QIqahNCLdv9Fbqv9KlM0Pln/RW7U7UvtRtyAsfVf6VIq3RjOQnagVzlvGUsTaeEFowJY/ypPh3NEvh9VNsSRM1XfGC3P2aMNsB3/wBKqeAWuU0eRQFOJmqOpmtzpWuIcrm1b73pVS6kjaWEi0YdauCa6O3hOGNV7iW5BiYlAAGJ/WrLuMWSFkXNsQcGmyXEP2Ns2rD5DjiuHuNU1y8uZdWglC2ds2zygPvD1ruI7m4vtJS4jCFHiBFAcxLBNCbZf9Gb7tSNJCFObZvuj+lEH2pbZDhM7KkaS5Ct8qfdH9KB3KkMsP2ifFs3anzzQru/0RjyKIZLkXM/yp2qadbxicBMZFAGddzQtdQf6Mw+er6zQbhi1Y/NVS7W7+2W/wBz/WVpql2pHCfeoHcgeaHy+bVv4qjsZofsqYtW71ZmF1sHCfxVDYfavJQYTvQAvmQnb/orfdNQrJB9p5tW+5Vz/Sl2khPumq6G6a94VPuUAOkmi3HFs33a8tvpIn193EBGLwD9a9bkW7CuQqfcryjVI7mG4887cNfD+dJmZ6Ws0bR82rDp2qcyQ/N/orfeqFZLuSNSAmMCrLNdKG4T71MZn2UsPmSZtW/1lXN0JyRbMfnrMfUptNtbm6m2BI3JrG0/xtqbXUL3VksFjcSYST0+tBV0dDczQ+dFi2b75qxFNF8v+it1NJMtyJISAhBYkGrEa3fHCdaBlWSSFoSTat900yzmhEKf6K33fSrUiXXkn7n3TTLKO68uP7n3aAEW4i3Y+yt9z0qtvh+3Sn7M33RWlsut38H3KqrFd/bpfuY2CgBTPESw+yt0FQ6lLDvj/wBFb/WCr0kd0m44ToKr6gLtpI8BPvigB0s0PH+it96sLxlcRR6I/wDorANMB/OujZbrGMITurA8ctcf2PGHCAfaVH86CDC8Byww6lcJ9nbpn9K7WO4j2qfsrd65LwmtxH4ku0AT7ox+VdpH9qGAfL70CM+SSL7ZFm1b/V+lWvMgEf8Ax7N930qOT7XJfQgbP9XV147raPufdoKSM25li8mQ/Zm+4O3uKd9oi8n/AI9m6CrFwt39mk4T7g/mKVVu/J6R52igogkuIdzf6K2MjtUNvNB5k3+it9+r7x3Z34EfUVWtY7zzp/lT/WUAOaaHj/RWHzVBdT26yW/+itnef61faK84+596ql5Hd+bb8J99v60ASLND+7BtW610GlMPsSYBA9KxolvF2Z8vGa2dMkItFDAZpoaMDXZI45YzNJ5S7TzVMXFoIUzen7vSrniO1+2IqbeWQgNjpXFN4PvcD/TGHy+lNikzpL2ez8mfF4x/dioptW0y1jijfUArFOhrlNS0PWNHia5tm+3FV+aFh1FWNI8GJqVtLd6pbMbuZPkUdI6km7Opaazba32vqgrmfGs9p5tui3Zb5qs+G9WtrGSXSdTtwtzAMRs4++vas7xTJa6j4mtrS1txIVTe20ZxUsiWxY8D3Vq2lXqtdkAT8DHvXQ3slm0bH7Wfvr/SuU8N31jpOjahNPbZ/wBIwqgcnmtO48SQNAS2jSgFlI/dn2ovYcdjV1TULLTNPmuWuztTkD1NcjDaw6vod9qT3DJeTSeZHxyFXkfyrRnuD4lvoLVdMaCzVgZCyEZrqJbSzhUpHZAIG2gbaVyrGZ4R1e01TRYZpLwrMHKyKexFahuLIsn+mHqa4q3tJfDOqS3lvZG5sZnPmQhc7T7CtL/hLLWRty6LMUyf+WZp3A2WubNbyEi7PQ9verKXFo2MXZ6HtXGyeONMivYBNps0PB+9GfWt2Pxf4eW38zCkhSduOfpRcZPqGoadDC0cl+EZo8ANVmC6s44FxeH7orkE8Ojxdb3mpXNq0OUP2VQCMY6GrXh3xBbRxnT9VtFt7qMYDMMBxRcRs+JryzbS1AuiQXTPHuKx/CclnDd6opuiuXH8qZrWo2uqXlvp2n23nu0is7KMhQCCeaksZbPS7vVpp7b5EI/h9qaJOmjkshJzeH7wpNSvdPtyryXvyK+Sx6Vztv4ugmyYNFmkYnjdGearX2nX/iySKO8sxYWJkyY1GC1Mq7LejWVlr11d6ld3AdGby4lI7etTeF7y3U3umyXZH2d28v3XrXQWNnZ2cMcEdlhI+B8tc7rtn/ZetQ6paac0ykMksar1GDzQFzdtZrNLVP8ATGzz0FL51rIqZumA2nqK5W1XWtbTdDZrYQqTjcvJqfyNesUQiGO6AXoQKm4G0otmvmxeHHl1ZaS1XduuyCFrk18Sapb3p87w8D8nVVp954o1C8UxW3h/ZIy43svT3o5kBs6hrWmRgxtqAVyV+U/hWqlxYtDuF6SDiuPHgu3k0u4a9hMl5Nglx/AfarvhbUrXToZtO1KFVmh+6zj7y1RBJ4xurL7HHtu90nmcCq3guS1j0mQG6IPmnIqpJHB4n8SebDb/AOg2ucMBwzYpdN1K10XSbmX7F5shnKom3qakS3OqSSzwo+0ty3XFc34y1q2iSCzsrvzLqYlCF52jPWnxaTrOrIHl22cbHOxV5Aq1p/hXT9FmjkNs09w+S0j8mqLJLPTbC30QWj3m5mQ7hjgmsrw54isdPsLixvrtoZIchcqcFe1dWI7T5M2fb+7UOo6Xptxas76cjN5fUpzQBWTxJoz2641L+H0obXtHbP8AxMh0FJb6LpZt1zpyfd/u1Y/4RnSGUltNU/KP4fpQBVj1jSPOnP8AaijpUra9o53f8TZOo71EvhPRJLi4B03HTt7VBdeA9CYufsDDkdM0ASXOtaQ11Af7UjPz+taq6tpLYxqkfX+9XKXfw90JrqDFnIPn9TVuX4b6L8u23mHzepoEbUuraa3TUkON38VR2N5YmNCL9T1/irAb4b6RjiOZev8AEaWy+G+nrFGymcdf4jQPU1Nd8RWOj6cZPtu+YjakanJJrmNL8TXOl6xANWu90F0gKOufk9jXS6X4L0zT7gXMtu9y207fMyQKdq2h2OsNJbyWgAKZU7fumpuGpqm8spIZWW9bb5eRxXm2oTWsmn2xNzndeg/+PVsR6Xr0Mb2ccUbQldokIGQKreJtIttB0PT0kh3vHKHdyOvOTSd2J7HYSXNnHCgW6bOB2qdbi0ZmzdsOc81xkcuo+JczWUC2tmuFVivLe9Xo/CeqXSt591iMnDbRzQUivqN3ZaxrEOlRXZdDJulYdB7V02saZp95pUlpHc/d+5x0Iqt4Z8PafokMiJZmSVpPmlYZJ/GtkR26v/x5/wAf92gLHMaH4is0tobe9vvKuYGKFWHXHet6313SJCoGprnPTOKr6loul3t1DJJpylt5529aq33gXRtQCsLJomU8FMigZrNd2TpxeFsoenNFnNZ+Wp+2HG2uWfwrfaYpbTpd6BT8kgzSW99r1tbqG0WOcY6gDmmhM64zWWeL3+GoFnsvt0n+mfwCucTxFqcbHzvDXG3+FaWLxOFvJDLoMi/IOkZqhXOrmuLPY3+mHGB2qrqV5p9vskkvtqBxkmsObxpYR7/M0mcDA/5ZH/Csy7u4/GOpWsUOnyQ6ejjzC6kbjQO7O2S+sLiMPHfb1LcEVz/jb7LNY2yrdEn7Sp/nVTSbyx8N6lc6beQGOPfuikccEemaueINS0u+ks4YEjkcy5wvNAmUtBkto/FdwDdYyg5x7V2CzWWwE3fPNcno6wL40lVrT5dvp7V1f+grtzbr3oEtio1xZ/bIf9KP3Kra14t0jRVRZLqSaUr/AKuIZIqbVNQ0zTYvtDQJlYyR9ccVk+D9Jhfz9SvbIPNc5KhlzhaBmrZ69per6dJLBeNjYMqw5HIq8s1l5P8Ax9kfKK5HXbeLw5qcl9b2BawmQCVEX7pyOcU4+Ljqa+Xo+ivMcDc8iED9aAOsaa03sPtmORUFvJZrNP8A6bn95XNyahr+450OM8jsKht9Q1zzZv8AiQx/f9BQO7Ox86zLD/TcfNUF09m0tuftpOHP9a57+0Nd3f8AIBjPzegqvPqGvtJBjQ4x857D3oC7Oyjms/k/0zv6V0WksWskKncvY15lHqHiBtq/2JF19BXpPh4zf2TB5yCOTHzKO1NFxKusLIs8Yix909aoyfbMx/cHy1e16NTcR73KfKelZ0kcH7vE7fd9abMyK/F55Nxyv+rqSD7aI48Ff9XVbUIYjbz/AOkN/q/WpbeGHy4/9Ib/AFfrUlrYi1Tw6NYG+eNfNCDEi8NVCx8Oro95cNAN0rRcu5ya2/LhXP8ApDfcHeqdxbw/b5sTsf3Y70CZ5ppMd3qHiAWRKmOOXzGHuDXpmpG5WHoh+deMfSvLvASJN478QB5SFibC8+9eoXUNu0GftJzvWpJJtt6FJUIDuHanN9uw2dv+sp00FuuWFy3Ud6Z+5bI85v8AWetNAQaWt0d+4Kf3h7Va23W4ACMDJ/hFQWMMIUgTkfvD3qQ28O4E3LZye9MRVexkuL63EsUMgIPDKPWpD4btmdSbKAHBPSq5SJb62Inboe/vWmsUDbD9oboe9Axs8V1FZsItiIIsBQKyb7Ql1iFPtEas4X744NXb5YfIkAuG4j9aZbxx+SP37D5fWhgJo2jDSd628SLwMsRzXF6wbqTxO9mpXEsgZhXfQwxLu/ft0HevNImjuvipcQCc4hUE81IHpax3UTqFWNQCBwop959saSLGziT0qBYoMn/SG+8O9JcrD50X+kN/rPWjUZeT7auPu/e9KUi92liU/i7VBttzjFy2d3rSssDQkfaW/i7/AFpoohs5LzyVA285p229fA+X7pqpaRwrbx4uG796swxwcEXDcqe9MBix3n2ohto/d1OYbv5z8v3PSoBDC15/x8H7nrViaOCMOBcN931pWQFS/wDtq27AMoOV7fSquoeGBr203CgOuPnU4NTahbwNbtm4bOV/pVuCKEQnFy2eO9MRDb2E2k2rW9vHGiKcDjmuL0P7RqHic2nyskMm8r713MlvDucmdvvetea/DRhN4w1+WWVgiT7VOfapZPU9VxeMytlQdx4qpdC986Ekp3qyy2+1SLk/ePes65jha4gzcsRz396oGWFF423BToaS6+3fYHGU+5TfJg+XE7dD3pJoYTan/SGI8s96AGWq332ZeV+7WhH9s8o5Zfujt9KoQQwrbr+/P3fWrEccCxtm4b7o70ALD9r+1Tcr2qS6W9wxDJ1Haq0CW/2q4P2k447+1PmjiZmxcHGR3oArXP2tbyDlfv1eke9LKfl+9WZeQx/bIf8ASDjf61ptBCVU/aD19aB2IZGu2Xnb/F/WmWBvfJQEr3pJooVUYnbq3enaakBgXM5HWgdh7f2gyIAVPB7VW23327jb/qxV3yoAgH2hvunvVRVgN1gzsT5Y70rD6FtYb0ydU+7XBfG43kfhmBcgM08a5HuRXfNHCCSJ2zt9a4z4qWENzpdmDOxH2iM4J9xRYzepuaFa3VjodlCuzGxSeK21+2YIBT71Z0dvALO3AnP3FHX2q75EPP8ApDZ3etFiojLX7aJJOV/1npViQX2Tyv3/AEqnaQwb3/0hs+Z61ZaGE5/0hvv+tFiiCZbzzYclfvmrca3vABXkmqk1vB5kH+kN9896nWGIMhFw3X1osQNkjvliYbk+4aWz+2C1jBK9Kjlji2Nm4b7p70lnDCbdP9Ib7vrTAuf6ZyMp930qqPtn26QEx42DtUghg5/0hvu+tVlhhOoSYnb7g7+1AFiaOdndSsR4H8IqC6juo/LCLGo8wfdGKfJbw+Y/+kN271HfQwfJ/pDf6wd6CkLquijVI1F1FHKQ3BxyKr2fhOCynEsUKCQMcE84q+0EJ/5eGxu9aPLh6/aG4Y96CTzzxNdXtjq1w0bhHb5Qy9RWzpfgO4uLGGWS/mLsu4/NXOeNvJj8QW8Xnn99IO/vXpNnaww28QFy33PWh7Cuc2PAoW7g86aSfC7grtxXWIt3GiIgQKqYHFUmhiN5Fm4Yny/Wrfkwcf6Q33fWpRoRXUd3Jbyo4jZdg4I9xT4Ibi3t8RJGg2j7oxUV1DD5Mn+kN9wd/cU9YYTCP9Ib7o71QiX/AE3LEleoqC3a8M8/K/fp5hh+f/SG6jvUFrBB503+kN9/1oGXs3mcZUfNVWc3nnQcr99v608ww+YP9Ib7/rVe5t4vMh/0hvvt3+tAMuw/bBt+796tnTUZrRSxwc1gRQQLs/0hjye9b+lOPsaY+YetNAZviS48iaMmFpsqelY7anEPL/0Fvu+9butCT7QnlMAdp4NUmS6/d8x/dpsgx77VYzBcf6C/+r96mttTi8tP9Bcfu/erl8lytvPkx/6upIo7oRoQY/8AV1JSKzahFj/jxf7g9agbUoW1CYfYG/1Y9a0yLsZ5j+4Kr/6T/aE+Sn3BQM8t8AssPizxPKbJ2DOMcHj5hXd3mpRmAgWLj5x2NT6V4dn0W61C4jkQm6Kls/UVo3kNwI2GUzvX+lAGa2oJ82LKTqPWnrfKrc2L/wCs961FjutrHMf3hSul1uOWj+/QBlWOoLtP+gv/AKw+tPk1JN4/0F+p9at2f2nBw0YPmGnMt55i5aPqaCWYzahH9qt/9BfofX1q2NQRUH+gv0PrUpW5a9tvmj6H+dX3juWUYaPoaBGJcajF9mlIsXz5fvUtpfIbcE2L/d96uzx3X2aT5o/9VUtv9qEK4aM/JQWVV1GP5v8AQHIwPX2rzPRWA+K2rzmxcjy145969bIu13fNH0H9KwdN8Pz23iK/1ASI0koVSKRJI2qJub/iXv8AeHrUd1qSFoj9gcfvPetpobs7wWj+8KhvIrpZIAGjP7ymFij/AGgm1cae/wB73pV1BOM2D4+b1962I0utoO6P71R7bsLndHnLf1oKMiz1BDCuLBsc+tOXUo1UL9gcnafWtCyW78lPmj71P5NyWU7o/umgRgf2kn2o4sn+571ba/WRT/oDn5ferfkXP2w8x/6urUcV1sf5kHy0AYepX8YgYfYHH3fX2qeG+iWP/jwkzx61d1CK6ZG3PH/D/Spgtz5fDx9qBlCW+Rw4Fi/3veuD8E7LbVdYf7C53T57+gr0xlulLHfGfmrI0XQ57Ga6lV0YzS5NKwuoi6pHtVfsEn3vemNfx/aIP+Je54PrWt5N2pHMf3jTJlu/OtsGMdf50waKf9pRrtBsG6H1psmootq5+wPjyz61ptFdNsO5KbcLdfZHy0f+rNBNjMTUENumLF/u+9EmoIqk/YH+6PX2rVtUuTaqN0f3aJIbvafnjPAoAw4dRX7VNiwft6+lWZL5fm/0B+o9auW8d2LmfLR9qtOt3g/NHjIoGjnrjUEa7hzYP9/3rTGpIwUfYH6+9SXC3P2mHLJ9+rardBxhk+9QUZUl5GF3Gwf+L1qvp+pR+SM2D4yfWtyb7UyYzH/FUFkty1qgBj4zQBRXUo8AfYX+6exqJb+P7Z/x4P8A6setayLdrj5o/umo9t0brBePhKAIm1JFZgbB8bfesHxlGdWsYEismBSRXOc+tddItwytlo87aqXn2oQZ3J0X+lBNmZcepIsMamwfKgDvV8alHyTYP973qz5Vz5ecx9qm23Yz80eN1AzHtNSjMkn+gP8A6z3q62ox8/6A/wB73pbMXRlk+aP/AFlWybvcQWj+/QMyLjUk86L/AEB/vn1qePUo8L/oD9fepLv7WskXzRn5jVqFbttmWj60EtGbJqUbQsfsD/dPrSWmpxrbx/6A/wB33q7NHdiNhujxtNMsxdeQnzJ92gViEapHu/48H+571XbVEW9l/wBAf7g9a1UW73H5o/uVXK3LXsnzR/dFAiCTU05b7A/b1qO81CNiv+gP/rB61ptHc4f5k4xVa/W7Dx4dP9YKCkxH1FMY+wN973pn9pRqr5sH+8fWr227HO9PvUpW78s/OnLmgR4344vlk8c6CBZPtL5K88816qNSjVI1GnP0965DWtJu7zxfpM5VWEbH5scdTXfKl15qHemMGgFEyZNSjW7hP2B/ue9WP7SQt/x4v933qVo7k3kZ3Rn5Ks/6TuHzJ92kizMu9QjEEn+gv9wevqKVdSj8kf6C/wB0etXLr7V5MmGT7g/mKUC68n7yfdFMCs2oR4b/AEBuo9aq22pJ5sx+wv8Af961tt0ythkByKrWy3YmmG5P9ZQBF/aKb/8AjxfO/wB6iuNTjMsIFi/329fetRVuWb7yffqrdR3KzQfMn32/rQBHHqKfJ/oDH5veun0eVWsEIXYP7tY0KXXyYdOpzW1pceLNctzmmhrcz9eVTMhd/LG09KzCtv8Au/8ASWHy1qa9JiZP3Xm/KazTMn7vNqw+WmzMZex232ef/Smz5dSRx2/lx/6Ux/d028kT7PPi1JHl05Zo/LT/AERv9XUlIcy25Yf6Q2NlVjDb/wBozf6S33BVkyozD/RWHyVH5kf9oTf6K33BQMSSGBkb/Sm4I/nSX32cBv8ASW++v9KmkmjWN/8ARG6r/Oo75k2MfsrZ3r/SgBx+znd/pLfeFDJBuJ+0t9+l82PJBtm+8Ke0kO5v9Gb79AFCzWDn/SG/1hqR4oTIp+1MRk0WcqbWItWP7w1ajnjJXNm2MmglmaI4De2/+kN0P86vbIGQAXLZwaiaaJL63xaN0P8AOrQmj2qfsrdDQIp3CQC2fNy3+rqW3jg8kf6SfuCi7ljFs/8Aoh/1dLDKn2cYtW+7QWSNHb/Nm5bO1f6VWh8gXVwPtB6irIlTJzat0X+lQQzR/a7n/RDwRQLcfJ5G58XLfeFQ3UcPmQn7Sf8AWVZ8yJtxNow+YVHeSRCSEfZW/wBZQBKnkbcfaD96mMtv5f8Ax8N/F/WpBJGqqfsrfeoaSLB/0Vv4v60AyvYpbmFP9JbvUu23AB+0t900ljNCLdP9EbvUhuIjj/RG+6aCSqog+2HNy3+rqxi3Cti6b7vvUKzQi8/49W/1dWWniO7Fo33aBplS+SDyWP2ljyv9Km8u38s/6Q3akvpI/IP+it1X+lP+0RbSBat2oKBo7Yk/6S336r2ccC7h9pb/AFnvVpposn/RGHzVWtbiM7v9Fb/WUAWFjt2x/pLfeNV5Y4BcW/8ApLd/51ZWaPgfZG+8agmmj+0W5+yt3oAseXb7V/0lu9VruOD7K/8ApJ+4asi4j2r/AKK3eoLqRDA2bVv9WaAEt47cWqf6U33akC25z/pLfdFJayR/ZV/0Rvu1M0ka5xasPlH9KAKcSQfabj/SG7VOyQc/6U3UVDFcL9quP9Fbt29qn81Nxzat1FAFW8WH7ZAPPJG+rYW38wf6Q33veoLuZBdwj7K336teajOB9mY/NQBGy2+3P2lsfNUditssKf6S3Oammmj8vm2b+KobG4i+zxgWrHrQA9Y7dtv+kt0PrULQwG7yLlvuVZWZDgi0YfKagEi/av8Aj2b7lAErR2/zZuW+7UF9Hb+TkXDY+X19qsyTRqrD7Kx+Wq99OrRY+ysPu/0oAm8q3WMn7S2OKeFtzu/0k/epkkyeX/x6t2p/nRgNi1P3qAKdmtv50mblv9ZVpkt95/0hvv1Xs5I/MkP2Zv8AWVa8yJmP+jN9+gCneLb+ZD/pLfeNWIUt8oPtLdfU1DeSR+bD/orffNWIZI9y/wCit1oFYZLHbbf+Plvumo7VLbyU/wBJP3anmljEf/Hq33DUVnNF9nX/AEVj8tAMkVLY5xdN9yoAtv8AapMXB+6KtJNErc2jcpVZZoRfS/6M33RQQSlbYLJm4Paq999mMkY+0tjeKtyTREP/AKK3QVVv5I90Z+yt98UAWttscj7Sx+akZbcL/wAfLYDGl86FV4tGzup0k0PlnNo33jQMpWQtpFVvOyQ55/GripbbVP2k55qnp08Qj/49G++f51bjmj+X/RG70FlRvs32yMfaTylWSlvx/pB+7UDSRfbIv9Fb/V1bSWHI/wBFb7tAFO6WDyX/ANIP3B/SpkjtvJybhvuimXTp5Un+iN9wfzFSLNH9n5tGHAoAc32ePcBOTyKqQeT50xE5+/VppI2Z/wDRW7VBayR+dN/orf6ygCdUgzn7QfvVWulgaSDM5++39ateam7/AI9WxvqteSIs1v8A6K2N7f1oAnt44Pk/0gjk10GkqBZJg5GetYEM0Y2ZtW61v6SwNkhA2+1NDRm+IftAuEFtjO05yay9urYj+ZPu+tbeuxqzKSOenWsnyx5Z68D1NUBFeLqy2lwSyY8v1FLH/awijO5OY/WmtGHjkUliCvPzGljjHloPmwB/eNKwD2j1Ysp3oPk9aizqq6hMNyfcHepmjHPLdP7xpnkrukbnOMZ3GiwBMurNGw3IOV7+9N1BdUWJsyJw69/pTjGNvft/EaWaJWjOcn5h/EaLFWDy9U5Ysh5HensNTyfmT7/rTGQfMOcfU0qxg569c/eNFgsV7OPVNjYdAfMPerMK6thcvH949/rTY4UCkjI5/vGmhB6t1/vGiwWIJF1b7bbndH0Pf3q2qat8g3p0PeoGjXch5z/vGrYjXYD82cf3jRYViref2t9lk+ZP9X60+3XVfsw5T7vrSyQq0Zzk/L/eNO2BVUAsBt/vGiw7INurDcdydF7/AEqvCuqtc3PzIDkd6sMox1bt/EaiWNfNfryf7xosFkSmPV/n+ePG4d6hvE1XzIRuXPmetSMuM4Ldf7xpCgaNSSSd/qaLBYeserFQNycN60OurFPvJ/F3+tMx+8blv++jUioGh5Ld/wCI0WIa1K1kurLbp8yY571MseqsoYsn3T3ohjVVAGcf7xp8sYyg+bGP7xosKyKpGqfbPvJnZ61aZNX+b5kHy+tQCJftGec4x941YI+bGW6eposOyK1+dWW3Y5Q8r3+lSquq7S25B070+aJWTByRx3NJ5a7iOf8Avo0WGKV1SQuSycN61BZrqe1vmQnzPUU5kCyHBbr/AHjQsaqoIyMtnqaLDsTbdWOMFOGPeoJF1X7RANyZwe/vUmPduv8AeNNkjXzEPzZH+0aLDsSKuq7R8yd+9QXK6r9nJ3x/c9akVegy3/fRps0amEg5xj1NFhWCFNVWBDvj+761I/8Aa7Z+ZPujvRBGvkr16epppUfNy3T1NITILcau11cfMh6d6sY1ZXOWTqO9MtY13Oecnr8xqz5a8nnP+8aQtSjenVPtkA3JnzPWrKpqsbg70+960xoVZ0JySDkcmnPGPVuv940BqEg1RkPzR4+bvUFj/aq26cpyT3qURjbjLY5/iNFvCq4AyBz/ABGi4ajsatwNyAbT3quq6v8Aa/vJ9z1qyV6ct6feNRmMC4B+bOP7xoFqPl/tdQ/zR/d9arXg1dod2Ux8vf6VZkQFTkt0/vGo/LDKQckcfxGgNQkGrBeWTt3qUrqu1vmj+961H5YLYO7H+8aey/NjLdfU0DK9j/arNJ8yA+Z61bYaqpb5kPz+tQW0aqz4yPmz1NTFfc9fU0AVrpNVaSH505c96sQx6qpUl06+tNmiU7Cc9fU04xgFMbuv940AMnGqFc7kxtPem2cWq/Z0O6P7vrT5IxtYc4x6mkijCwrjI49TQA/ydWZjh0xs9ap+Xq39oSDcn3R3q6q/N1bp6mo/KXznbndjrk0CsOli1YbxuTkDvVe+TVVaIbk++O9XCg8s8t0/vGoJo1Zkzk856mgLIkaLVsgbk+960jR6sFZdyfePelZfmHLdfU03b8x5br/eNAWRVsBqvl/eT757+9XIRqxKDcnQ96jihRV4yOf7xqRUAxgt0/vGgZTZdXW8j+ZPuetXFXV1UNmPG31FQ+WGwxzkDg7jUqqNoGWxj+8aAI7xtXW3YlkxsHf3FLHHqrW7Eun3R3p88SsuDkjA/iNPaJRCAM+nU0ARmPUxuIkTqO9V7ZdV86b50Pz+tWmiXnr27mmxQqryYyMnPU0AHl6t13J9/wBaiuV1XdBl4/vnv9alReerfe/vGnzQo3l5ycH1NAxIl1X5eYzz6iug0jf9hTzCN/esERqrADP/AH0a6LTVC2aADiqA/9k="><b></b></p></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Wolff-Parkinson white syndrome</li><li>2. Atrial flutter</li><li>3. Atrial fibrillation</li><li>4. Sinus arrhythmia</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul><li>The given ECG is suggestive of sinus arrhythmia.</li><li>In sinus arrhythmia, there will be a cyclical alteration of the heart rate (as depicted in the given image), especially during respiration.</li><li>There will be an increased heart rate during inspiration and will be decreased during expiration (respiratory sinus arrhythmia).</li><li>The presence of sinus arrhythmia can be a normal phenomenon, commonly seen in children.</li><li>There won&#8217;t be any specific treatment required for sinus arrhythmia.</li><li>The sinus rate will be altered- increased (sinus tachycardia) or decreased (sinus bradycardia).</li></ul><p><b>Other options:</b></p><ul><li><b>Option A:</b><span> In Wolff-Parkinson-White (WPW) syndrome, there will be short PR interval in the ECG and the QRS complex will be prolonged (wide QRS complex).</span></li><li><b>Option B:</b> In atrial flutter, there will be narrow complex tachycardia in the ECG and saw-tooth pattern can be seen in the leads II, III and aVF.</li><li><b>Option C:</b> In atrial fibrillation, there will be an irregularly irregular cardiac rhythm, P waves will be absent and fibrillatory waves can be present.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 88</h3>
                <p><b>A 76-year-old female patient presents with a hemoglobin (Hb) level of 7.3 g/dL (73 g/L) and shows signs of ataxia and confusion upon admission to the hospital. What should be the nurse’s primary intervention for this patient?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Create a darkened, quiet environment.</li><li>2. Allow family members to stay with the patient.</li><li>3. Ensure that the top bedside rails are raised and the call bell is within easy reach.</li><li>4. Inquire about possible causes of the patient’s anemia.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option a.</b> Create a darkened, quiet environment: While providing a quiet and darkened room can aid in the patient’s comfort and rest, it does not address the immediate safety risks associated with her confusion and ataxia. The primary concern should be preventing falls or injuries that could occur due to her impaired state. Therefore, this intervention is not a priority in this scenario.</li><li><b>Option b. Allow family members to stay with the patient:</b> Having family members present can offer emotional support, but it does not resolve the safety concerns related to the patient’s current condition. The nurse must take responsibility for implementing safety measures that will protect the patient from potential harm due to her confusion and lack of coordination, making this option secondary to immediate nursing interventions.</li><li><b>Option c. Ensure that the top bedside rails are raised and the call bell is within easy reach:</b> This is the most appropriate nursing intervention because it prioritizes the patient’s safety. Given the patient’s ataxia and confusion, she is at an increased risk for falls. By raising the bedside rails and ensuring that the call bell is accessible, the nurse can help prevent potential injuries and enable the patient to call for assistance when needed. This action directly addresses the safety concerns that arise from her symptoms.</li><li><b>Option d. Inquire about possible causes of the patient’s anemia:</b>While it is essential to understand the underlying cause of the patient’s anemia, this question does not address the immediate risks posed by her current state of confusion and ataxia. The patient may be unable to provide accurate or reliable information due to her condition, making this intervention less effective in the short term. Ensuring patient safety takes precedence over exploring the causes of her anemia at this moment.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 89</h3>
                <p><b>A 45-year-old patient presents with symptoms such as joint pain (arthralgia), impotence, weight loss, and liver enlargement. Laboratory tests reveal elevated serum iron, total iron binding capacity (TIBC), and serum ferritin levels. Which condition does this presentation indicate, and what is the appropriate treatment?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Thalassemia; Combination chemotherapy</li><li>2. Hemochromatosis; Deferoxamine</li><li>3. Myelodysplastic syndrome; Filgrastim</li><li>4. Delayed transfusion reaction; Deferasirox</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li>Option a. Thalassemia; combination chemotherapy:</b></li><li>Thalassemia is an inherited blood disorder characterized by reduced production of hemoglobin, leading to anemia. Common symptoms include fatigue, pallor, weakness, and jaundice. While joint pain may occur in thalassemia patients, the specific combination of symptoms such as impotence, weight loss, and liver enlargement does not align with typical presentations of thalassemia. The treatment for thalassemia usually involves blood transfusions and chelation therapy to manage iron overload, not combination chemotherapy. Thus, this option is incorrect.</li><li><b>Option b. Hemochromatosis; Deferoxamine:</b> The patient’s symptoms—arthralgia, impotence, weight loss, and liver enlargement—combined with laboratory findings of elevated serum iron, TIBC, and ferritin levels strongly indicate hemochromatosis. This condition is characterized by excessive iron accumulation in the body, which can lead to damage in various organs, particularly the liver. Deferoxamine is an iron-chelating agent that helps remove excess iron from the body, making this option the correct choice for treatment.</li><li><b>Option c. Myelodysplastic syndrome; filgrastim:</b> Myelodysplastic syndrome (MDS) encompasses a group of disorders resulting from dysfunctional blood cell production, leading to various symptoms, including fatigue, frequent infections, and bleeding tendencies. However, the symptoms described in this case—particularly the combination of arthralgia, impotence, and liver enlargement—do not typically present in MDS. Filgrastim is used to stimulate white blood cell production, especially in cases of neutropenia, and does not address the conditions or lab findings in this scenario. Therefore, this option is incorrect.</li><li><b>Option d. Delayed transfusion reaction; deferasirox:</b> A delayed transfusion reaction occurs when a patient’s immune system responds adversely to transfused blood, typically manifesting symptoms like fever, rash, or jaundice. The symptoms of arthralgia, impotence, weight loss, and liver enlargement do not align with a transfusion reaction. Deferasirox is also an iron chelator, used primarily for managing chronic iron overload after repeated blood transfusions, but it is not relevant in the context of a delayed transfusion reaction. Hence, this option is also incorrect.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 90</h3>
                <p><b>A patient has presented with features of cardiac tamponade. Which of the following is a true finding?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Pulsus Paradoxus is always present</li><li>2. Kussmaul sign is always present</li><li>3. Tall A wave is present</li><li>4. Jugular veins column is visibly distended</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><li>In cardiac tamponade, there can be an acute cardiac failure due to the compression effects of massive pericardial effusion.</li><li>In these patients, there can be hypotension, tachycardia and markedly elevated jugular venous pressure (JVP).</li><li>The elevated jugular venous pressure in these patients can clinically manifest with distended jugular veins, which is very commonly seen in patients with cardiac tamponade.</li><p><b>Other options:</b></p><ul><li><b>Options A and B:</b><span> The pulsus paradoxus (increased fall in the pulse during the inspiration) and Kussmaul&#8217;s sign (paradoxical rise in jugular venous pressure during the inspiration) can also be seen in cardiac tamponade (not always present).</span></li><li><b>Option C:</b> The &#8216;a&#8217; wave in the jugular venous pressure (JVP) will be caused by the atrial systole and large &#8216;a&#8217; waves are seen in conditions like tricuspid stenosis.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 91</h3>
                <p><b>How does myelodysplastic syndrome (MDS) differ from acute leukemias?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. MDS has a slower disease progression.</li><li>2. MDS does not result in bone marrow failure.</li><li>3. MDS is a clonal disorder of hematopoietic cells.</li><li>4. MDS affects only the production and function of platelets and WBCs.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option b. MDS does not result in bone marrow failure:</b> This statement is inaccurate because myelodysplastic syndromes can indeed lead to bone marrow failure over time. In MDS, the bone marrow is often dysfunctional, producing inadequate and ineffective blood cells, which can ultimately result in decreased bone marrow function and failure. While MDS may allow for some degree of blood cell production for a time, it can progress to significant marrow dysfunction.</li><li><b>Option c. MDS is a clonal disorder of hematopoietic cells:</b> While this statement is true, it does not distinguish MDS from acute leukemias. Both MDS and acute leukemias are clonal disorders arising from hematopoietic stem cells in the bone marrow. Thus, this characteristic does not provide a difference between the two conditions, making this option incorrect in the context of the question.</li><li><b>Option d. MDS affects only the production and function of platelets and WBCs:</b> This statement is misleading as MDS can affect all three major blood cell lines: red blood cells (RBCs), white blood cells (WBCs), and platelets. Patients with MDS may experience anemia (due to ineffective RBC production), leukopenia (reduced WBCs leading to increased infection risk), and thrombocytopenia (low platelet count, increasing bleeding risk). Therefore, it is incorrect to claim that MDS only affects platelets and WBCs.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 92</h3>
                <p><b>A patient experiencing thrombocytopenia with active bleeding is scheduled to receive two units of platelets. What action should the nurse take to properly administer the platelets?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Check for ABO compatibility.</li><li>2. Agitate the bag periodically during the transfusion.</li><li>3. Take vital signs every 15 minutes during the procedure.</li><li>4. Refrigerate the second unit until the first unit has transfused.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option a. Check for ABO compatibility:</b> This choice is incorrect because platelets carry a minimal risk of hemolytic transfusion reactions due to the absence of A, B, or Rh antibodies in platelet products. While it is a good practice to match blood types for transfusions, it is not essential for platelet transfusions as it is for red blood cell transfusions. Thus, checking for ABO compatibility is not a required step for administering platelets.</li><li><b>Option b. Agitate the bag periodically during the transfusion:</b> This is the correct choice. Platelets can adhere to the sides of the storage bag, and gently agitating the bag helps to re-suspend them, ensuring that the patient receives the full therapeutic dose. This practice is crucial for maximizing the effectiveness of the platelet transfusion.</li><li><b>Option c. Take vital signs every 15 minutes during the procedure:</b> This option is misleading. While monitoring vital signs is important, it is typically only necessary to check them before starting the transfusion and to remain with the patient during the first 15 minutes to observe for any immediate adverse reactions. Taking vital signs every 15 minutes throughout the entire transfusion process is not standard practice and may not be necessary unless there are specific concerns.</li><li><b>Option d. Refrigerate the second unit until the first unit has transfused:</b> This choice is incorrect because platelets are stored at room temperature, and refrigerating them can negatively affect their function and viability. The second unit should remain at room temperature and can be prepared for administration once the first unit has been transfused.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 93</h3>
                <p><b>A 55-year-old woman with acute coronary syndrome is receiving unfractionated heparin (UFH) as an anticoagulant. She experiences sudden severe bleeding. What is the recommended reversal agent for UFH?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Protamine sulfate</li><li>2. Fresh frozen plasma (FFP)</li><li>3. Vitamin K</li><li>4. Activated charcoal</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Protamine sulfate is the recommended reversal agent for unfractionated heparin (UFH) in cases of severe bleeding. </li><li>Protamine sulfate is a positively charged molecule that binds to heparin, a negatively charged anticoagulant, forming a stable complex. </li><li>This complex helps neutralize the anticoagulant effects of heparin by preventing further anticoagulant activity.</li></ul><p><b>Other options:</b><ul><li><b>Option B:</b> Fresh Frozen Plasma contains clotting factors and is used for the reversal of warfarin, not UFH.</li><li><b>Option C:</b> Vitamin K is used as a reversal agent for warfarin, not UFH.</li><li><b>Option D:</b> Activated charcoal is used to absorb toxins and prevent their absorption from the gastrointestinal tract. It is not a reversal agent for anticoagulants.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 94</h3>
                <p><b>What does the nursing responsibility in the management of a patient with hypertensive urgency often include?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Monitoring hourly urine output for drug effectiveness.</li><li>2. Titrating IV drug dosages based on blood pressure measurements every 2 to 3 minutes.</li><li>3. Providing continuous electrocardiographic (ECG) monitoring to detect side effects of the drugs.</li><li>4. Instructing the patient to follow up with a healthcare professional within 24 hours after outpatient treatment.</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Monitoring hourly urine output for drug effectiveness:</b> While monitoring urine output can be important in managing hypertension, it is not typically necessary in cases of hypertensive urgency. This approach is more relevant in hypertensive emergencies where there may be renal impairment or fluid overload. For hypertensive urgency treated on an outpatient basis, this is not a standard nursing responsibility.</li><li><b>Titrating IV drug dosages based on blood pressure measurements every 2 to 3 minutes:</b> Titrating IV drug dosages is primarily associated with hypertensive emergencies where rapid blood pressure control is necessary. In hypertensive urgency, oral medications are usually administered, and close monitoring does not require such frequent adjustments. This option is incorrect as it reflects the management of a more severe condition.</li><li><b>Providing continuous electrocardiographic (ECG) monitoring to detect side effects of the drug:</b> Continuous ECG monitoring is essential in hypertensive emergencies, especially when patients are at risk for arrhythmias or myocardial ischemia. However, for hypertensive urgency, patients are often treated in an outpatient setting where continuous monitoring is not required, making this option not applicable for the management of hypertensive urgency.</li><li><b>Instructing the patient to follow up with a healthcare professional within 24 hours after outpatient treatment:</b> This is the correct answer. After treatment for hypertensive urgency, it is crucial for the patient to follow up with a healthcare professional within 24 hours to assess the effectiveness of the treatment and make any necessary adjustments. This follow-up helps ensure that blood pressure is adequately controlled and reduces the risk of complications.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 95</h3>
                <p><b>The nurse is encouraging a sedentary patient with significant risks for coronary artery disease (CAD) to engage in regular physical exercise. In addition to decreasing the risk factor of physical inactivity, the nurse informs the patient that exercise will also directly contribute to reducing which of the following risk factors?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Hyperlipidemia and obesity</li><li>2. Diabetes mellitus and hypertension</li><li>3. Elevated serum lipids and a stressful lifestyle</li><li>4. Hypertension and elevated serum homocysteine</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option a) Hyperlipidemia and obesity:</b> Regular exercise is effective in managing weight and reducing obesity, as it helps burn calories and improve metabolic processes. Additionally, exercise enhances lipid metabolism, leading to increased levels of high-density lipoprotein (HDL) cholesterol, which is beneficial in lowering overall cholesterol levels. This directly contributes to a reduced risk of coronary artery disease.</li><li><b>Option b) Diabetes mellitus and hypertension:</b> While regular physical activity can help manage blood sugar levels and improve insulin sensitivity, which benefits individuals with diabetes, the primary direct effects of exercise focus on hyperlipidemia and obesity. Although exercise can indirectly aid in controlling hypertension, its direct contribution is more significant for lipid profiles and weight management.</li><li><b>Option c) Elevated serum lipids and a stressful lifestyle:</b> Exercise can help reduce elevated serum lipids by promoting better lipid metabolism. However, the phrase “stressful lifestyle” is too vague and does not directly correlate to a measurable risk factor in the same way that obesity and hyperlipidemia do. While exercise can also alleviate stress, the primary direct effects of exercise on CAD risk are more specifically linked to managing obesity and lipids.</li><li><b>Option d) Hypertension and elevated serum homocysteine:</b> Although regular exercise can contribute to lowering blood pressure (hypertension) and may have some effect on serum homocysteine levels, the direct impact of exercise is primarily on hyperlipidemia and obesity. Elevated serum homocysteine is often addressed through dietary changes rather than exercise alone, making this option less relevant.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 96</h3>
                <p><b>A 55-year-old female admitted in the coronary care unit due to an anterior wall myocardial infarction 24 hours ago starts complaining of lightheadedness and weakness. A 12 lead ECG is done which shows prolonged PR intervals and few P waves are not conducted. Her heart rate is 29 beats per minute and blood pressure is 85/60 mmHg. Which of the following will be the best choice of treatment for this patient?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Adenosine 6 mg</li><li>2. Temporary pacemaker</li><li>3. Synchronized cardioversion</li><li>4. Atropine 6 mg</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>AV heart block is a known complication of myocardial infarction and the patient’s ECG combined with bradycardia, points towards a diagnosis of Second Degree Atrioventricular heart block. </li><li>Heart block and bradycardia in unstable patients warrants active intervention. </li><li>Asystole may ensue and a temporary pacemaker should be inserted promptly. </li><li>Temporary pacing can provide effective rhythm pacing in the short term. </li><li>Further evaluation may indicate the need for a permanent pacemaker depending on the degree of ventricular damage.</li></ul><p><b>Other options:</b><ul><li><b>Option A:</b> Adenosine is used to treat Supraventricular tachycardia.</li><li><b>Option C:</b> Synchronized cardioversion is used to treat patients with unstable tachycardia.</li><li><b>Option D:</b> Atropine dose should not exceed 3 mg and while it may prove useful in treating bradycardia, temporary pacing is usually more effective.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 97</h3>
                <p><b>A patient is admitted to the hospital for evaluation of chest pain and shows no abnormal serum cardiac markers 4 hours after the onset of pain. Which non-invasive diagnostic test can help differentiate angina from other types of chest pain?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 12-lead ECG</li><li>2. Exercise stress test</li><li>3. Coronary angiogram</li><li>4. Transesophageal echocardiogram</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option a) 12-lead ECG:</b> A 12-lead ECG is essential for initial assessment and can identify abnormal heart rhythms and ischemic changes. However, a single ECG may not provide conclusive evidence of coronary artery disease (CAD) since it can show normal results even in patients with CAD. Therefore, while useful, it cannot differentiate between angina and other causes of chest pain effectively on its own.</li><li><b>Option b) Exercise stress test:</b> The exercise stress test is a non-invasive procedure that evaluates how the heart responds to increased physical activity. It can reveal ECG changes indicative of impaired coronary circulation when the heart’s oxygen demand is elevated. This makes it a valuable tool for differentiating angina, which typically causes chest pain during exertion due to coronary artery blockage, from other types of chest pain that may not show changes during exercise.</li><li><b>Option c) Coronary angiogram:</b> A coronary angiogram is an invasive diagnostic procedure that visualizes the coronary arteries to identify any narrowing or blockages. While it can provide detailed information about the coronary anatomy and confirm CAD, it is not suitable as a first-line non-invasive test for differentiating angina from other types of chest pain. It also carries risks associated with invasive procedures.</li><li><b>Option d) Transesophageal echocardiogram:</b> A Transesophageal echocardiogram (TEE) is a specialized ultrasound procedure used to obtain detailed images of the heart and its structures. Although it can help identify certain cardiac abnormalities, including issues with heart valves or thrombi, it is not primarily used to assess for CAD or differentiate angina from other types of chest pain. Additionally, it is more invasive than other non-invasive tests.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 98</h3>
                <p><b>The evaluation team for cardiac transplantation is assessing patients. Which patient is most likely to receive the greatest benefit from a new heart?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. A 24-year-old man with Down syndrome who has received excellent care from parents in their 60s</li><li>2. A 46-year-old single woman with a limited support system who has alcohol-induced cardiomyopathy</li><li>3. A 60-year-old man with inoperable coronary artery disease who has not complied with lifestyle changes and rehabilitation programs</li><li>4. A 52-year-old woman with end-stage coronary artery disease who has limited financial resources but is emotionally stable and has strong social support</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Option a) A 24-year-old man with Down syndrome who has received excellent care from parents in their 60s:</b> While this patient has received excellent care, the presence of Down syndrome may complicate his overall health and prognosis. Cardiac transplantation is typically reserved for patients whose overall medical and psychological conditions allow for successful recovery and adherence to complex postoperative care. The patient’s developmental and cognitive challenges may hinder his ability to comply with the rigorous management required after transplantation.</li><li><b>Option b) A 46-year-old single woman with a limited support system who has alcohol-induced cardiomyopathy:</b> Alcohol-induced cardiomyopathy is often associated with a history of substance abuse, which can be a contraindication for cardiac transplantation. Moreover, having a limited support system post-transplant can impact recovery, as patients require assistance with medication management, follow-up appointments, and lifestyle changes. Therefore, this patient’s circumstances do not position her as an ideal candidate for transplantation.</li><li><b>Option c) A 60-year-old man with inoperable coronary artery disease who has not complied with lifestyle changes and rehabilitation programs:</b> This patient has not demonstrated compliance with previous treatment recommendations, which raises concerns about his ability to adhere to the complex postoperative regimen required after transplantation. Noncompliance with lifestyle modifications suggests a lack of motivation or ability to engage in self-care, making this patient a less favorable candidate for transplantation.</li><li><b>Option d) A 52-year-old woman with end-stage coronary artery disease who has limited financial resources but is emotionally stable and has strong social support:</b> This patient represents the ideal candidate for cardiac transplantation. Despite her limited financial resources, her emotional stability and strong social support are critical factors that can facilitate a successful recovery. Support from family and friends is essential for adhering to medication regimens and attending follow-up appointments. Additionally, she has no contraindications for transplantation, which increases her chances of benefiting significantly from a new heart.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 99</h3>
                <p><b>A patient admitted to the hospital with myocardial infarction develops severe pulmonary edema. Which of the following symptoms should the nurse expect the patient to exhibit?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Bradycardia</li><li>2. Slow, deep respirations</li><li>3. Air hunger</li><li>4. Stridor</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Patients with pulmonary edema experience air hunger, anxiety, and agitation.</li><li>Patients usually present with shortness of breath, which may be acute in onset (from minutes to hours) or gradual in onset occurring over hours to days, depending upon the etiology of pulmonary edema.</li><li>Tachypnea is usually present, with the patient gasping for breath. Dyspnea and tachypnea are usually present, and may be associated with the use of accessory muscles of respiration. After initial airway clearance, oxygenation assessment, and maintenance, management mainly depends upon presentation and should be tailored from patient to patient. </li><li>Respiration is fast and shallow and heart rate increases. </li><li>Tachycardia and hypotension may be present along with jugular venous distention. Auscultation of the heart helps to differentiate between the various causes of valvular lesions causing pulmonary edema.</li><li>Stridor is noisy breathing caused by laryngeal swelling or spasm and is not associated with pulmonary edema. Fine crackles are usually heard at the bases of lungs bilaterally, and progress apically as the edema worsens. Rhonchi and wheeze may also be presenting signs.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 100</h3>
                <p><b>Which of the following recurring conditions most commonly occurs in clients with cardiomyopathy?</p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Heart failure</li><li>2. DM</li><li>3. MI</li><li>4. Pericardial effusion</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Cardiomyopathy is a disease of the heart muscle that makes it harder for your heart to pump blood to the rest of your body. Cardiomyopathy can lead to heart failure. The main types of cardiomyopathy include dilated, hypertrophic and restrictive cardiomyopathy. </li><li>Because the structure and function of the heart muscle is affected, heart failure most commonly occurs in clients with cardiomyopathy. Heart failure can occur when the heart muscle is weak (systolic failure) or when it is stiff and unable to relax normally (diastolic failure). Cardiomyopathy, which means “disease of the heart muscle”, is one of many causes of heart failure. </li><li>Type 1 and type 2 diabetic patients are at increased risk of cardiomyopathy and heart failure is a major cause of death for these patients. Cardiomyopathy in diabetes is associated with a cluster of features including decreased diastolic compliance, interstitial fibrosis, and myocyte hypertrophy.</li><li>Myocardial infarction results from prolonged myocardial ischemia due to reduced blood flow through one of the coronary arteries.</li><li>Pericardial effusion is most predominant in clients with pericarditis. Pericardial effusion puts pressure on the heart, affecting the heart’s function. If untreated, it can lead to heart failure or death.</li></ul></div></div>
        <div class="credits">
            <p class="rainbow-text">Credit: Code Written by BHASKAR</p>
        </div>
        </body></html>